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All substances are poisons, 
there are none which is not a poison, 
only the dose permits something not to be poisonous. 
 
Paracelsus 
 
*** 
 
True happiness is not made in getting something.  
True happiness is becoming something.  
This can be done by being committed to lofty goals.  
We cannot become something without commitment. 
 
 Marvin J. Ashton 
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Abstract 
Carbon monoxide (CO) is commonly considered to be toxic due to the propensity of 
this gaseous molecule to bind to ferrous iron in haemoglobin and cytochromes, thereby 
inhibiting respiration and the transport of oxygen around the body. However, CO is 
produced endogenously by haem oxygenases and has various cytoprotective functions 
including being vasodilatory, anti-inflammatory and anti-apoptotic. The development of 
CO-RMs (Carbon Monoxide-Releasing Molecules), which are generally transition 
metal carbonyls that release CO under certain conditions, has facilitated research into 
the physiological effects of CO and the potential use of CO as a therapeutic agent. 
Furthermore, CO-RMs have been found to reduce significantly the viability of various 
Gram-positive and Gram-negative bacteria, which is thought to be caused in part by the 
binding of CO from CO-RMs to the terminal oxidases of aerobic respiratory chains. 
Interestingly, CO-RMs are known to elicit many effects distinct from those of CO gas, 
including acting as more potent bactericidal agents. 
 
This thesis aims to increase the current knowledge of the antibacterial effects of CO-
RMs, with a particular focus on the interactions with respiration, oxidases and thiol 
compounds. In contrast to CO gas, CORM-3 was not preferentially inhibitory to 
respiration at low oxygen tensions; however, in accordance with the relative resistance 
of cytochrome bd-I to CO gas, this oxidase was found to be the most resistant of E. coli 
to respiratory inhibition by CORM-3, and possession of this oxidase conferred some 
protection against growth inhibition in the presence of this CO-RM.  
 
Inhibition of E. coli respiration by CORM-3 was photosensitive and light reduced 
significantly the toxic effects of this compound, suggesting that CO from CORM-3 
binds to ferrous haems in a classical, light-sensitive manner. This supports the 
hypothesis that the binding of CO from CORM-3 to haemoproteins is largely 
responsible for killing by these compounds. However, in opposition to this hypothesis, 
the non-haem oxidase AOX from Vibrio fischeri was found to be hypersensitive to 
inhibition by CORM-3, but not to CO, emphasising the complex effects of these 
compounds. 
 
IV 
 
Data are presented to show that thiol-containing compounds, which have been widely 
reported to abolish the biological effects of CO-RMs, substantially reduce the uptake of 
ruthenium-containing CO-RMs. The generation of reactive oxygen species by CO-RMs 
is also demonstrated and investigated. 
 
Finally, the generation and preliminary characterisation of CO-RM-resistant E. coli 
mutants is described. This work was done with the aim of revealing previously 
unappreciated bacterial targets for CO-RMs. Sugar-transporting phosphotransferase 
systems were identified as a possible means of CO-RM entry into the bacterial cell. 
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Chapter 1 
 
Introduction 
 
1.1 Carbon Monoxide (CO)  
Carbon Monoxide (CO), a small, diatomic, gaseous molecule, is commonly considered 
to be a poison and an atmospheric pollutant. Natural sources of CO include 
photosynthesis and natural combustion such as forest fires and volcanoes, while a major 
source of anthropogenic CO is the partial oxidation of carbon containing compounds 
during energy generation from fossil fuels and the exhausts of internal combustion 
engines. CO inhalation causes approximately 170 deaths each year in the USA when 
gas appliances such as household boilers are used without adequate ventilation (U.S 
Consumer Product Safety Commission). CO also contributes to damaging ozone 
production by reacting with other pollutants, thereby reducing levels of atmospheric 
NO, which is then less effective at eliminating ozone (Assembly of Life Sceinces 
(U.S.). Committee on Medical and Biologic Effects of Environmental Pollutants, 1977). 
 
CO has a molecular weight of 28 and is relatively unreactive due to a stable triple bond 
between the two atoms and, consequently, has a high activation energy of 213 kJ mol-1. 
It is however, able to form complexes with some transition metals that have low 
oxidation states (Davidge et al., 2009a). Despite these complexes being stable due to the 
triple M-C≡O bond, this process renders the CO susceptible to hydroxide attack, and 
therefore more reactive than in the diatomic form. CO has a low boiling point (-191.5 
°C) and therefore exists as a gas at room temperature. 
 
1.1.1 Gasotransmitters 
Together with NO and H2S, CO is classified as a gasotransmitter (for more information 
see the following comprehensive reviews; (Kajimura et al., 2010; Kajimura et al., 2012; 
Li et al., 2009; Tinajero Trejo et al., 2013). These three molecules share many 
properties; they are all small, uncharged, membrane-permeable gases, and are highly 
toxic, primarily due to their interactions with metalloproteins and propensity to inhibit 
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respiration (Wikstrom et al., 1981), yet all are produced endogenously in small amounts 
by mammalian systems and play vital roles within the body. All three gases are 
regulators of the cardiovascular and nervous systems (Furchgott, 1999; Liu et al., 2011; 
Marks et al., 1991; Murad, 1999; Wang, 2003), and NO and CO also have important 
effects on the immune system. Indeed, the realisation that CO was more than just a toxic 
molecule (Marks et al., 1991) followed on from the initial appreciation of the vital 
beneficial activities of NO (Ryter et al., 2004), for which Murad (1999), Furchgott 
(1999) and Ignarro (1999) were awarded the Nobel Prize for Physiology or Medicine in 
1998. Each gasotransmitter is considered to have potential in a variety of therapeutic 
applications (Szabo, 2010). NO is an effective pulmonary vasodilator in patients with 
pulmonary hypertension (reviewed by(Griffiths and Evans, 2005) and decreases the risk 
of brain injury in premature infants with respiratory failure (Kinsella et al., 2006). H2S 
induces relaxation of blood vessels, inhibits inflammation, and modulates neuronal 
activity (Gadalla and Snyder, 2010). CO is an anti-inflammatory (Boczkowski et al., 
2006) and protective agent following organ transplants (Akamatsu et al., 2004) and of 
the cardiovascular system (Furchgott and Jothianandan, 1991) (see sections 1.1.2.5 and 
1.2.8.2). 
 
1.1.2 Historical use of CO as an experimental tool 
The history of the experimental use of CO to elucidate the cellular components 
responsible for respiration has been comprehensively reviewed by Keilin (1966). Early 
work investigating the interaction of CO with biological systems was conducted by 
Haldane and Smith (Keilin, 1966), who in 1896, showed that the binding of CO to 
haemoglobin was reversible by light. Critical work was also performed by Louis Soret, 
who obtained UV absorption spectra of dilute blood samples and found that treatment of 
these samples with CO caused a red shift in the spectra of these samples (Keilin, 1966). 
Soret’s pioneering work led to the designation of the γ-band of visible absorption 
spectra as the ‘Soret’ region. 
 
Inhibition of respiration in yeast was first noted by Warburg (reviewed by(Keilin, 
1966). Warburg concluded that the CO/O2 ratio was critical in determining the extent of 
respiratory inhibition caused by CO, thereby confirming that CO and O2 compete for 
the same respiratory protein. He further investigated the finding of Haldane and Smith 
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that inhibition of respiration by CO was photosensitive, a property shared by 
haemoglobin (Hb), which led to his realisation that the unidentified respiratory 
components and haemoglobin were related (reviewed by(Keilin, 1966). Warburg 
proceeded to develop photochemical action spectra, which involved examining the 
effects of light on respiration by yeast in the presence of CO, in order to further 
investigate the nature of the respiratory component (Keilin, 1966). 
 
Britton Chance (Chance et al., 1953) developed the work of Warburg and obtained 
photochemical action spectra of a variety of eukaryotic tissues and of prokaryotes, 
leading to a demonstration of the photodisociation of the CO-bound adduct of 
cytochrome a3, which in turn led to him identifying the oxidase of the mitochondrial 
respiratory chain. The use of action spectra to study the photorelief of inhibition of 
respiration by CO became an established assay to confirm the presence of terminal 
oxidases (Castor and Chance, 1959; Lemberg and Barrett, 1973). The relationship 
between cytochromes and aerobic respiration was further appreciated by Keilin (1966), 
who studied microorganisms sepctroscopically and found cytochromes to be present in 
aerobic yeast and the bacterium Bacillus subtilis, but not in the obligate anaerobe 
Clostridium sporogenes. 
 
1.1.3 CO in mammalian systems 
1.1.3.1 Toxicity of CO  
In mammalian systems, prolonged inhalation of CO leads to tissue hypoxia, as the 
preferential binding of CO to haemoglobin prevents the transport of O2 around the body 
(Goldbaum et al., 1975; Stewart, 1974). The toxic effects of CO inhalation depend on 
the relative CO and O2 tensions (Wu and Wang, 2005). The affinity of haemoglobin for 
CO is 200 – 250-fold higher than that of O2 (Rodkey et al., 1974); therefore upon 
inhalation, the majority of CO is sequestered by haemoglobin. Currently, the United 
States Occupational Health and Safety Administration (OSHA) has advocated a safe 
carbonmonoxyhaemoglobin (COHb) level of 8–10%, which is equivalent to exposure to 
50 parts per million (ppm) for 8 h. 
  
Hypoxia is most evident and detrimental in the brain and heart as these organs have a 
high requirement for oxygen. Symptoms of exposure to CO include headaches (which 
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typically begin when blood COHb levels reach 20%), dizziness and vomiting (typically 
experienced with COHb levels of 30%). Higher levels of COHb in the blood lead to 
collapse, convulsions (COHb of 40 – 50%), coma and death (COHb of 60 – 80%) 
(Roughton and Darling, 1944). However death has been reported at COHb levels of 30 
– 40%, while other individuals with more than 40% CO-bound Hb have shown no 
symptoms (Goldbaum et al., 1975). These discrepancies suggest that it is not the 
oxygen-carrying capacity of the blood, but rather, the dissolved CO level, that is critical 
in determining toxicity, as it is this free CO that is able to bind to other cellular targets 
such as respiratory cytochromes, a view shared by Chance et al. (1970). Indeed, when 
dogs inhaled 13% CO, they died within 15 min – 1 h and were found to have COHb 
levels of 54 – 90%, yet when dogs were bled to anaemia and then the blood replaced 
with blood from a donor dog with 80% COHb, the dogs were able to survive with 
COHb levels of 60% (Goldbaum et al., 1975).  
 
More recently, Alonso et al. (2003) presented further evidence that COHb levels are not 
sufficient to explain the toxicity of CO, and proposed that this involves both tissue 
hypoxia and direct cellular damage. In this work, mitochondria from muscle tissue were 
treated with 50, 100 and 500 ppm CO, which reduced cytochrome c oxidase activity by 
20, 42 and 55% respectively. However, the conclusion that CO is toxic due to binding 
to respiratory cytochromes was to some extent disputed by Coburn (1979), who 
reviewed data that suggests that CO tensions of more than 1000-times those that occur 
when HbCO is at 5 to 10% saturation only cause a slight reduction in oxygen uptake. 
Instead, he suggests that CO binding to myoglobin (Mb) in heart and skeletal muscle, is 
a major cause of toxicity, even at less than 5% HbCO saturation (Coburn, 1979). This is 
supported by recent evidence, which shows that exposure to chronic levels of CO can 
cause arteriosclerotic heart disease and cardiac hypertrophy (Wang, 2004). Other toxic 
effects of CO are caused by the interaction of CO with haem proteins including 
cytochrome P450, cytochrome c oxidase, catalase and myoglobin (Piantadosi, 2002).  
 
1.1.3.2 CO as an inhibitor of respiration  
The final step in aerobic respiration in mammalian systems, in which oxygen is reduced 
to water, is catalysed by cytochrome c oxidase. This enzyme contains haem and is 
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therefore susceptible to inhibition by CO, a compound that binds avidly to FeII in the 
ferrous form of haem (Cotton and Wilkinson, 1980). 
 
Haem consists of a porphyrin ring and a central iron ion. There are several different 
types of haem, each with variation in the functional groups attached to the main 
porphyrin ring. For example, c-type haems are very similar to b-type haems, but have 
cysteine SH-groups attached to the vinyl side chains, thus covalently binding haem to 
the apoprotein. This has no effect on the redox or catalytic properties of the haem, but in 
bacteria, c-type haems are only present in the periplasm, (Wood, 1983). Depending on 
the redox state of the iron, several small molecules, such as O2, NO, H2S, HCN-, can 
bind to this moiety. 
 
In general, high spin haem proteins are able to bind ligands, while low spin haems are 
involved in electron transfer (Collman et al., 1980). Cytochrome c oxidase has 4 redox 
centers that partake in the reduction of O2; CuA and CuB and haems a and a3. Electrons 
are transferred from ferrocytochrome to CuA, and then passed to haem a, and 
subsequently to the haem a3/CuB binuclear center, before finally being transferred to O2 
(Babcock and Wikstrom, 1992). Both O2 and CO are able to bind to this site only when 
both the iron and copper are in the reduced state. The site at which O2 is reduced to 
water, haem a3/CuB, is hydrophobic and therefore preferentially binds neutral species 
(or anions associated with a proton) (Rich et al., 1996). Figure 1.1 shows a 
diagrammatic representation of the redox centers of cytochrome c oxidase, and indicates 
the sites of binding of CO. 
 
A recent study on the effects of endogenous CO on mammalian respiration showed that 
treatment of HEK293 cells with 20 µM CO inhibits respiration by 40% in the presence 
of 20 µM O2, and that the degree of respiratory inhibition is greater at lower oxygen 
concentrations, consistent with competitive inhibition by this compound (D'Amico et 
al., 2006). Furthermore, mitochondrial oxygen uptake has been shown to be 
significantly reduced in kidneys after the endogenous production of CO was increased 
(Sandouka et al., 2005).  
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1.1.3.3 A comparison with other respiratory inhibitors  
CO is not unique as an inhibitor of respiratory oxidases. These enzymes are also 
inhibited by other small gaseous molecules, including NO, H2S and hydrogen cyanide. 
The roles of the first two as gasotransmitters are discussed above, here the mechanisms 
by which they inhibit cytochrome c oxidase will be compared, a subject that has 
recently been comprehensively reviewed by Cooper and Brown (2008). 
  
NO has more complex effects on cytochrome c oxidase than CO, as it is able to inhibit 
this enzyme by both competitive and non-competitive mechanisms (Cooper and Brown, 
2008) and is able to bind to both the reduced and oxidised enzyme. Non-competitive 
inhibition is mediated by the binding of NO to CuB in oxidised cytochrome c oxidase 
(Cooper et al., 1997) and results in the oxidation of NO to nitrite and the reduction of 
the enzyme (Torres et al., 2000). The inhibition of respiration by NO causes reduction 
of the components of the electron transport chain, which leads to formation of 
superoxide and hydrogen peroxide (H2O2), which can act as important signalling 
molecules, as described below (section 1.2.8.2.4). 
 
H2S also binds to and inhibits cytochrome c oxidase in a non-competitive manner and at 
more than one site, at reduced CuB and at oxidised haem a3 (Hill et al., 1984). As with 
NO, H2S can be oxidised by this enzyme (Petersen, 1977).  
 
Like CO, cyanide inhibits respiration by binding to the binuclear center of cytochrome c 
oxidase, but unlike CO, it binds to these components in their oxidised or reduced forms 
and in a non-competitive manner (Antonini and Brunori, 1971). It is thought that HCN 
inhibits a turnover intermediate (Mitchell et al., 1992). Cyanide-insensitive, terminal 
oxidases exist, such as alternative oxidase (AOX) present in plants and some bacteria, 
which is resistant to CN- due to an absence of haem (see Chapter 5) and the CIO  
(cyanide insensitive oxidase) subfamily of oxidases present in some species of bacteria 
(Matsushita, 1983). P. aeruginosa contains a CIO, which is homologous to cytochrome 
bd quinol oxidases, but does not contain haem d (Cunningham et al., 1997). This 
oxidase is induced upon entry into stationary phase (Cooper, 2003), during which HCN 
(at approximately 300 µM) is produced as one of many virulence factors (Blumer and 
Haas, 2000) and is therefore proposed to be involved in growth under cyanogenic 
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conditions (Cunningham et al., 1997; Cunningham and Williams, 1995) and in the 
pathogenicity of this bacterium (Gallagher and Manoil, 2001) as demonstrated in 
Caenorhabditis elegans (Zlosnik et al., 2006). 
 
1.1.3.4 Endogenous production of CO 
Despite the established perception of CO as a toxic gas, CO has more recently been 
recognised as an important biological molecule that is produced endogenously in both 
prokaryotes (Engel et al., 1972) and eukaryotes (Sjostrand, 1949) and which has many 
beneficial roles (see section 1.1.7 below). Sjostrand (1949), found that the 
decomposition of Hb led to the production of CO. Coburn et al. (1963) then showed that 
when a person breathes into a closed system, the amount of CO detected over time 
increases, which confirmed that CO is produced endogenously in humans, and that CO 
production by the body is substantially increased during conditions such as haemolysis, 
when the levels of free haem are raised.  
 
The enzyme required for the breakdown of haem, haem oxygenase (HO), was identified 
by Tenhunen et al. (1969). The breakdown of haem by HO requires molecular oxygen 
and NADPH. NADPH activates O2 and reduces FeIII in haem to FeII, which is necessary 
for the cleavage of haem. The breakdown of haem produces CO, FeII and biliverdin (a 
green pigment) (Tenhunen et al., 1969), which is later converted to bilirubuin (a yellow 
pigment) by biliverdin reductase; this process and the biological effects of the 
breakdown products are summarised in Figure 1.2. Haem breakdown can be visualised 
during bruising. Such an injury will initially appear purple / red as oxygenated haem is 
released under the skin. Haem oxygenase uses oxygen to break down haem, generating 
anaerobic conditions and therefore deoxy-haem, causing the bruise to appear blue. The 
formation of bilirubin will then lead to the bruise becoming yellow (Mann, 2012). 
 
Haem oxygenase exists in most mammalian species in both an inducible (HO-1) and a 
constitutive (HO-2) form (Tenhunen et al., 1969), although a third isoform, HO-3, has 
been found in rats. HO-3 is a less powerful enzyme than HO-1 or HO-2 and is thought 
to be involved in haem-sensing (McCoubrey et al., 1997). The degradation of haem is 
necessary in mammalian systems, as excess free haem is cytotoxic due to its oxidative 
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effect. Additionally, the products of haem breakdown, CO and bilirubin, have beneficial 
effects; bilirubin has antioxidant (Stocker et al., 1987) and anti-inflammatory properties 
(Sarady-Andrews et al., 2005), while CO is also anti-inflammatory and is involved in 
regulating the generation of cGMP, which has many important roles in the cell.  
 
The different isoforms of HO share some cellular defence functions, but also have 
distinct roles within the body. HO-2 is most abundant in the brain and testes, but is also 
constitutively expressed in other tissues, such as in endothelial tissues and the liver 
(Ewing and Maines, 1992). In the neuronal system, CO is an important signalling 
molecule that regulates neurotransmitters and neuropeptide release. HO-2 is also 
responsible for maintaining homeostatic haem levels within the cell, and has an 
important role in inactivating radicals derived from NO (Maines and Panahian, 2001).  
 
Induction of HO-1 protects ischemic kidneys against tissue damage by degrading 
oxidant-generating haem from denatured hemoproteins and converting it to bilirubin 
and CO. The production of cytoprotective compounds by HO-1 necessitates that its 
expression is up-regulated by various stimuli that cause cellular stress, such as 
hyperoxia, heat shock and bacterial endotoxins, as well as haem and haem derivatives 
(Sardana et al., 1981), including CO itself (Carraway et al., 2002). Induction of HO-1 
can comprise several different pathways including those involving cAMP (Durante et 
al., 1997), protein kinase C, Ca2+-calmodulin-dependent protein kinase and the 
phosphoinositol pathway (Terry et al., 1999). In some tissues, mitogen-activated protein 
kinases and the phosphorylation of tyrosine also play a role in the activation of HO-1 
(Elbirt et al., 1998). In contrast, there are conditions under which it is important to 
preserve haem by the down-regulation of HO-1 expression. This can occur in response 
to hypoxia (Nakayama et al., 2000) or interferon-γ (Takahashi et al., 1999) and can 
involve Bach1, a haem-regulated repressor (Sun et al., 2002). 
 
Although the majority of the CO produced endogenously is derived from the 
degradation of haem by haem oxygenase enzymes, some CO is also produced by the 
breakage of methylene bridges in haem by hydrogen peroxide or ascorbic acid (Bonnett 
and McDonagh, 1973), or by the inactivation of cytochrome P450, which also leads to 
haem breakdown (Karuzina et al., 1999). 
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1.1.3.5 The physiological functions of endogenous CO 
Contrary to the traditional view of CO as a toxic molecule, it is now known to have 
various cytoprotective functions such as acting as a neural messenger (Verma et al., 
1993) and having vasodilatory (Furchgott and Jothianandan, 1991), anti-inflammatory 
and anti-apoptotic properties (Boczkowski et al., 2006). Examples of studies that have 
furthered our understanding of the effects of CO in these systems are listed in Table 1.1. 
CO is also involved in the regulation of many other physiological systems including the 
reproductive system (Ewing and Maines, 1995; Middendorff et al., 2000), the renal 
system (Hill-Kapturczak et al., 2002) and the control of circadian rhythms in a process 
involving sGC (soluble guanylate cyclase), and cGMP (cyclic guanosine 
monophosphate) (Artinian et al., 2001), and through interaction with the NPAS2 
(neuronal PAS domain protein) transcription factor (Dioum et al., 2002). HO-1 
knockout mice have been important in increasing our understanding of the important 
roles that CO plays within the body and in particular the understanding that HO-1 is 
required for mammalian iron reutilization. Such mice have an embryonic survival rate 
of only 5%, and individuals that survive are extremely vulnerable to stress and do not 
have a normal life span (Poss and Tonegawa, 1997).  
 
The most abundant and obvious target for CO is ferrous iron in haem and cytochromes. 
However, CO exerts some of its biological effects via a variety of signalling pathways 
within the cell, although the precise mechanisms by which CO mediates its effects on 
targets that do not contain a transition metal are not well understood (Boczkowski et al., 
2006). Section 1.2.8.2 provides a more detailed explanation of the mechanisms by 
which CO interacts with biological targets in order to evoke these effects. 
 
Abnormalities in CO metabolism and function are associated with a range of 
pathological conditions such as hypertension, heart failure, inflammation and 
neurodegenerative disease (Wu and Wang, 2005). Elevated production of CO has been 
noted in inflammatory pulmonary diseases, including cystic fibrosis, asthma and 
infectious lung disease (Kharitonov and Barnes, 2002). The important role of HO-1 in 
human health was highlighted by a case of an individual who lacked the ability to 
produce HO-1. This person experienced growth retardation, anaemia, thrombocytosis, 
hyperlipidaemia and leukocytosis, as well as high levels of ferritin and haem in their 
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Biological 
effect 
Evidence Reference 
Vasorelaxation The relaxation of pulmonary blood vessels in response to 
exogenous CO (involving binding of CO to cytochrome P450). 
 
(Sylvester and 
McGowan, 
1978)  
 The relaxation of rat coronary arteries in response to CO. 
 
(McGrath and 
Smith, 1984) 
 Inhibition of HO activity by zinc protophorphyrin-IX increased 
vascular resistance by decreasing the production of CO. 
 
(Suematsu et al., 
1994) 
 CO causes vasorelaxation of vascular smooth muscle cells via the 
cGMP signalling pathway and by affecting the activity of calcium-
activated K (KCa) channels. 
(Wang et al., 
1997) 
 CO caused vasorelaxation of rabbit aorta by stimulation of sGC, but 
was 1000-fold less potent than NO at eliciting these effects. 
(Furchgott and 
Jothianandan, 
1991) 
 CO relaxes vascular tone in the heart, thereby improving cardiac 
blood supply. 
 
(Grilli et al., 
2003)  
Neuronal 
effects 
HO co-localises with NOS in the CNS leading to the suggestion 
that CO is an endogenous neuronal messenger. 
 
(Verma et al., 
1993) 
 CO modulates the HPA response. 
 
(Snyder et al., 
1998) 
 CO inhibits the secretion of oxytocin by the hypothalamus. (Kostoglou-
Athanassiou et 
al., 1996) 
Anti-
inflammatory 
effects 
Low concentrations of CO inhibit the expression of LPS-induced 
pro-inflammatory cytokines: TNF-α, IL-1β, and macrophage 
inflammatory protein-1β, and increase the LPS-induced expression 
of the anti-inflammatory cytokine IL-10 via activation of MAPK. 
(Otterbein et al., 
2000) 
 CO inhibits LPS-induced GM-CSF production in macrophages 
(GM-CSF is a cytokine generated in response to LPS, which 
promotes proliferation, maturation, and effector functions of 
leukocytes). It does this by preventing the activation of the 
transcription factor NF-κB, which regulates GM-CSF transcription, 
by preventing the phosphorylation and degradation of the 
regulatory subunit IκB-α. 
(Sarady et al., 
2002) 
Anti-apoptotic 
effects 
Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured 
fibroblasts and these effects are mimicked by the exogenous 
administration of low concentrations of CO. 
 
(Petrache et al., 
2000) 
 CO produced by HO-1 protects endothelial cells from TNF-alpha-
mediated apoptosis by activiating p38 MAPK. 
(Brouard et al., 
2002) 
 CO protects pancreatic beta-cells from apoptosis in a process 
involving sGC activation. 
(Gunther et al., 
2002) 
 
Table 1.1 The physiological effects of CO. This table summarises some of the key 
studies that have led to our appreciation of some of the main roles CO plays within the 
body.  
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serum and low levels of bilirubin, and sadly died aged 6 years (Ohta et al., 2000; Yachie 
et al., 1999). 
 
CO-based therapies are currently in the early stage of development, and include CO 
inhalation therapy, development of CO-RMs and induction of HO-1 to increase the 
production of endogenous CO (see section 1.2.8 below).  
 
1.1.4 CO in bacteria 
1.1.4.1 Bacterial haem oxygenases 
The production of CO by bacteria was first noted by Engel et al. (1972) who detected 
the generation of this gas by species of  Bacillus and Staphylococcus using gas 
chromatography. The first bacterial HO, HmuO from Corynebacterium diptheriae 
(Schmitt, 1997), was discovered because of its homology to human HO-1. Interestingly, 
there is relatively little sequence identity between bacterial HOs; however, important 
regions within the protein are conserved and these proteins often have the same overall 
fold with key ligands located with the same spatial relationship to the haem (Schuller et 
al., 2001; Zhu et al., 2000a). Bacterial HO genes are often confirmed by the inability of 
mutants in the gene to grow when haem or haemoglobin is the sole source of iron (for 
examples, see (Ratliff et al., 2001; Ridley et al., 2006; Schmitt, 1997). The ability to 
produce bilirubin is also indicative of HO-1 activity (Wegele et al., 2004; Zhu et al., 
2000b).  
 
Not all bacteria possess HOs; however, there does seem to be a higher incidence of this 
enzyme in pathogenic or haemolytic species (Davidge et al., 2009a). For example, 
Neisseria species have HemO (Zhu et al., 2000a), while Campylobacter jejuni has the 
HO Cj1613c (Ridley et al., 2006), which shares similarity with HugZ in Helicobacter 
pylori (Guo et al., 2008). In addition, the opportunistic pathogen Pseudomonas 
aeruginosa has two HOs: PigA, which has 37% similarity to HemO from Neisseria 
(Ratliff et al., 2001), and BhpO, which is a typical HO, but may also have a role in the 
production of phytochromes (Wegele et al., 2004). Other pathogenic species of Shigella 
and Enterobacter also have HOs. Further evidence to support this generalisation is the 
absence of HO in E. coli K12 strains, but the presence of the HO, ChuS, in the 
enterohemorregic strain 0157:H7 (Suits et al., 2005).  
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The proposed roles of HO in bacteria include iron acquisition, the production of 
chromophores and the establishment and maintenance of an anaerobic environment 
(reviewed by(Davidge et al., 2009a). With regards to the last, the HO HemT has been 
found in pathogenic species of Clostridium that colonise wounds in which 
anaerobiosisis is beneficial, but not in non-pathogenic Clostridium species 
(Bruggemann et al., 2004). The requirement of a functional HO for growth when haem 
is the only source of iron, for example during pathogenesis, has led to the identification 
of HOs as potential targets for antimicrobial therapy (Furci et al., 2007) (see section 
1.2.8 below). 
 
There is a second, seemingly smaller, group of bacterial HOs that do not resemble 
mammalian HOs. Examples have been found in Staphylococcus aureus, designated IsdI 
and IsdG (Skaar et al., 2004), Listeria monocytogenes (Wu et al., 2005) and Bacillus 
anthracis (Skaar et al., 2006) amongst others (Puri and O'Brian, 2006). Such HOs are 
regulated by iron and the utilisation of haem as a source of iron is a major role of these 
enzymes (Skaar et al., 2004; Skaar et al., 2006). 
 
1.1.4.2 Bacterial metabolism of CO  
Despite the propensity of CO to inhibit aerobic respiration, many bacteria, both aerobic 
and anaerobic, use CO as their main carbon and energy source (Ragsdale, 2004). Indeed 
the CO/CO2 pair has a favourably low redox potential of -524 to 558 mV 
(Oelgeschlager and Rother, 2008). As seen in equation (1), the oxidation of CO to CO2 
generates two protons and two electrons through the simultaneous reduction of water. 
 
CO + H2O → CO2 + 2H+ + 2e-       (1) 
 
The metabolism of CO by some bacterial species (known as carboxidotrophic bacteria) 
has been comprehensively reviewed (King and Weber, 2007; Oelgeschlager and Rother, 
2008; Ragsdale, 2004). This process requires a CO dehydrogenase (CODH) enzyme, 
the active site of which contains iron along with either nickel in anaerobic bacteria, or 
molybdenum in aerobic bacteria (reviewed by(Ragsdale and Kumar, 1996). 
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The ability of aerobic bacteria, such as Oligotropha carboxidovorans and Pseudomonas 
thermocarboxydovorans, to use CO relies on a CO-insensitive respiratory chain 
involving ubiquinone and cytochromes, such as cytochrome b561 in P. 
thermocarboxydovorans (Jacobitz and Meyer, 1989). Anaerobic bacteria that can utilize 
CO include sulfate reducers, acetogens and hydrogenogens (Oelgeschlager and Rother, 
2008). Many CO utilizing, sulfate reducers are thought to convert CO to CO2 in order to 
detoxify the CO as well as to produce reducing power (Sipma et al., 2006); however 
Desulfotomaculum carboxydivorans is remarkable in its ability to grow in 100% CO 
and in the absence of sulfate (Parshina et al., 2005). Acetogenic bacteria are obligate 
anaerobes, which use CO to form acetic acid and CO2, according to equation (2).  
 
4CO +2H2O → CH3COO- +2CO2 + H+      (2) 
 
This process provides a mechanism for autotrophic carbon assimilation (Oelgeschlager 
and Rother, 2008), and the formation of an ion motive force, which thereby allows ATP 
generation (Muller, 2003). 
 
Another group of anaerobic carboxidotrophs are the hydrogenogens (Svetlitchnyi et al., 
2001). These oxidise CO and concomitantly reduce protons from H2O to produce 
molecular hydrogen, as shown in equation (3).  
 
CO + H2O → CO2 + H2      (3) 
 
The best studied of this group, the facultative anaerobe Rhodospirillum rubrum, is able 
to generate energy by aerobic respiration, fermentation or photosynthesis depending on 
the oxygen tension of the surroundings. In the absence of both oxygen and light, R. 
rubrum can use CO as a terminal electron acceptor  (Kerby et al., 1995) using CO 
dehydrogenase (CooS), which deprotonates water at a Ni-Fe-S centre forming 
hydroxide which then attacks CO (Ragsdale and Kumar, 1996). A CO hydrogenase 
(CooH), with a CO-insensitive Ni/Fe center, then transfers the electrons produced to H+ 
to form molecular hydrogen (Bonam et al., 1989). This process translocates protons 
across the membrane, allowing the subsequent generation of ATP (Fox et al., 1996; 
Maness et al., 2005). The expression of the coo operon in this bacterium is regulated by 
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the haem-containing protein CooA, which senses CO as described below (Aono et al., 
1996). Carboxydothermus hydrogenoformans is another example of a bacterium that 
undergoes carboxidotrophic hydrogenogenesis, although it can also grow on other 
electron donors and acceptors. It is a strict anaerobe and is able to grow more rapidly on 
CO than many other species (Svetlitchnyi et al., 1991). 
 
1.1.4.3 Bacterial sensing of CO 
The two main types of bacterial CO sensors use haem in order to detect this gas. Such 
sensors are similar to the CRP/FNR transcription factors and globin coupled sensors 
(GCS) as they have a regulatory globin-like domain and a transducer domain (Thijs et 
al., 2007). CooA, from R. rubrum is a typical example of a haem-based CO sensor 
(Aono et al., 1996). It regulates the expression of CO-utilising genes (Shelver et al., 
1995), including the coo operon (Bonam et al., 1989). Mutants of cooA, which were 
devoid of haem, were found to be constitutively active (Youn et al., 2006). CooA is able 
to discriminate between CO and NO; although NO is able to bind to CooA, forming a 5-
coordinate NO-haem complex, this does not trigger the binding of this sensor to DNA 
(Reynolds et al., 2000). CO binds to CooA only when the haem is in the ferrous form, 
as the distal ligand is displaced when the iron is reduced, thereby allowing preferential 
binding of CO (Clark et al., 2007). The binding of CO to CooA forms a 6-coordinate 
complex (Aono, 2003; Aono et al., 1996; Aono et al., 1998; Shelver et al., 1997). This 
stabilises the CooA dimer, which allows the binding of DNA to a specific sequence of 
DNA (Roberts et al., 2001) and thus transcription of the CODH genes. Histidine at 
residue 77 is required for the CO-responsiveness of this sensor (Youn et al., 2006). 
Other haem-based CO sensors include the two component system FixLJ in Rhizobium 
meliloti (Gilles-Gonzalez et al., 1991; Rodgers and Lukat-Rodgers, 2005), RcoM from 
Burkholderia xenovorans (Kerby et al., 2008) and HemAT in B. subtilis (Hou et al., 
2000). In Mycobacterium tuberculosis, the haem-containing sensor kinases DosS and 
DosT are able to bind CO (Kumar et al., 2007), which induces the Dos regulon, thereby 
inducing dormancy in this organism (Kumar et al., 2008).  
 
In E. coli, the direct oxygen sensor, DOS, is also able to bind to CO, although the 
purpose of this binding is not understood (Delgado-Nixon et al., 2000) The Kd of DOS 
for oxygen is 340 µM, while that of CO is 3.1 µM (Taguchi et al., 2004). The haem 
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binding domain of DOS has 60% sequence similarity to the PAS (signal tranducing 
domain) of FixL, while the C-terminal domain is similar to phosphodiesterases 
(Delgado-Nixon et al., 2000). The ferrous form of DOS has phosphodiesterase activity, 
but this is inhibited by CO, NO and etazolate (Sasakura et al., 2002). 
 
1.2 Carbon Monoxide-Releasing Molecules (CO-RMs)  
1.2.1 An introduction to CO-RMs 
When the beneficial physiological roles of CO became apparent, it was realised that 
molecules that could release CO in a controlled, targeted manner would facilitate 
research into the physiological effects of CO, and could potentially have therapeutic 
applications (Motterlini et al., 2002). Such molecules would allow CO to be stored in a 
solid form and then solubilised to allow injection directly into target sites in the body, 
thereby avoiding the need to inhale CO for therapeutic purposes (see section 1.2.8.1). 
 
Initial proponents of this idea, Brian Mann and Roberto Motterlini, realised the potential 
of transition metal carbonyls as stable CO carriers; however those that were 
commercially available were insoluble in water, and many required photolysis in order 
to release the CO. These molecules were shown to have some striking vasoactive 
properties (Motterlini et al., 2002). However, in order to be therapeutically useful, CO-
RMs need to be non-toxic, be sufficiently water-soluble, pure and stable, and to release 
CO at an adequate rate (Davidge et al., 2009a). Table 1.2 Shows the structure of several 
commonly used CO-RMs and lists their properties, CO release mechanisms and some 
physiological effects. 
 
Common initial tests to identify potentially therapeutically useful CO-RMs are the 
ability to cause vasodilation in pre-contracted aortic rings (Clark et al., 2003; Motterlini 
et al., 2002; Motterlini et al., 2005b) and the ability to decrease levels of pro-
inflammatory markers in response to lipopolysaccharides (LPS) (Crook et al., 2011; 
Hewison et al., 2010; Sawle et al., 2005).  
 CO-RM 
CORM-1 
[Mn2(CO)10] 
CORM-2 
[Ru(CO)3Cl2]2 
CORM-3 
(Ru[CO]3Cl
(glycinate)) 
CORM-A1 
(Na2[H3BC
O2]) 
CORM-401 
[Mn(CO)4(S2
CNMeCH2C
O2H)] 
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1.2.2 Early CO-RMs 
1.2.2.1 CORM-1  
The first Carbon Monoxide-Releasing Molecule (CO-RM) to be investigated for 
biological effects was [Mn2(CO)10] (CORM-1) (Motterlini et al., 2002). CORM-1 was 
found to cause a reduction in vasoconstriction in rat hearts following photo-excitation, 
providing the first evidence of a pharmacological effect caused by CO from a transition 
metal carbonyl. These effects mimic those of the HO-1/CO pathway. However, CORM-
1 had many problems that made it less than ideal as a potential therapeutic; it was not 
water-soluble and required photolysis to trigger CO release. However, promisingly, low 
concentrations of this compound (100 µM) were not toxic to vascular smooth muscle 
cells over a period of 24 h. 
 
1.2.2.2 CORM-2 
The second CO-RM to be identified was tricarbonyldichlororuthenium (II) dimer 
[Ru(CO)3Cl2]2 (CORM-2) (Motterlini et al., 2002). Such ruthenium-based compounds 
were thought to have great potential as CO-RMs as many ligands can bind to this metal 
allowing manipulation of the CO release kinetics (Forresti et al., 2004). In contrast to 
CORM-1, CO release is not induced by photo-excitation, but spontaneously by 
substitution of the ruthenium coordinated CO for DMSO from the solvent. When 
dissolved in DMSO, the CORM-2 dimer immediately dissociates to form tri-carbonyl 
and di-carbonyl monomers (Motterlini et al., 2002). CO release occurs in the presence 
of dithionite-reduced myoglobin; each mole of [Ru(CO)3Cl2]2  releases 0.7 moles of CO 
with a half-life of approximately 1 min. Recent evidence suggests that sulfite species 
such as dithionite dramatically increase the release of CO from several CO-RMs 
including CORM-2 (see section 1.2.3.1 below) (McLean et al., 2012). CORM-2 is 
commercially available and by early 2012, approximately 150 papers had been 
published describing its biological effects (Mann, 2012).  
 
1.2.3 Water soluble CO-RMs 
1.2.3.1 CORM-3 
One disadvantage of the CO-RMs mentioned so far is their lack of solubility in water. 
This prompted Motterlini and colleagues to synthesise a range of water soluble CO-
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RMs, the most promising of which was tricarbonylchloro(glycinato)ruthenium(II), 
known as CORM-3 (Ru[CO]3Cl(glycinate)) (Clark et al., 2003). As mentioned above, 
ruthenium is particularly amenable to chemical modification as it can exist in many 
oxidation states. CORM-3 is derived from CORM-2, but with the addition of a glycine 
coordinated to the ruthenium. Glycine was chosen as an ideal ligand as it does not 
contain a chiral center and therefore avoids the formation of diastereomers (Mann, 
2012).  
 
When CORM-3 is dissolved in water, [HO]- groups attack the CO group forming an 
acidic solution of pH 2.5 – 3 (Davidge et al., 2009a). CORM-3 releases CO rapidly at 
physiological pH with each CORM-3 molecule releasing 1 molecule of CO, leaving 2 
carbonyl groups attached to the ruthenium moiety. Subsequently, the glycinate group 
becomes monodentate and is lost from the compound (Johnson et al., 2007).   
 
CORM-3 has a very complex solution chemistry, which makes it difficult to fully 
elucidate the mechanism of CO release (Davidge et al., 2009a). It was initially thought 
that electron-withdrawing ligands found endogenously in the cellular environment, such 
as thiol compounds or imidazole, combined with physiological pH, was sufficient to 
trigger CO release from CORM-3 (Alberto and Motterlini, 2007). In addition, the Cl- 
ligand of CORM-3 is very labile, and the exchange of this ligand for another in solution 
is thought to favour subsequent CO release (Davidge et al., 2009a). It was known that 
CO was released from CORM-3 in the presence of dithionite-reduced myoglobin, but 
no spontaneous CO release could be detected using a CO electrode. It was therefore 
assumed that CO release from such CO-RMs required an acceptor, such as reduced 
myoglobin in order to trigger CO release. However, a recent study by McLean and co-
workers (2012) has advanced our understanding of the mechanisms by which CO is 
released from such CO-RMs. It was found that reduced myoglobin alone was not 
sufficient to cause CO release from CORM-3, but that dithionite, a necessary 
component of the myoglobin assay used to detect CO release from CO-RMs, or other 
sulfite species, greatly facilitated CO release. Based on this new evidence, it is thought 
that in vivo, endogenous sulfite species, or other similar intracellular components, 
trigger CO release (McLean et al., 2012). This has implications for how CO release 
from CO-RMs is measured, as the myoglobin assay can only measure CO release in the 
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presence of dithionite. An alternative ‘haemoglobin assay’ has been proposed in which 
the spectroscopic changes that occur when oxy-ferrous haemoglobin (which is stable in 
the absence of dithionite) binds to CO are measured (McLean et al., 2012). It is of great 
importance for the future use of CO-RMs that intracellular CO release can be measured 
and understood.  
 
Another recent study investigated the effects of the interactions of proteins with 
CORM-3 on CO loss (Santos-Silva et al., 2011). The authors note that no CO is 
detected in the headspace of a closed vial of a solution of CORM-3 using a gas 
chromatography thermal conductivity detector (GC-TCD), which, in agreement with 
McLean et al. (2012), suggests that CO is not released spontaneously from CORM-3. 
They suggest instead that interactions between proteins and CORM-3 may cause the 
chloride ion, glycinate group and one CO group to be lost from this CO-RM. If correct, 
this has important implications for the use of CO-RMs as therapeutic agents, as it 
suggests that CO-RMs would become deactivated by plasma proteins before reaching 
their target site. An X-ray structure of hen egg white lysozyme soaked with CORM-3 
was obtained, and revealed that the remaining fragment of CORM-3 binds to the protein 
at three exposed sites by interacting with histidine and aspartate groups. A further study 
by this group investigated the CO release profile of CORM-3 and Ru(CO)3Cl2(1,3-
thiazole), which is structurally similar to CORM-3, and found that there was only 
marginal CO loss from this compound or CORM-3 in the presence of a range of serum 
proteins. They did however find that when lysozyme was soaked with Ru(CO)3Cl2(1,3-
thiazole), protein–Ru(CO)2 adducts were formed leading to the hypothesis that such 
CO-RMs deliver CO in vivo through the decay of their adducts with plasma proteins 
(Santos et al., 2012).  
 
1.2.3.2 CORM-A1 
CORM-A1, also known as sodium boranocarbonate (Na2[H3BCO2]), is a water-soluble 
CO-RM that does not contain a transition metal and loses CO by becoming protonated 
at physiological pH. CORM-A1 releases CO at a much slower rate than CORM-3, with 
a half-life of 21 min at pH 7.4; however, lower pH leads to faster CO release to 
myoglobin. Temperature also affects the rate of CO release from CORM-A1, with 
lower temperatures causing slower release. The slow CO-release rate may be beneficial 
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in allowing the CO to reach biological targets and to elicit long-acting effects, thereby 
mimicking endogenous CO produced by HO-1(Motterlini et al., 2005b).  
 
1.2.3.3  CORM-401 
Due to the potential difficulties of using ruthenium as a therapeutic agent, attention was 
turned to developing manganese-based CO-RMs. Of these, CORM-401 
[Mn(CO)4(S2CNMeCH2CO2H)],  had low cytotoxicity and was considered to have 
much potential. CORM-401 is water-soluble at pH 7.4 and this molecule releases more 
than 3 CO groups to dithionite-reduced myoglobin from each CO-RM molecule, a 
desirable property of efficient CO-RMs (Crook et al., 2011). CORM-401 releases some 
CO spontaneously by a reversible, dissociative process, although it is now known that 
dithionite is able to accelerate the rate of CO release from CORM-401 (McLean et al., 
2012). The presence of pyridine and phosphorus ligands and myoglobin also promote 
CO release from CORM-401 in a concentration-dependent manner. This is because 
these compounds either react with the CO-RM backbone or with CO, thereby 
preventing reassociation with CO (Mann, 2012). 
 
1.2.3.4 Iron indenyl carbonyls 
A group of CO-RMs have been developed based on iron indenyl carbonyls, which are 
made water-soluble by the addition of functional groups to the cyclopentadienyl ring. 
The most promising is [Fe(ᵑ5-C9H7)(CO)2(NCMe)][BF4] as it is not toxic and has a half-
life for CO release of 210 min; however, it only slightly reduces the production of 
nitrite (a marker of inflammation) in macrophages stimulated with LPS. The X-ray 
structures have been obtained for several of these compounds (Hewison et al., 2010). 
 
1.2.4 PhotoCO-RMs 
The term ‘photoCO-RM’ (photoactivated carbon monoxide-releasing moiety) (Rimmer 
et al., 2010) describes a compound that releases CO when exposed to a specific 
wavelength and intensity of light (Schatzschneider, 2011). Indeed, as outlined above 
(section 1.2.1 and 1.2.2), many of the early CO-RMs to be investigated released CO 
upon irradiation (Motterlini et al., 2002). The theoretical benefit of this mechanism of 
CO release is that it can be precisely controlled by the administrator of the CO-RM and 
therefore circumvents some of the problems faced with other CO-RMs that release CO 
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according to the physiological environment. There are of course disadvantages to the 
requirement for a particular light source in order to trigger CO release, including 
potential damage to tissues cause by certain wavelengths. 
 
The use of light to modify drugs in situ is not without precedent; examples of  
photodynamic therapy include the use of light to generate singlet oxygen (1O2) with the 
aim of destroying malignant cells (Brown et al., 2004), and the activation of pro-drugs 
in anti-cancer treatment (Farrer and Sadler, 2008). PhotoCO-RMs must be stable in the 
dark in order for the compound to accumulate in target tissues prior to photoexcitation, 
after which CO will be released, and ideally will not rebind to a high degree, but rather 
bind a solvent molecule in order to stabilise the remaining molecule (Schatzschneider, 
2011).  
 
The next group of compounds to be thoroughly explored for their potential as 
therapeutically relevant photoCO-RMs were those based on monocationic manganese(I) 
tricarbonyls [Mn(CO)3(tmp)]+ (Niesel et al., 2008). The potential for modification of the 
tmp ligand at the pyrazole ring and at the central methane carbon atom adds to the 
usefulness of this group (Schatzschneider, 2010). Such compounds are stable in the dark 
and, in the absence of light, do not affect the viability of HT29 human colon cancer 
cells, but typically release 2 CO groups per molecule upon irradiation at around 360 nm, 
and in this activated form, significantly reduce the viability of such cells (Niesel et al., 
2008). In order to allow such photoCO-RMs to be targeted to specific cancer cells, the 
[Mn(CO)3(tmp)]+ compound was conjugated to a targeting peptide (Pfeiffer et al., 
2009). An interesting development in the design of photoCO-RMs was the linkage of 
[Mn(CO)3(tmp)]+ to silicium dioxide nanoparticles which have the potential to deliver 
CO-RMs into solid tumours, without adversely affecting CO release (Dordelmann et al., 
2011). 
 
Another group of photoCO-RMs are based on the sodium salts of the water soluble 
tungsten carbonyl complex Na3[W(CO)5(TPPTS)] (Rimmer et al., 2010). These are 
stable in aerated media, but release approximately 1 CO upon irradiation; further CO is 
then released due to aerobic oxidation. These photoCO-RMs have been suggested as 
suitable for topical applications using UVA as an excitation source.  
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Recently, a manganese-based photoCO-RM has been described that has therapeutic 
potential (Ward et al., 2012). Particular advantages of this CO-RM are that it releases 3 
CO molecules from each CO-RM molecule, is activated by light from a LED (light 
emitting diode) at 400 nm, and is not toxic to RAW 264.7 murine macrophages before 
and after irradiation. Further investigation of the biological activities of photoCO-RMs 
is now needed. PhotoCO-RMs that release CO at wavelengths near to IR are desirable 
for therapeutic purposes.  
 
1.2.5 Recently designed CO-RMs with modified CO release or delivery 
mechanisms 
1.2.5.1 Enzyme-Triggered CO releasers  
A number of enzyme-triggered CO-RMs have been described (Romanski et al., 2011). 
These are acyloxybutadiene-iron tricarbonyl complexes, and are stable in solution but 
are activated to release CO after entry into the cell by cleavage of the ester group by 
intracellular esterases. By varying the dienylester ligand, it is possible to manipulate the 
biological and pharmacological properties of such CO-RMs and it is hoped that, after 
further development, this type of CO release mechanism will allow precise, tissue 
controlled delivery of CO.  
 
1.2.5.2 Carbon monoxide-releasing micelles 
A novel idea to enable the delivery of CO-RMs therapeutically is the incorporation of 
CO-RMs into carbon monoxide-releasing micelles (Hasegawa et al., 2010). These are 
based on existing ruthenium-based CO-RMs, conjugated to a polymeric micelle forming 
a spherical structure 30 - 40 nm in diameter. The micelles are stable in buffer and 
serum, but interestingly, release CO in the presence of cysteine and other thiol 
compounds (see Chapter 5). The micelles release CO at a slower rate than CORM-3, 
and yet they were able to prevent NF-κB activation in human monocytes that had been 
stimulated with LPS while CORM-3 was not. Interestingly, the micelles were 
significantly less toxic than CORM-3. They also have the advantage of slowing the 
diffusion of the CO-RM into tissues, which is particularly advantageous for the 
targeting of CO-RMs to distal tissue drainage sites. 
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1.2.5.3 Other modifications of interest 
Much current work is focusing on how to modify CO-RMs to allow them to be targeted 
to specific cell or tissue types or to alter the rate of CO loss in order to render them 
more suitable for therapeutic applications. One such example is the modification of 
CORM-A1 to reduce the CO release rate to allow this compound to reach the target 
cells prior to the release of CO (Pitchumony et al., 2010). This is achieved by adding 
histamine, morpholine, aniline or ethylene-diamine groups to the [H3BCO] moiety. 
Another example is the conjugation of CO-RMs to a polymeric carrier system to 
facilitate the passive transport of the CO-RM to tumours or to sites of inflammation 
(Bruckmann et al., 2011). This involves the addition of an organometallic fac-Mn(CO)3 
moiety, to a methacrylate or methacrylamide polymer backbone. These complexes are 
triggered to release CO by light and are of the appropriate size and weight to allow 
passive drug delivery. 
 
1.2.6 The future of CO-RM development 
Future design of CO-RMs and work to characterise them should pay special attention to 
understanding the mechanism of CO release from CO-RMs. It is desirable for CO-RMs 
to have high CO release ratios, so that less drug needs be administered in order to 
achieve a therapeutic effect. In addition, future CO-RM design needs to focus on 
making CO-RMs more suitable for use as a medical drug. Currently we have water-
soluble, bioactive CO-RMs such as CORM-3 and CORM-A1, but in order for CO-RMs 
to be a realistic therapy they must have highly attuned absorption into tissues and 
excretion from them, have higher biocompatibility and contain no potentially harmful 
components (Motterlini and Otterbein, 2010). 
 
It is also important that we gain a better understanding of how CO from CO-RMs enters 
cells (Mann, 2012). For example, it is not known whether CO-RM enters via specific 
transporters, or by passive diffusion. Furthermore, little is known about the fate of the 
CO-RM backbone or the released CO after it has entered cells (Mann, 2012). However, 
Raman microscopy has shown that when HT29 human colon cancer cells are exposed to 
CO-RM, most of the CO-RM localises around the nucleolous (Meister et al., 2010). 
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It is also vital that future CO-RMs are designed with the importance of the availability 
of reliable control molecules in mind. Currently, despite the reported use of three 
different control molecules for CORM-3: inactive CORM-3 (iCORM-3), myoglobin 
inactivated CORM-3 (miCORM-3) and RuCl2(DMSO)4, there is no control molecule 
for this compound for which the chemistry is completely understood, or that mimics the 
in vivo breakdown products of this CO-RM precisely. Recent work in the field of 
photoCO-RMs aims to avoid the problems associated with uncharacterised and 
potentially unstable break-down products following the release of CO by carrying an 
additional ‘pendant ligand arm’ for each labile CO, which is able to replace the CO 
group following its release (Nagel, Mclean et al., unpublished). Well-defined iCO-RMs 
such as these could be synthesised and used as control compounds. 
 
1.2.7 Methods of detecting CO   
It is also important that better techniques are developed to monitor CO release from 
CO-RMs, particularly now that it is known that the CO release rates measured by the 
widely used myoglobin assay are affected by the presence of dithionite. Furthermore, a 
recent paper by Atkin et al. (2011), highlighted problems associated with the processing 
of data from myoglobin assays and inaccuracies that arise from shifts in the isosbestic 
points upon CO-RM addition. Alternative methods of CO detection include measuring 
spectroscopic changes when CO binds to haemoglobin (McLean et al., 2012) or other 
overexpressed intracellular globins (Lauren Wareham and Mariana Tinajero Trejo, 
unpublished), the use of gas chromatography to detect CO in the gas phase of a closed 
system (Santos-Silva et al., 2011), or the detection of redox changes in a haemin 
modified electrode (Obirai et al., 2006). A recent paper has described a novel means of 
intracellular CO detection based on the genetic insertion of a fluorescent probe into the 
coo operon (Wang et al., 2012). This operon is under the control of CooA, a highly 
selective CO sensor (see section 1.1.4.3). This technique has the potential to allow the 
distribution of CO to be monitored within a living cell. An electrochemical microsensor 
able to detect CO and NO has also been reported (Lee and Kim, 2007). The sensor 
consists of a platinum electrode and a Ag/AgCl reference electrode covered with a gas-
permeable membrane, and has a detection limit of < 5 nM and is therefore sufficient for 
analysing physiological levels of NO and CO.  
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1.2.8 The therapeutic effects of CO and CO-RMs  
As discussed above, CO is capable of initiating myriad beneficial effects within 
mammalian systems, which has led to research into ways that CO can be harnessed as a 
therapeutic agent to treat cardiovascular disease, sepsis, acute injury of the kidney, liver  
and lung, and to prevent organ transplant rejection (Motterlini and Otterbein, 2010). 
While there are obvious concerns regarding the administration of a ‘toxic’ compound to 
patients, there are some advantages of the therapeutic use of CO: it is relatively 
unreactive aShivand therefore does not undergo undesirable reactions with intracellular 
compounds, and is a natural compound that is not metabolised by the body to produce 
harmful breakdown products.   
 
There are currently three main approaches to the administration of CO as a therapeutic. 
The first is by the induction of HO-1 expression. This can be achieved through the 
administration of haem or protoporphyrins and has been shown to have beneficial 
effects in pathologies such as hyperoxia-induced lung injury, nephrotoxicity and sickle 
cell disease (Belcher et al., 2006; Nath et al., 1992; Otterbein et al., 1999). The second 
involves the inhalation of gaseous CO, and the third the delivery of CO using CO-RMs, 
both of which are described below. 
 
1.2.8.1 CO inhalation therapy 
There have been several clinical trials into the use of CO gas inhalation therapy. These 
involve the inhalation of air containing CO, usually at a dose of 100 – 250 ppm. One 
phase II trial investigated the use of CO gas to prevent the development of postoperative 
obstructions of the bowel following colon surgery, while another investigated the use of 
CO to improve the toleration of donor kidneys in transplant patients (reviewed by 
Mann, 2010). Many questions must be answered before CO inhalation can be 
considered as a credible therapy. These include questions about the dose of CO 
required, and whether this is best delivered in multiple, low dose sessions, or in less 
frequent, larger doses (Motterlini and Otterbein, 2010).  
 
A recent study with cynomolgus macaques investigated the efficacy of inhaled CO in 
reducing LPS-induced lung inflammation and found that exposure to 500 ppm CO over 
6 h decreased tumour necrosis factor-α (TNF-α) production, but did not affect levels of 
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IL-6 or IL-8. Lower concentrations of CO (250 ppm, 6 h) were less effective at inducing 
these effects in primates, despite being effective in rodent models. Treatment with 
relatively high levels of CO (500 ppm over 6 h) increased COHb levels by more than 
30% (Mitchell et al., 2010). The propensity of CO to bind to haemoglobin poses a 
significant danger and limitation, particularly as other cellular targets have lower 
affinities for CO. However, despite similar reservations regarding the pharmacological 
use of NO, which also has toxic effects, inhaled NO is currently used to treat premature 
babies with pulmonary hypertension (Bloch et al., 2007). 
 
1.2.8.2 The therapeutic effects of CO-RMs  
CO-RMs were developed to provide a means by which CO could be stored in a stable, 
solid form and then solubilised prior to administration via intravenous or subcutaneous 
injection. This has the advantage of allowing CO to be delivered directly to the site at 
which it is required, thus bypassing haemoglobin in the blood and lowering the 
necessary dose, as well as reducing the likelihood of systemic side effects. Studies into 
the therapeutic effects of CO and CO-RMs are now numerous, and this area has been 
extensively reviewed (Johnson et al., 2003; Motterlini and Otterbein, 2010; Romao et 
al., 2012). Consequently, only a brief overview of this work will be given here. Table 
1.3 summarises some of the preeminent findings in this field, while Figure 1.3 presents 
some of the biological targets know to interact with CO in order to mediate these 
physiological effects. The beneficial effects of therapeutically applied CO mimic those 
of endogenous CO, such as the modulation of vascular tone and attenuation of 
inflammation, and many of the same pathways are involved in the mediation of these 
effects. 
 
1.2.8.2.1 Vasoactive properties 
CO-RMs are considered to have great potential in regulating vasoactive processes in a 
variety of diseases (Motterlini and Otterbein, 2010). CORM-2 causes vasodilation and 
reduces hypertension in rat aorta, whereas the control molecule RuCl2(DMSO)4, which 
is structurally similar to [Ru(CO)3Cl2]2, but with the carbonyl groups replaced  
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CO-RM Evidence of pharmaceutical potential Reference 
CORM-1 
[Mn2(CO)10] 
Reduces vasoconstriction and maintains coronary perfusion pressure 
in isolated rat hearts, yet is not toxic to vascular smooth muscle cells 
after 24 hrs. 
 
 (Motterlini et al., 
2002) 
 Causes in vivo dilation of porcine cerebral arteriole smooth muscle 
cells via activation of large conductance, calcium dependent 
potassium channels. 
 
(Xi et al., 2004) 
 Increases renal blood flow by 54%, glomerular filtration by 38%, and 
urinary cGMP excretion by 128%. 
 
(Arregui et al., 
2004) 
 Reduces neutrophil migration, leukocyte rolling and adhesion to 
endothelial cells in acute inflammation. 
 
(Freitas et al., 2006) 
CORM-2 
[Ru(CO)3Cl2]2 
Causes vasodilation and reduces hypertension in aorta from rats 
through activation of sGC. 
 
(Motterlini et al., 
2002) 
 Reduces proliferation of human smooth muscle cells by increased 
mitochondrial ROS production and subsequent decreased 
phosphorylation of ERK1/2 and cyclin D1 expression. 
 
 (Taille et al., 2005) 
  CO from this compound causes production of ROS by complex III of 
the electron transport chain. This affects the redox state of key 
cysteine residues in cardiac L-type Ca2+ channels, inhibiting ion 
transport, which has cardioprotective effects. 
 
(Scragg et al., 2008) 
 Reduces inflammation by attenuating LPS-induced production of 
ROS and NO by preventing expression of intracellular adhesion 
molecule-1 and activation of NF-κB.  
 
(Cepinskas et al., 
2008) 
 Protects against acute renal failure caused by ischemia. 
 
(Vera et al., 2005) 
CORM-3 
(Ru[CO]3Cl(gly
cinate)) 
Prevents cardiac allograft rejection and protects against ischemia 
reperfusion injury in mice. This involves the activation of HO-1, sGC 
and ATP-dependent potassium channels. 
 
(Clark et al., 2003) 
 Prevents human platelet aggregation. 
 
(Chlopicki et al., 
2006) 
 Reduction of microglia activity in strokes and other 
neuroinflammatory diseases. 
 
(Bani-Hani et al., 
2006) 
CORM-A1 Causes significant but slow-acting and sustained vasodilation of 
precontracted aortic rings, mimicking the effects of endogenous CO. 
 
(Motterlini et al., 
2005b) 
 Increases renal blood flow and the rate of glomerular filtration. 
 
(Ryan et al., 2006) 
CORM-401 Reduces nitrite production in RAW 264.7 macrophages by 70% 
following stimulation with LPS. 
 
(Crook et al., 2011) 
[Mn(CO)3(tmp)
]+ with targeting 
peptide 
Such photoCO-RMs have the potential to be targeted to specific 
cancer cells.  
(Pfeiffer et al., 
2009). 
[Mn(CO)3(tmp)
]+nanoparticles 
Such photoCO-RM nanoparticles have the potential to deliver CO-
RMs into solid tumours. 
 
(Dordelmann et al., 
2011) 
Table 1.3 The pharmacological effects of CO-RMs. This table summarises key 
literature into the effects of CO-RMs on mammalian systems.   
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Figure 1.3 The interaction of CO with biological targets and the subsequent effects 
CO mediates its biological effects by binding to haem-containing proteins such as 
soluble guanylate cylase (sGC), which produces cyclic guanosine monophosphate 
(cGMP), inducible nitric oxide synthase (iNOS), or cytochrome c oxidase, or to 
transition metals such as Fe2+ in potassium (K+) channels. Inhibition of respiration, due 
to CO binding to cytochrome c oxidase produces reactive oxygen species (ROS), which 
is a messenger for downstream signalling via mitogen activated protein kinases 
(MAPK) and extracellular-regulated-signal kinase (ERK1/2). 
 
This is a simplified representation of the interaction of CO with a selection of biological 
targets. The precise mechanism by which CO exerts its effects on many of these targets 
is not fully understood, nor is the interplay between many of these pathways, or the 
complex interactions with NO.  The information used to generate this figure was 
obtained from Boczkowski et al., (2006), Dulak and Jozkowicz (2003) and Mann and 
Motterlini (2007).  
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with DMSO, is unable to cause these effects, suggesting that CO, rather than the CO-
RM backbone is the causative agent (Motterlini et al., 2002). Importantly, no 
cytotoxicity was experienced in vascular smooth muscle cells treated with up to 420 µM 
CORM-2 over 3 h. CORM-3 also has significant vasodilatory properties, which are 
induced at concentrations of CORM-3 as low as 25 – 50 µM (Foresti et al., 2004). 
CORM-3 is also able to protect myocardial cells and isolated rat hearts from ischemia-
reperfusion injury and can prevent cardiac allograft rejection in mice (Clark et al., 
2003). A major advantage of CORM-3 is that is has relatively low toxicity: 
concentrations less than 500 µM are not toxic to porcine aortic endothelial cells or to 
primate peripheral blood mononuclear cells in vitro (Vadori et al., 2009). Furthermore, 
the non-metal CO-RM, CORM-A1 causes significant but slow-acting and sustained 
vasodilation of precontracted aortic rings, thereby mimicking endogenous CO, while the 
inactive compound (iCORM-A1) does not.  
 
The main mechanism by which CO-RMs (and indeed CO gas) mediate their vasoactive 
properties is by the activation of the haem-containing protein, soluble guanylate cyclase 
(Foresti et al., 2004; Motterlini et al., 2002; Motterlini et al., 2005b) and the 
subsequent production of cGMP, an important second messenger with wide reaching 
effects (Kharitonov et al., 1995). Both CO and NO activate sGC, but NO does so to a 
much greater extent (30 – 100-fold more than CO). However, the effects of CO on 
cGMP production can be increased by the benzyloid derivative YC-1 (Friebe et al., 
1998). 
 
The activation of potassium channels by CO has also been implicated in the vascular 
activities of CO-RMs (Clark et al., 2003; Foresti et al., 2004). One mechanism by 
which CO may modulate the activity of such channels is by interacting with an 
associated haem group. Calcium-dependent Slo BK channels, interact with a haem 
group via a conserved haem-binding sequence motif. The association of haem with the 
channel inhibits the transport of K+ across the membrane and therefore reduces the 
frequency of channel opening (Tang et al., 2003). Interestingly, HO-2 is part of the 
large-conductance, Ca2+-sensitive potassium BK channel complex and CO was shown 
to be involved in regulating the activity of this channel (Williams et al., 2004). 
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Haem-independent mechanisms may also be involved in the activation of such 
channels. There have been two separate reports of CO interacting with histidine and or 
aspartate residues to open such channels (Wang and Wu, 1997; Hou et al., 2008). There 
is also evidence that reactive oxygen species (ROS) generated from the inhibition of 
respiration by CORM-3 can transduce signals to K+ channels (Clark et al., 2003) (see 
section 1.2.8.2.4). 
 
1.2.8.2.2 Anti-Inflammatory properties 
CO-RMs are also considered to have great potential as anti-inflammatory agents 
(Motterlini and Otterbein, 2010). Several CO-RMs have been shown to decrease levels 
of anti-inflammatory intermediaries and to reduce levels of TNF-α and NO in LPS 
stimulated macrophages (Sawle et al., 2005). 
 
CO delivered by CO-RMs may also be beneficial in the treatment of inflammation 
associated with arthritis. CORM-3 reduced levels of inflammatory cytokines in joint 
tissues and reduced the recruitment of inflammatory cells, joint inflammation and 
degradation of cartilage in animal models of arthritis (Ferrandiz et al., 2008). In 
addition, CORM-2 has been shown to substantially reduce the inflammatory response 
induced by cytokines in human colonic epithelial cells. This includes reduced 
expression of nitric oxide synthase-2 (NOS-2) and subsequent production of nitrite as 
well as differential-regulation of inflammatory genes involved in intestinal 
inflammation and cancer progression (Megias et al., 2007). 
 
Many of the anti-inflammatory effects of CO and CO-RMs involve activation of the 
mitogen-activated protein kinase (MAPK) pathway. This pathway allows the 
transduction of signals via a series of serine/threonine-specific protein kinases and is 
involved in the regulation of  proliferation, differentiation, gene expression, mitosis, cell 
survival, and apoptosis in a wide variety of eukaryotic cells (Johnson and Lapadat, 
2002). It is well established that CO activates p38 MAPK and down-regulates 
extracellular-signal-regulated kinases, ERK1 and ERK2, but it is not understood how 
this is achieved. There is evidence that CO prevents ERK1/2 activation by CO gas after 
lung ischemia-reperfusion in rats, and that this involves the activation of sGC (Mishra et 
al., 2006).  Alternatively, it is possible that CO affects the MAPK pathway directly, by 
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interaction with Mn2+ in the serine/threonine phosphatase, protein phosphatase 2C, 
which is important in regulating stress responses in eukaryotes (Das et al., 1996). 
 
The regulation of NO production by CO also mediates the anti-inflammatory properties 
of CO-RMs. CO binds to haem in inducible nitric oxide synthase (iNOS), supressing 
NO production (White and Marletta, 1992). This has important implications for the use 
of CO in antimicrobial therapies as NO is a key mediator of host defences against 
microbial infection (Motterlini and Otterbein, 2010) (see section 1.3.1). NO also has 
important roles in the regulation of vascular tone (Furchgott and Jothianandan, 1991), 
platelet aggregation (Sylman et al., 2013) and smooth muscle relaxation (Sharma et al., 
2013). Interestingly, NO is a major regulator of sGC and, consequently, there is much 
interplay between the pathways involving iNOS and sGC. 
 
1.2.8.2.3 The effects of CO and CO-RMs on organ transplantation 
Much research has been undertaken into the protective potential of CO in organ 
transplant systems, and it has been found to have significantly beneficial effects 
(Akamatsu et al., 2004). An early study into the biological activity of CORM-3 
investigated cardiac allograft rejection in mice and found that treatment of recipients 
with CORM-3, but not an inactive control compound, greatly increased the survival rate 
of transplanted hearts (Clark et al., 2003). CO-RMs have also been shown to prevent 
ischemia reperfusion injury in intestinal grafts via a sGC-dependent mechanism (Nakao 
et al., 2006b). The reduction of pro-inflammatory cytokines by CO-RMs is also thought 
to be important in increasing the survival rate of transplant patients (Nakao et al., 
2006a). In addition, CO-RMs and saturated solutions of CO added to the organ 
preservation solution have been shown to greatly benefit the health of the transplanted 
organ (Musameh et al., 2007; Pizarro et al., 2009; Sandouka et al., 2006). The 
mechanisms by which CO and CO-RMs induce these effects is not fully understood, but 
there is evidence that sGC (Nakao et al., 2003), cytochrome p450 (Nakao et al., 2008) 
and the reduction of inflammatory cytokine levels (Nakao et al., 2006a) are involved. 
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1.2.8.2.4 The effects of CO and CO-RMs on cell proliferation and apoptosis 
involves MAPK signalling and ROS production 
CO can both promote and prevent apoptosis. For example, CO from HO-1 or CORM-
A1 has been shown to contribute to neuronal cell death following bradykinin-induced 
neuronal dysfunction (Yang et al., 2013). In contrast, CO has been shown to prevent 
apoptosis in hepatocytes by inhibiting mitochondrial membrane permeabilization, which 
would otherwise release pro-apoptotic factors into the cell (Queiroga et al., 2011). CO 
also prevents apoptosis by activating MAPK signalling. Administration of CORM-3 to 
a mouse model of peritonitis-induced sepsis elevated levels of ROS, which stimulated 
mitochondrial biogenesis and expression of peroxisome proliferator-activated receptor γ 
co-activator-1α (Lancel et al., 2009). Mitochondrial ROS and subsequent signalling 
involving ERK1/2 has also been implicated in the inhibition of proliferation of airway 
smooth muscle cells by CORM-2 (Taille et al., 2005). CO has also been attributed an 
important role in mitochondrial biogenesis (Suliman et al., 2007). Again, the production 
of ROS by inhibition of respiration is implicated in the increased expression of specific 
transcription factors that initiate transcription of mitochondrial proteins. 
 
The binding of CO to cytochrome c oxidase in the eukaryotic respiratory chain inhibits 
respiration and therefore causes an accumulation of reduced components along the 
electron transport chain. ROS form when this reducing power is transferred to O2 at 
ubiquinol forming superoxide (O2-) (Poderoso et al., 1999). ROS are known to be 
involved in diverse intracellular signalling processes, and therefore constitute second 
messengers of CO signalling (Gutterman et al., 2005). Indeed, CO has been found to 
increase the production of ROS in RAW 264.7 cells, which initiates signalling 
pathways, including p38 MAPK, and therefore has anti-inflammatory effects 
(Zuckerbraun et al., 2007). It should be noted however, that inhibition of cytochrome c 
oxidase by endogenous CO is only thought to occur at very low levels (D'Amico et al., 
2006), in part because of the propensity for haemoglobin and myoglobin to sequester 
free CO. 
  
NADPH oxidase is widely distributed, but particularly important in phagocytes where 
it produces superoxide, which is an important host defence (Babior et al., 2002). This 
protein contains haem and thus is susceptible to inhibition by CO, and consequently, 
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CO is also able to reduce levels of ROS (Taille et al., 2005), although, this same work 
also showed that inhibition of respiration by CO delivered by CORM-2 increased the 
production of ROS, which then decreased cyclin D1 expression, preventing muscle 
proliferation. This exemplifies the complex balance that controls the biological effects 
of CO. 
 
1.2.8.2.5 Limitations to the therapeutic use of CO-RMs 
Despite the many potential advantages of CO-RMs compared to CO gas as a therapeutic 
agent, they also have some disadvantages. For example, consideration must be given to 
the fate of the CO-RM backbone following the release of CO. It is important that the 
resulting compound, and any residual breakdown products are not toxic, and that they 
are not metabolised by the body to subsequently produce toxic products. CORM-2 and 
CORM-3, which have potent therapeutic effects, both contain ruthenium, which is not 
found naturally in the body and therefore accumulation in cells and tissues would be 
undesirable. 
 
1.3 Antimicrobial activity of CO and CO-RMs 
1.3.1 The effects of CO and CO-RMs on the clearance of bacteria by the innate 
immune response 
Carbon monoxide is thought to be a key anti-inflammatory molecule involved in the 
resolution of inflammation and the prevention of sepsis; indeed, during infection, many 
host stress response genes are induced, including HO-1, which, as detailed above 
(section 1.1.3.4), catalyses the production of several anti-inflammatory molecules, 
including CO (Otterbein et al., 2000; Zhou et al., 2004). CO is anti-inflammatory, in 
part due to inhibition of haem-containing nitric oxide synthase (NOS), which prevents 
the production of NO, an inflammatory mediator. CO also increases the expression of 
interleukin-10 (IL-10) an anti-inflammatory molecule and decreases the expression of 
the pro-inflammatory cytokines, ICAM-1 and TNF-α through activation of a MAPK 
pathway (Otterbein et al., 2000).  
 
There is much evidence that CO plays an important role in host survival following 
bacterial infection (reviewed by(Chung et al., 2009). When challenged with endotoxin 
from the cell wall of gram negative bacteria, HO-1-deficient mice experienced 
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exacerbated organ injury and mortality caused by oxidative stress, compared to wild 
type mice (Wiesel et al., 2000). However, treatment of such mice with exogenous CO 
reduced the inflammation experienced and increased the survival rate (Otterbein et al., 
2000). Furthermore, HO-1 deficient mice suffered increased lethality compared to wild 
type mice in a cecal ligation and puncture (CLP) model of abdominal sepsis, but this 
was ameliorated by the administration of CO, either by overexpression of HO-1, or 
delivery of CO by CO-RMs (Chung et al., 2008). CORM-2 and CORM-3 have also 
been shown to reduce the inflammatory response caused by application of LPS to RAW 
264.7 murine macrophages (Sawle et al., 2005).  
 
Inhalation of 250 ppm CO for 1 h before exposure to a lethal dose of LPS increased 
survival in rats by 86% compared to those without CO treatment (Sarady et al., 2004). 
Moreover, treatment with this amount of CO for 3 h prior to LPS administration 
reduced levels of the pro-inflammatory cytokines (IL-6 and TNF-α) and increased 
production of IL-10 in a rat macrophage cell line. Similar results were found with CO-
RM treatment of human umbilical vein endothelial cells (Cepinskas et al., 2008), 
suggesting that endogenous CO can modulate the inflammatory response and protect 
cells and organisms by the restoration of homeostasis. 
 
Paradoxically, the anti-inflammatory role of CO might suggest that this gas could 
inhibit the innate immune response against microbial infections; indeed, there is 
evidence that administration of CORM-2 decreases the production of superoxide and 
NO in macrophages and blocks the oxidative burst, the first defence of macrophages 
against pathogens (Srisook et al., 2006). This led to the suggestion that the anti-
inflammatory properties of CO may be sufficient to resolve inflammation in 
inflammatory models of disease, but not to clear live pathogens from the host (Chin and 
Otterbein, 2009).  
 
However, there is evidence that CO is also able to promote bacterial clearance, and that 
it does not supress host defences. For example, over-expression of HO-1 was found to 
reduce death following E. faecalis infection, but not during E. coli infection, without the 
suppression of circulating inflammatory cells (Chung et al., 2008). Furthermore, CO has 
been shown to increase phagocytosis of heat killed E. coli by RAW 264.7 macrophage 
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cells, by increased expression of Toll-like receptor 4 (TLR-4) (Otterbein et al., 2005), 
while, more recently, CORM-3 (Desmard et al., 2009) and CORM-2 (Desmard et al., 
2012) have been shown to increase survival and antimicrobial response following 
bacterial infection in mice.  
 
This previously unappreciated role of CO in promoting the innate host response to 
infection has significant implications for the potential use of CO and CO-RMs as 
antimicrobial agents.  Importantly, the finding that CO can eradicate bacterial infections 
in immuno-compromised mice (Desmard et al., 2009) suggests that CO may have a 
direct bactericidal effect, as discussed below. 
 
1.3.2 The effects of CO-RMs on bacterial growth and viability  
Until recently, very little research has been done into the effects of CO on bacterial 
growth and viability. Despite this, CO gas has been used for many years to reduce 
bacterial growth in the meat packaging industry. CO reacts with myoglobin on the 
surface of the meat to produce carboxymyoglobin, which has a bright red colour, 
making the meat more visually appealing to consumers (El-Badawi et al., 1964). It was 
later found that CO could extend the shelf-life of packaged beef by inhibiting microbial 
growth (Clark et al., 1976). Another early observation of the deleterious effects of CO 
on bacteria (Weigel and Englund, 1975), reported that this gas inhibited DNA 
replication in aerobically grown E. coli cells, which they suggested could be caused by a 
reduction in the amount of ATP available.  
 
Significant new research has provided evidence that CO and CO-RMs can have a direct 
bactericidal effect (Davidge et al., 2009b; Desmard et al., 2009; Nobre et al., 2009; 
Nobre et al., 2007). Work by Saraiva and colleagues found that CORM-2 and CORM-3 
and the CO-RMs ALF021 and ALF062 could significantly reduce the viability of both 
E. coli and S. aureus cells, providing the first evidence that CO from CO-RMs is 
bactericidal towards both Gram-positive and Gram-negative bacteria. CO was shown to 
be the causative agent of these effects as CO-RMs had no effect in the presence of 
haemoglobin a CO-scavenger, and inactive control compounds, also had no effect on 
cell viability (Nobre et al., 2007).  
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The potential of CORM-3 as an antimicrobial therapeutic was also demonstrated by the 
ability of very low concentrations (0.5 – 10 µM) to inhibit the growth of an antibiotic 
resistant strain of P. aeruginosa in vitro at concentrations of that were 50-fold lower 
than concentrations that were toxic to eukaryotic cells (Desmard et al., 2009). 
Moreover, 10 µM CORM-3 was as effective at reducing the bacterial count in vitro as 
the established antibiotics amikacine (50 mg l-1, or 0.8 mM) and ticarcilline (50 mg kg-
1). CORM-2 is also effective at preventing P. aeruginosa biofilm maturation and at 
killing cells within established biofilms (Murray et al., 2012). Interestingly, CORM-2 
was found to be more effective when combined with tobramycin, an established 
antibiotic used to treat P. aeruginosa pulmonary infections. 
 
Davidge et al. (2009b) found both aerobic and anaerobic cultures of E. coli to be 
sensitive to CORM-3; however, they demonstrated that CORM-3 completely prevented 
the growth of aerobic cultures at lower concentrations (100 μM) than was needed to 
prevent the growth and viability of anaerobic cultures (200 μM). Moreover, 30 μM 
CORM-3 reduced the number of viable cells 10-fold in 2 h in aerobic conditions, 
whereas 100 μM CORM-3 had no effect on the viability of anaerobic cultures within 
this time. The greater susceptibility of aerobic cultures concurs with our understanding 
of CO as a known inhibitor of aerobic respiration; however as CO is known to be a 
competitive inhibitor with oxygen, it is surprising that CO is inhibitory even at high 
oxygen concentrations. In contrast, Nobre et al. (2007) found CO-RMs to be more toxic 
towards anaerobic cells than aerobic cells, which they suggest may be due to CO 
binding to the ferrous form of haemoproteins, which are abundant at low oxygen 
concentrations. They propose that the stronger effect of CO-RMs on anaerobically 
grown cells implies the existence of significant targets of CO other than the 
cytochrome-containing terminal oxidases of aerobic respiration. The reasons for the 
different findings with regards to aerobic and anaerobic cultures of these two groups are 
not clear, but may be due to the type and concentration of CO-RM used: Davidge et al. 
used CORM-3, whereas Nobre et al used high concentrations of ALF 021, ALF 062 and 
CORM-2. It is possible that CORM-2 and CORM-3 have different mechanisms of 
toxicity, as is discussed in Chapter 5. Inspection of the results of Nobre et al. (2007) 
reveals that, after 30 min, the viability of aerobic cultures was much more affected by 
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the addition of CORM-2 than that of anaerobically grown cultures, but that by 1 h after 
the addition of CORM-2, this trend has reversed, although to a lesser extent. 
 
Interestingly, CO-RMs are more effective at preventing bacterial growth than the 
equivalent concentration of CO-saturated solution (Davidge et al., 2009b, Nobre et al., 
2007). This was unexpected as CO gas delivered in solution is expected to be highly 
membrane-permeable, but may indicate that CO-RMs deliver CO directly to 
intracellular targets, a hypothesis confirmed by assaying for the presence of CO in the 
extracellular medium using myoglobin. In the absence of E. coli, CO from CORM-3 
rapidly bound to Mb; however in the presence of E. coli, only 28% of the initial CO was 
found to be present in the extracellular medium after 10 min, suggesting it had been 
taken up by the cells and was therefore no longer accessible to the Mb. Further evidence 
of the direct delivery of CO by CO-RMs is that ruthenium from CORM-3 (Davidge et 
al., 2009b) and molybdenum from ALF062 (Nobre et al., 2007) were found to 
accumulate inside E. coli cells. Accumulation of ruthenium was greater in aerobic cells 
(where the concentration of ruthenium was 7-fold greater than that in the culture) 
compared to that in anaerobic cells (in which the concentration of ruthenium was 2.1-
fold greater than in the culture), which may partly explain the greater sensitivity of 
aerobic cells to CORM-3 (Davidge et al., 2009b). Table 1.4 presents a comparison of 
the effects of CO and CO-RMs on bacteria. 
 
1.3.3 The effects of CO-RMs on bacterial respiration 
It has been known for nearly 90 years that CO inhibits bacterial respiration (reviewed by 
Keilin, 1966). As described previously (section 1.2.3.2), CO mediates this inhibition by 
binding to ferrous iron in the haem groups of terminal oxidases in the aerobic 
respiratory chain. This led to the assumption that bacterial respiration was a major target 
of CO from CO-RMs (as discussed in Chapter 3). For example, CO gas is known to 
bind to cytochrome c oxidase in P. aeruginosa (Parr et al., 1975) and, more recently, 
aerobic cultures of P. aeruginosa treated with CORM-3 have been shown to exhibit 
reduced oxygen uptake followed by a reduced growth rate (Desmard et al., 2009). 
Furthermore, when cultures of E. coli were stressed with 30 μM CORM-3 for 2 h and 
then washed before respiration was measured, respiration rates were significantly 
diminished (although this effect was not immediate) (Davidge, 2009). Spectroscopic 
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analysis of several bacterial species, including E. coli (Davidge et al., 2009b), P. 
aeruginosa (Desmard et al., 2009) and C. jejuni (Smith et al., 2011), treated with 
CORM-3 has confirmed that CO from such compounds binds rapidly to the terminal 
oxidases of the respiratory chain, as discussed in Chapter 3. 
 
A recent publication has provided a detailed study of the effects of CORM-3 on 
microbial respiration (Wilson et al., 2013). Addition of CORM-3 to cultures of E. coli 
resulted in a period of respiratory stimulation followed by inhibition, while higher 
concentrations of CORM-3 resulted in increased stimulation for a shorter time period, 
followed by more marked inhibition. It was concluded that the initial increase in 
respiration rate upon CORM-3 addition is not due to a direct stimulatory effect of 
CORM-3 on oxidase activity, or to the uncoupling of electron transport from the 
generation of the proton motive force as is true of classical respiratory uncouplers such 
as CCCP (Lou et al., 2007). Instead, it is hypothesised that CORM-3 enables the 
movement of potassium or sodium ions into the cell, which results in less back pressure 
from positive charges outside of the cell, and therefore favours proton extrusion coupled 
to respiration (Wilson et al., 2013). It was also found that incubation of CORM-3 with 
the bacterial suspension under anoxic conditions for increased time periods resulted in 
greater inhibition. Respiratory inhibition was also observed in P. aeruginosa, 
Salmonella enterica serovar Typhimurium and the yeast Candida albicans, although a 
higher concentration of CORM-3, 250 µM instead of 100 µM, was needed to see these 
effects in yeast.  
 
It was initially assumed that the inhibition of respiration by CO from CO-RMs was a 
major cause of killing by these compounds (Davidge et al., 2009b; Desmard et al., 
2009). However, the fact that cultures grown anaerobically also experience decreased 
viability in the presence of CO (Nobre et al., 2007, Nobre et al., 2009 and Davidge et 
al., 2009b), suggests that aerobic respiration is not the only site of action of CO in 
bacteria. Further evidence that the inhibition of respiration may not be the main cause of 
killing by CO-RMs is provided by a study on the effects of CORM-3 on the growth and 
respiration of C. jejuni (Smith et al., 2011). In this bacterium, 100 µM CORM-3 
diminished the rate of respiration, but had no effect on the growth rate. This was 
unexpected, as it was assumed that CO-RMs would be more inhibitory to C. jejuni as it 
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grows under microaerobic conditions, which could be expected to favour competitive 
inhibition by CO. It was suggested that C. jejuni may be better able to tolerate CO, due 
to its ability to grow on haem as an iron source consummate with its pathogenic lifestyle 
(Smith et al., 2011). 
 
1.3.4 The effects of CO-RMs on gene expression 
To date, three studies have investigated the effects of CO-RMs on transcriptional 
regulation in E. coli. Nobre et al. (2009) concluded that CORM-2 has a greater effect on 
gene expression in anaerobic cultures as genes belonging to eight functional classes 
were down-regulated anaerobically, but not affected aerobically; this is in agreement 
with the findings of this group that anaerobic cultures are more sensitive to this 
compound. This work showed that the expression of the redox sensors OxyR and SoxS, 
which activate the expression of Fur, a repressor of ferric ion uptake, is up-regulated by 
CORM-2. The gene oxyR was up-regulated in aerobic conditions in the presence of 
CORM-2, whereas the expression of soxS was up-regulated at all oxygen tensions. 
Evidence was also presented that CORM-2 affects methionine metabolism and biofilm 
formation.  
 
In contrast, Davidge et al. (2009b) found transcription in aerobic cultures to be affected 
more by CORM-3 than that in anaerobic conditions. They found CORM-3 to up-
regulate 63 genes and down-regulate 183 genes aerobically compared to the up-
regulation of 29 genes and down-regulation of 41 genes anaerobically. Many of the 
down-regulated genes encode important aerobic respiratory complexes confirming that 
aerobic respiration is a major target of CORM-3 (Davidge et al., 2009b). Most notable 
was the 10 - 22-fold reduction in transcription of the cyo operon, which encodes the 
cytochrome bo’ terminal oxidase involved in aerobic respiration; the sdh operon that 
encodes succinate dehydrogenase, which links the citric acid cycle to the electron 
transport chain and the nuo operon, which encodes NADH dehydrogenase-1. In 
contrast, cytochrome bd-I, which has a high affinity for oxygen was up-regulated by 
CORM-3. The increase in cytochrome bd-I levels and the reduction in cytochrome bo’ 
was confirmed spectrophotometrically (Davidge et al., 2009b). Anaerobically, although 
fewer genes were affected, there was still down-regulation of some of the genes 
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involved in respiration, including those encoding some of the subunits of cytochrome 
bo’ and cytochrome bd-I (Davidge et al., 2009b).  
 
Both groups found genes involved in regulating transition metal metabolism, 
homeostasis and transport within the cell to be differentially expressed, particularly 
those involved with iron, zinc and copper. This is consistent with the propensity of CO 
to bind to transition metals (Boczkowski et al., 2006). 
  
The most affected gene in the presence of CORM-3 was spy, an envelope-stress-
induced periplasmic protein that is regulated by the transcription factors BaeSR and 
CpxAR and is induced by zinc and copper. The spy gene was up-regulated more than 
100-fold anaerobically, and 26-fold aerobically, although the reason for this dramatic 
up-regulation is not understood. Other zinc-related genes were also affected leading to 
the suggestion that CORM-3 adversely affects zinc release (Davidge et al., 2009b). This 
gene was also up-regulated by CORM-2, and was affected more in aerobic conditions 
than in anaerobic conditions (Nobre et al., 2009). 
 
Interestingly, genes encoding transporters were affected, which could suggest attempts 
by the cell to prevent entry of CORM-3, or to increase efflux. The genes encoding the 
methyl-galactoside transporter (mglABC) were down-regulated, while those encoding 
the mdtABC operon, which is involved in a multi-drug export system, were up-regulated 
by 8 - 13-fold (Davidge et al., 2009b). 
 
This work used statistical modelling of the array data to identfy 8 transcription factors 
that are significantly affected by CORM-3: ArcA, FNR, CRP, Fis, Fur, BaeR, CpxR and 
IHF (Davidge et al., 2009b). It is difficult to envisage how most of these are affected by 
CO, although the response of ArcA is understood. The two-component system, ArcAB 
responds to changes in the redox state of the respiratory chain. Inhibition of respiration 
by CO from CORM-3 would lead to accumulation of reduced ubiquinone, which allows 
auto-phosphorylation of ArcB and the subsequent phosphorylation of ArcA, which 
inhibits the transcription of ArcA-regulated genes, including those encoding 
components of the aerobic respiratory chain (Davidge et al., 2009b). 
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A subsequent time-resolved transcriptional analysis compared the effects of a sub-lethal 
concentration of CORM-3 (40 μM) with the control compound iCORM-3 on gene 
expression in aerobically grown E. coli (McLean et al., 2013). The control compound 
evoked a much smaller transcriptomic response than CORM-3, with only 2% of the 
genome significantly affected, compared to 23% at 40 min in the presence of CORM-3. 
 
Both CORM-3 and iCORM-3 altered the expression of several genes involved in energy 
metabolism, amino acid metabolism and ABC (ATP-binding cassette) transport. The 
expression of genes involved in sulfate transport and utilization were also affected by 
both. However CORM-3 had a wider range of effects than iCORM-3, and also affected 
the expression of genes involved in signal transduction, carbohydrate metabolism and 
cell motility. That motility is affected by CO was confirmed by swarming assays, in 
which significantly less swarming occurred in an atmosphere of 50% CO compared to 
control conditions. Following the discovery that the dppABCDF operon, which encodes 
a dipeptide permease, is down-regulated, growth and ruthenium uptake analysis was 
performed to assess whether this transporter is responsible for CO-RM uptake; however 
this was not found to be the case. This transporter is also capable of acting as a haem 
permease (Letoffe et al., 2006), which could indicate a role in the acquisition of haem to 
replace haem centers that have been damaged by CO. 
 
1.4 The aerobic respiratory chain of Escherichia coli 
Respiration is an essential process that allows the generation of a proton motive force 
across a proton-impermeable membrane, by the net movement of protons from the 
cytoplasm to the periplasm in gram negative bacteria (Poole and Cook, 2000). This 
proton gradient can be used for the production of ATP or other processes that require 
energy, such as solute transport or motility. 
 
Aerobic respiration in bacteria involves the transfer of electrons from an electron-
donating substrate through a series of electron carriers that are sequentially oxidised and 
reduced, before the final transfer of the electrons to O2, and the formation of H2O. The 
complete reduction of O2 to H2O requires 4 electrons. Aerobic respiration is favourable 
compared to anaerobic energy production,  as the redox potential of oxygen reduction to 
water is + 815 mV and therefore results in more ATP generation than other terminal 
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electron acceptors such as the reduction of NO3- to NO2- (with a redox potential of + 
430 mV), or that of fumarate to succinate (+ 33 mV) (Poole and Cook, 2000). However, 
the use of oxygen as an electron acceptor requires its activation by a metal center, 
generally provided by two haem groups or a haem-copper center in the active site of 
terminal oxidases. 
 
Most bacteria have a degree of redundancy in their respiratory chains, which allows 
them to respond to, and survive in, many different environmental conditions (reviewed 
by(Poole and Cook, 2000). E. coli is a particularly good example of this. As 
exemplified above, not only can E. coli respire both aerobically and anaerobically using 
a variety of different substrates (and in the case of anaerobic respiration; using a range 
of electron acceptors), its aerobic respiratory chain can consist of 5 possible 
NADH:quinone oxidoreductases and 3 possible terminal oxidases. NADH 
dehydrogenase 1 (NDH-1) (Ohnishi et al., 1994) translocates 4 protons across the 
membrane for each pair of electrons that it accepts (Calhoun et al., 1993), while NDH-2 
(Bjorklof et al., 2000) is not electrogenic (Calhoun et al., 1993). The other three 
NADH:quinone oxidoreductases; WrbA (Patridge and Ferry, 2006), YhdH 
(Sulzenbacher et al., 2004) and QOR (Thorn et al., 1995), are also not thought to 
contribute to the generation of the proton motive force. A diagrammatic representation 
of the main components of the branched aerobic respiratory chain of E. coli is shown in 
Figure 1.4. 
 
By using different combinations of these respiratory chain components, different 
amounts of ATP can be produced for each molecule of oxygen that is reduced. This 
flexibility may allow the cell to respond to the varying rate at which electrons enter the 
respiratory chain, and allow more efficient production of products from the carbon 
source by minimising ATP and therefore biomass production (Calhoun et al., 1993). 
The expression of respiratory chain components is precisely regulated and depends on 
several factors, including growth rate and the environmental conditions such as pH.
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1.4.1 The terminal oxidases of the aerobic respiratory chain 
The three terminal oxidases that can be expressed in E. coli are cytochrome bo’, 
cytochrome bd-I and cytochrome bd-II. All three catalyse the oxidation of ubiquinol and 
the reduction of oxygen to water, yet each have distinctive properties, outlined below. 
Each oxidase has a different affinity for oxygen (D'mello et al., 1996), contribution to 
proton translocation (Calhoun and Gennis, 1993) and pattern of expression as a result of 
transcriptional regulation (Gunsalus, 1992; Tseng, 1996). A diagrammatic 
representation of cytochrome bo’ and cytochrome bd-type oxidases can be seen in 
Figure 1.5. 
 
1.4.1.1  Cytochrome bo’ 
Cytochrome bo’ is a haem-copper oxidase containing the redox centres haem b, haem o’ 
and CuB. It is expressed at high oxygen concentrations as it has a relatively low affinity 
for oxygen (Km = 0.016 – 0.35 µM (D'mello et al., 1995)), but a high affinity for 
ubiquinol. Cytochrome bo’ is a proton pump and actively translocates up to 4 protons 
across the bacterial membrane for each pair of electrons that it accepts (Puustinen et al., 
1989). A low-spin six-coordinate haem (haem b) oxidises ubiquinol and transfers 
electrons to the binuclear centre, which is composed of a five-coordinate high-spin 
haem o’ and a copper ion (CuB). It is at this binuclear centre that oxygen is reduced to 
water (Mogi et al., 1994). 
 
Cytochrome bo’ is encoded by the cyo operon, the expression of which is repressed 
under anaerobic conditions by the ArcA/ArcB two-component system and the 
transcriptional regulator, Fnr (Gunsalus and Park, 1994). The expression of this oxidase 
is also affected by the available carbon source used for growth and is up-regulated by 
iron limitation. 
 
1.4.1.2 Cytochrome bd-I 
Cytochrome bd-I has 3 redox centres, low-spin haem b558 and high-spin haem b595 and 
haem d (Borisov, 1996; Junemann, 1997; Trumpower and Gennis, 1994). Oxygen binds 
to heam d and is reduced to water by a unique di-haem site comprising haems b595, and 
d. Cytochrome bd-I has an exceptionally high affinity for oxygen (Km of 3-8 nM 
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(D'mello et al., 1996)) and a relatively low affinity for ubiquinol. Unlike cytochrome 
bo’, cytochrome bd-I does not actively pump protons across the membrane; however, 
the oxidation of ubiquinol at the periplasmic side of the membrane releases protons, 
while the reduction of oxygen to water occurs at the cytoplasmic face of the membrane 
and requires the consumption of protons, therefore resulting in a net translocation of 2 
protons for each pair of electrons transferred to O2 (Puustinen et al., 1991). 
 
Cytochrome bd-I is encoded by the cydAB operon, and like cytochrome bo’, expression 
of this oxidase is repressed by Fnr anaerobically (Gunsalus and Park, 1994); however, 
in contrast, expression is induced under low oxygen conditions by the ArcA/ArcB two-
component system. This leads to maximal gene expression under microaerobic 
conditions. Arc also regulates the expression of this operon in response to heat shock.   
 
In addition to the role of cytochrome bd-I in enabling aerobic respiration in 
microaerobic conditions, it has also been suggested that this oxidase may be required to 
help E. coli survive when faced with unfavourable growth conditions (Avetisyan et al., 
1991) and environmental stresses (Poole and Cook, 2000; Poole et al., 1989), and that 
high levels of cytochrome bd-I may be related to increased virulence of certain 
pathogens (Borisov et al., 2007). Additionally, cytochrome bd-I may protect E. coli 
from NO-induced growth inhibition (Mason et al., 2009). Exposure of E. coli to NO up-
regulates expression of cydAB and causes greater inhibition of growth and respiration in 
a strain containing cytochrome bo’ as the only terminal oxidise (see section 3.3.3).  
 
1.4.1.3 Cytochrome bd-II 
The third, more recently recognised terminal oxidase, cytochrome bd-II (Sturr et al., 
1996), is able to reduce oxygen to water, but was initially suggested to be non-
electrogenic, and therefore was thought to provide a route by which catabolism could be 
uncoupled from ATP synthesis  (Bekker et al., 2009). However, a more recent paper has 
disputed this and presents evidence that cytochrome bd-II does generate a proton motive 
force and thus contributes to the synthesis of ATP and the transport of nutrients 
(Borisov et al., 2011b). This work shows that cytochrome bd-II generates this proton 
gradient in the same way as cytochrome bd-I, and that it too extrudes approximately 2 
H+ for each pair of electrons transferred to O2.  
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Cytochrome bd-II has a lower affinity for ubiquinol than the other terminal oxidases of 
E. coli, while the affinity of this oxidase for O2 is under dispute. Measurements made 
using a membrane-covered Clark electrode suggested the Km of cytochrome bd-II for 
oxygen was 2 μM (Bekker et al., 2009), although this method is insufficiently sensitive 
to accurately measure such values. A recent paper calculated the oxygen affinity of this 
oxidase using leghaemoglobin deoxygenation measurements and reported a Km value 
almost 10-fold lower (0.24 μM) (Jesse et al., 2013). Irrespective of this discrepancy, it 
is clear that cytochrome bd-II has a lower oxygen affinity than cytochrome bd-I. 
 
The amino acid sequences of both subunits of cytochrome bd-I and bd-II are highly 
homologous (approximately 60% identity). Cytochrome bd-II  is encoded by the appBC 
operon (Dassa et al., 1991), which is regulated by the transcriptional activator AppY 
(Atlung and Brondsted, 1994). Expression of this operon is induced by anaerobic 
conditions, upon entry into the stationary phase and by carbon or phosphate starvation. 
 
1.4.1.4 Kinetics of CO binding to and dissociation from the terminal oxidases of 
E. coli  
In cytochrome bd-I, CO binds predominantly to haem d, however, at high 
concentrations (mM) some CO binds to haem b558, despite this being a low-spin haem 
(Borisov, 2008). The Kd value for cytochrome bd-I in membranes is fast as compared to 
heme-copper oxidases, 70 nM for cytochrome bd-I, as measured using myoglobin 
(Borisov, 2008), compared to 1.7 μM for cytochrome bo’ (Cheesman et al., 1993). For 
cytochrome bd - I, the koff is 6 or 1.6 s-1 according to the method used (Borisov et al., 
2007). The experimentally determined Kd is consistent with the faster off 
 rate of 6 s-1 (Borisov, 2008). However, there are disagreements in the literature; 
Cheesman et al. (1993) report a Koff (CO) value of  < 10 s-1 for cytochrome bo’, but the 
dependence of the pseudo-first-order rate upon CO concentration suggests a value 
around 1 s-1. Subsequent citing of these data, however, gives a Koff (CO) value of 0.1 s-1 
(Hill, 1994). This suggests that the different sensitivities of cytochrome bo’ and bd-I for 
CO cannot be explained by the respective CO off-rates (Jesse et al., 2013). The affinity 
of cytochrome bd-II for CO has not been reported.  
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1.4.2 An exception to the rule: the alternative oxidase (AOX)  
In contrast to the terminal oxidases described above, some bacteria, notably the marine 
organism Vibrio fischeri, contain a functioning terminal oxidase that does not contain 
haem. This oxidase will be discussed in detail in Chapter 4. 
 
1.5 Conclusions and scope of thesis. 
Despite the established perception of CO as a respiratory inhibitor and ‘toxic’ molecule, 
appreciation has grown in recent years of the importance of this endogenous molecule 
in mammalian physiology, not least as a regulator of vascular tone and the 
inflammatory response to infection, as well as its vital role in maintaining cellular 
homeostasis. Preclinical and clinical trials into the use of CO as a therapeutic agent are 
underway, and CO, delivered through inhalation or through administration as a CO-RM, 
is hoped to have wide-reaching potential (Motterlini et al., 2005a).  
 
Many bacteria can utilize CO as a carbon source and many bacteria, particularly 
pathogenic and commensal species, possess HOs, and therefore produce this gas 
endogenously. There is a long history of the addition of CO to meat packaging in order 
to improve appearance, and reduce microbial growth  (Clark et al., 1976). However, it is 
only in the past six years, following the advent of CO-RMs, that CO has been 
investigated as a potential bactericidal agent. CORM-3 has been shown to be 
bactericidal to clinical isolates of P. aeruginosa at concentrations 50-fold lower than 
those that cause cytotoxicity to mammalian cells (Desmard et al., 2009). Several CO-
RMs have been shown to be bactericidal to numerous species of Gram-positive (Nobre 
et al., 2007) and Gram-negative (Davidge et al., 2009b) bacteria, although as yet, the 
mechanism(s) of killing by these compounds is not clear. 
 
CO-RMs are particularly promising as novel antimicrobial agents for several reasons. 
Firstly, the rapid rise in antibiotic-resistant microbes is limiting the usefulness of 
traditional antibiotics, which is likely to have devastating consequences within the next 
few years unless alternative therapeutically safe bactericidal drugs can be established. 
Secondly, CO-RMs provide ideal means of storing CO and facilitating its delivery, with 
the potential to control CO release, directly to the site at which it is needed. A variety of 
CO-RMs are available, with a wide array of properties, and much research and several 
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clinical trials are underway into the use of many of these as therapeutic agents. Thirdly, 
CO-RMs have been shown to be much more effective at killing bacterial cells than the 
equivalent concentration of CO gas (Davidge et al., 2009b; Nobre et al., 2007). This 
potentiation of the bactericidal effects of CO is hypothesised to be due to the delivery of 
CO into bacterial cells, causing an accumulation of CO at the micro-domains at which it 
acts, although this is still unproven. 
 
However, many questions remain in this new field. It is not well understood how CO-RMs 
kill bacteria. Initially, inhibition of respiration was considered to be a likely cause of the 
bactericidal properties of CO-RMs, and several pieces of evidence support this hypothesis. 
CO from CORM-3 has been shown to bind rapidly to the terminal oxidases of the aerobic 
respiratory chains of E. coli (Davidge et al., 2009b) and P. aeruginosa, and a reduction in 
oxygen consumption in the later has been observed following treatment with this 
compound, prior to a decrease in viability (Desmard et al., 2009). In contrast, there is 
evidence that inhibition of respiration is not the main cause of killing by CO-RMs. In C. 
jejuni, CO-RMs have been shown to inhibit respiration, without adversely effecting growth 
or viability (Smith et al., 2011), and transcriptomic analysis of E. coli treated with 
CORM-3 suggests that while respiratory genes are greatly affected by this compound, 
the expression levels of a wide variety of non-respiratory genes are also significantly 
affected (Davidge et al., 2009b). Furthermore, the growth and viability of anaerobic 
cultures is also adversely affected by treatment with CORM-3 (Davidge et al., 2009b) 
and CORM-2 (Nobre et al., 2009). 
 
An alternative hypothesis is that CO-RMs are bactericidal because they generate ROS 
(Tavares et al., 2011). Again there are several pieces of evidence both for and against 
this suggestion. Research has shown that CORM-2 generates hydroxyl radicals in vitro, 
and that E. coli mutants unable to resist oxidative stress are hypersensitive to killing by 
this compound (Tavares et al., 2011). However, other work has found no evidence of 
ROS formation by CORM-3 (Desmard et al., 2009; Desmard et al., 2012) or CORM-2 
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(Murray et al., 2012). Figure 1.6 shows a diagrammatic representation of our 
understanding of the effects of CO-RMs on bacterial cells. 
 
The work presented in this thesis therefore aims to investigate the mechanisms of 
bacterial killing by CO-RMs, particularly by water-soluble CORM-3. Initial work 
focused on investigating the effects of CO-RMs on bacterial respiration, and 
particularly on the interaction of CO from CORM-3 with the terminal oxidases of the 
aerobic respiratory chain of the model organism E. coli (Chapter 3). Important 
differences between the behaviour of CO gas and CO from CO-RMs necessitated a 
thorough comparison of the effects of these two compounds on respiration. This work 
was extended through an investigation of the effects of CORM-3 on the growth and 
respiration of a mutant strain of the marine bacterium Vibrio fischeri (Chapter 4). This 
bacterium naturally contains a non-haem oxidase, AOX (alternative oxidase); therefore 
it was hypothesised that, if inhibition of haem-containing terminal oxidases is the 
primary cause of killing by CO-RMs, a strain of V. fischeri containing AOX as the only 
oxidase should be resistant to killing by this compound. 
 
Another unanswered question with regards to the mechanisms of CO-RM action is why 
thiol-containing compounds such as N-acetyl cysteine (NAC), cysteine and reduced 
glutathione (GSH) prevent the bactericidal action of CO-RMs. There is conflicting 
evidence as to whether it is the anti-oxidant properties of these molecules that 
ameliorate the effects of CO-RMs (Desmard et al., 2012; Tavares et al., 2011). 
Therefore, a thorough investigation was undertaken into the mechanisms by which thiol 
compounds prevent killing by CO-RMs, and into whether CORM-3 causes the 
production of reactive oxygen species (Chapter 5). 
 
Finally, uncertainty surrounding the mechanisms of action of CO-RMs on bacteria led 
to a search for new bacterial targets of CO-RMs. Consequently, random transposon 
mutants of E. coli were generated and then screened for CORM-2-resistance (Chapter 
6).  
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Figure 1.6 The effects of CO-RMs on the bacterial cell. CO-RMs may release CO 
extracellularly (1); external CO could then be detected using myoglobin (2). 
Alternatively, CO-RMs may be transported into the cell (3) by unknown pathways 
(possibly via a membrane importer as shown). Once inside the cell, the CO dissociates 
(4) from the CO-RM (with formation of iCO-RM, the inactive form). CO will then react 
with biological targets, including the haem centres of terminal oxidases in the cell 
membrane (5). Other targets include membrane transporters (6) and transcription factors 
(7) that regulate gene expression. The fate of CO-RM or iCO-RM in the cell is 
unknown but it is possible that the compounds are exported (8). 
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Chapter 2 
 
Materials and Methods 
2. Materials and Methods 
2.1 Bacteriological Methods    
2.1.1 Strains 
The bacterial strains used in this work are described in Table 2.1 
 
2.1.2 Media 
All media were prepared with distilled, deionised water and sterilised by autoclaving at 
121 psi for 15 min. Unless stated otherwise, all chemicals were purchased from Sigma 
Aldrich and solutions were filter-sterilised as needed using Millipore filters with a pore 
size of 0.2 µm. 
 
2.1.2.1 Luria Bertani broth (LB) 
Into 1 l of H2O was dissolved tryptone (10 g), yeast extract (5 g) (both from Oxoid) and 
NaCl (10 g) (BDH). The pH was then adjusted to 7.0 (Sambrook and Russell, 2001). 
 
2.1.2.2 Defined minimal medium 
Into 990 ml of H2O was dissolved K2HPO4 (4 g), NH4Cl (1 g), CaCl2 (10 mg), K2SO4 
(2.6 g) and glycerol (5 g). To this, 10 ml of trace element solution was added. The pH 
was then brought to 7.4 and the media was autoclaved. Before use, 1 ml l-1 of 1 M 
MgCl2 was added. 
 
2.1.2.3 Trace element solution for defined minimal medium 
Into 700 ml of H2O was added EDTA (5 g) and the pH adjusted to 7.4. Then 
FeCl3.6H2O (0.5 g), ZnO (50 mg), CuCl2.2H2O (10 mg), H3BO3 (10 mg), ammonium 
molybdate (0.12 mg) and sodium selenite (17 mg) were added. The volume was brought 
up to 1 l with H2O and the media was filter-sterilised (Flatley et al., 2005). 
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Table 2.1 Bacterial strains used in this work 
  
 Phenotype Genotype Source/Reference 
Escherichia coli  
MG1655 Wild type, K12 Wild type 
F- lambda- ilvG  rfb-50 rph-1 
(Blattner et al., 1997) 
TBE023 Cyd+App+Cyo+ MG1655 ΔnuoB::kan Kindly given by Alex Ter 
Beek, University of 
Amsterdam 
TBE025 Cyo+ MG1655 ΔcydB nuoB appB::kan Kindly given by Alex Ter 
Beek, University of 
Amsterdam 
TBE026 App+ MG1655 ΔcydB nuoB cyoB::kan Kindly given by Alex Ter 
Beek, University of 
Amsterdam 
TBE037 Cyd+ MG1655 ΔappB nuoB cyoB::kan Kindly given by Alex Ter 
Beek, University of 
Amsterdam 
 
frvB mutant  frvB::kan  
From the Keio collection 
Kindly given by Simon 
Andrews, The University of 
Reading. 
manX mutant  manX::kan 
From the Keio collection 
Kindly given by Simon 
Andrews, The University of 
Reading. 
sgaU mutant  sgaU::kan 
From the Keio collection 
Kindly given by Simon 
Andrews, The University of 
Reading. 
    
Iq Express 
competent E. coli 
 BL21 MiniF lacIq (CamR) / 
fhuA2 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 
[dcm] R(zgb-210::Tn10--TetS) 
endA Δ(mcrC-mrr)114::IS10 
 
New England Biosciences 
gshA mutant  MG1655 ΔgshA::kan This work 
 
Vibrio fischeri  
ES114  Wild type  V. fischeri (Boettcher and Ruby, 1990) 
 
AKD788  ES114 Δaox ΔccoNOQP (Dunn et al., 2010) 
 
AKD789  ES114 ΔcydAB ΔccoNOQP (Dunn et al., 2010) 
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2.1.2.4 Evans medium 
The following solutions were added to 1 l H2O to the stated final concentrations: 
NaH2PO4.2H2O (10 mM), KCl (10 mM), MgCl2.6H2O (1.25 mM), NH4Cl (100 mM), 
Na2SO4 (2 mM) and CaCl2.2H2O (20 µM). Evans trace elements solution (5 ml) and 10 
µl of a 3 mg ml-1 solution of Na2SeO3.5H2O was then added along with nitrilotriacetic 
acid (0.38 g). The pH was adjusted to 7.5 with the addition of NaOH and the solution 
was autoclaved. Once cool, 20 ml of 1 M sterile glucose was added (Evans, 1970). 
 
2.1.2.5 Trace element solution for Evans medium 
Into 990 ml of H2O was added 8 ml of 37% HCl, ZnO (0.412 g,) FeCl3.6H2O (5.4 g), 
MnCl2.4H2O (2 g) CuCl2.2H2O (0.172 g), CoCl2.6H2O (0.476 g), H3BO3 (64 mg) and 
Na2MoO4.2H20 (4 mg). The solution was then filter-sterilised. 
 
2.1.2.6 LBS medium 
To 1 l H2O was added bactotryptone (10 g), yeast extract (5 g), NaCl (20 g) and 20 ml 
of a 1 M solution of Tris HCl. The pH was then adjusted to 7.5 and the medium was 
autoclaved. When solid LBS was required, 15 g l-1 of agar was added before autoclaving 
(Stabb et al., 2001). 
 
2.1.2.7 Artificial sea water (ASW) 
To make 1 l of medium, KCl (1.5 g) and NaCl (23.38 g) was dissolved in 809 ml H2O. 
To this 100 ml of 1 M MgSO4, 20 ml of 1 M CaCl2, 1 ml of 5.4% (w/v) K2HPO4, 50 ml 
of 1 M Tris HCl (pH 7.5) and 20 ml of 0.5 M N-acetyl glucosamine was added. The 
medium was then filter-sterilised (Reichelt and Baumann, 1973). 
 
2.1.2.8 SOC medium 
To 1 l H2O was added bactotryptone (20 g), yeast extract (5 g), NaCl (0.5 g) and 10 ml 
of a 250 mM solution of KCl. The pH was then adjusted to pH 7 and the medium was 
autoclaved. Before use, 10 ml of 1 M MgCl2 and 20 ml of sterile 1 M glucose was 
added. 
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2.1.2.9 TY medium 
To 100 ml H2O was added bactotryptone (1.6 g), yeast extract (1 g) and NaCl (1 g), the 
medium was then autoclaved (Sambrook and Russell, 2001). 
 
2.1.2.10 TB medium  
To 100 ml H2O was added bactotryptone (0.8 g) and NaCl (0.5 g). The medium was 
then autoclaved. 
 
2.1.2.11 TB soft agar  
To make TB soft agar, agar (0.7 g) was added to TB medium (100 ml) prior to 
autoclaving. 
 
2.1.2.12 Nutrient agar (NA). 
Nutrient agar (Oxoid) was dissolved at 2.8% w/v in H2O. 
 
2.1.2.13 Phage lysate plates 
To 500 ml H2O was added bactotryptone (4 g), yeast extract (2.5 g), NaCl (2.5 g), 
glucose (1 g) and agar (6 g). This was then autoclaved and cooled to approximately 50 
°C before the addition of 5 ml of 0.5 M CaCl2, 5 ml 1 M MgCl2.6H2O and 0.5 ml 10 M 
FeCl3 (all of which had been filter-sterilized), (Miller, 1972). Plates were refrigerated 
immediately after pouring to ensure a moist atmosphere. 
 
2.1.2.14 LBS Plates 
To make LBS plates, agar (7.5 g) was added to LBS medium (500 ml) prior to 
autoclaving (Stabb et al., 2001). 
 
2.1.3 Buffers and Solutions 
2.1.3.1 Phosphate buffered saline (PBS) 
To 1 l of H2O was added NaCl (8 g), Na2HPO4 (1.15 g), KCl (0.2 g) and K2HPO4 (0.2 
g). The pH of this solution was the adjusted to 7.4 before autoclaving.     
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2.1.3.2 KPi buffer 
Potassium phosphate buffer was made using 1 M stock solutions of K2HPO4 and 
KH2PO4. These were mixed together in the appropriate ratios to give the desired pH. For 
a solution of pH 7.0, 61.5 ml K2HPO4 and 38.5 ml KH2PO4 were mixed, for a solution 
of pH 7.4, 80.2 ml K2HPO4 and 19.8 ml KH2PO4 were mixed together and for a solution 
of pH 7.8, 90.8 ml K2HPO4 and 9.2 ml KH2PO4 were mixed together; each of these 
stocks was then diluted 1 in 10 to 0.1 M. 
 
2.1.3.3 Sonication buffer 
To 1 l H2O was added 50 mM Tris HCl (7.88 g), 2 mM MgCl2 (395.8 mg) and 1 mM 
EGTA (380.35 mg).  The pH of this solution was the adjusted to 7.4 and then filter-
sterilised.        
 
2.1.3.4 Vibrio phosphate buffer   
To 900 ml H2O was added 100 ml of 0.2 M potassium phosphate buffer (pH 7.8), 10 
mM MgSO4 (2.46 g) and 0.2 M NaCl (11.69 g).  
 
2.1.3.5 TAE buffer (50x) 
To 843 ml H2O was added 242 g Trisma base, 57.1 ml glacial acetic acid and 100 ml 
Na2EDTA (0.5 M, pH 7.8). This was then diluted 1:50 with H2O before use to give 1x 
TAE buffer. 
 
2.1.3.6 Phage lysate buffer 
To 500 ml H2O was added Tris base (0.61 g), MgSO4.7H2O (1.23 g), CaCl2.2H2O (0.37 
g) and NaCl (1.47 g). The pH was adjusted to 7.5 and the solution autoclaved (Miller, 
1972). 
 
2.1.3.7 Sodium dithionite solution 
A fresh solution of sodium dithionite (0.1 M) was made immediately prior to use in 5 
ml KPi (0.1 M, pH 7.0, previously degassed by bubbling with N2 from a cylinder (BOC) 
for 10 min) in a sealed 7 ml Bijoux bottle fitted with a Suba-Seal and vent. This solution 
was further degassed after addition of the sodium dithionite by bubbling with N2 for 10 
min.  
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2.1.3.8 CO-saturated solution 
CO-saturated solutions were made by bubbling the appropriate buffer with CO gas from 
a cylinder (BOC, Guildford) in a 7 ml Bijoux bottle fitted with a Suba-Seal and gas 
escape needle at room temperature for 15 min. This generates a solution of 
approximately 1 mM, as verified spectroscopically by a myoglobin assay (section 
2.3.1.1). 
 
2.1.3.9 N2-saturated solution 
N2-saturated solutions were made by bubbling the appropriate buffer with N2 gas from a 
cylinder (BOC, Guildford) in a 7 ml Bijoux bottle fitted with a Suba-Seal and gas 
escape needle at room temperature for 15 min.  
 
2.1.4 Strain Storage 
2.1.4.1  E. coli 
Strains were cultured on NA plates and stored at 4 °C and, when necessary, subcultured 
onto fresh plates. Glycerol stocks were made by adding 2 ml sterile LB medium 
containing 25% (v/v) glycerol onto a lawn of bacteria grown on NA. The bacteria were 
resuspended and removed using a sterile 1 ml pipette. This slurry was dispensed into a 
cryovial (Nalgene) and stored at - 80 °C. 
 
2.1.4.2 V. fischeri 
Strains were cultured on LBS plates and stored at 4 °C. Fresh plates were made directly 
from the glycerol stock prior to each experiment. Glycerol stocks were made by adding 
2 ml sterile LB medium containing 25% (v/v) glycerol onto a lawn of bacteria grown on 
NA. The bacteria were resuspended and removed using a sterile 1 ml pipette. This slurry 
was dispensed into a cryovial (Nalgene) and stored at - 80 °C. 
 
2.1.4.3 Bacteriophage 
P1 vir phage lysates were stored at 4 °C in air-tight vials containing a few drops of 
chloroform. 
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2.1.4.4 Antibiotics 
Kanamycin and ampicillin stock solutions (both 50 μg ml-1) were prepared in H2O and 
filter-sterilised using a 0.2 μm filter (Sartorius Stedim Biotech). Antibiotics were stored 
at - 20 °C. 
 
2.1.5   Culture conditions 
All cultures were grown aerobically with shaking at 200 rpm to ensure even oxygen 
distribution. 
 
2.1.5.1 Cultures for E. coli growth and viability studies 
E. coli starter cultures of the appropriate strain were grown in 10 ml LB broth for 7 h 
and then the LB removed by centrifugation at 5500 rpm for 5 min. The cells were then 
washed in aerobic defined minimal medium and pelleted once more, before being 
resuspended in defined minimal medium (10 ml) and a 0.1 % v/v inoculum added to 30 
ml aerobic defined minimal medium in side arm conical flasks. The cultures were kept 
at 37 °C and were shaken at 200 rpm. For growth studies, CO-RM was added after the 
OD of the cultures reached 30 Klett units at the concentration specified in the 
appropriate Figure legends, whereas for viability studies, CORM-3 was added at 50 
Klett units.  
 
2.1.5.2 Cultures for V. fischeri growth studies 
 
To measure the sensitivity of a strain to a range of CO-RM concentrations (0-100 µM), 
starter cultures were were grown in 10 ml LBS for 6 h. The LBS was removed by 
centrifugation at 4500 rpm for 5 min. The cells were then washed in ASW and pelleted 
once more, before being resuspended in ASW. An inoculum (20 µl) was added to 5 ml 
ASW in 20 ml Sterilin tubes with the appropriate volume of CO-RM. Cultures were 
incubated at 28 °C overnight and then OD600 measured using a Jenway 
spectrophotometer. 
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2.1.5.3 Cultures for the preparation of E. coli membrane particles  
To produce large quantities of cells from which to isolate membranes, starter cultures 
were grown in 5 ml LB broth and incubated at 37 °C with shaking at 200 rpm for 16 h. 
Each starter culture was then added to 995 ml of LB broth in 2 l baffled flasks, which 
were also kept at 37 °C, with shaking, until mid-exponential phase was reached. For 
each membrane preparation, 6 l of culture was grown. 
 
2.1.5.4 Cultures for the preparation of V. fischeri membrane particles 
Starter cultures were grown in 5 ml LBS broth and incubated at 28 °C for 16 h. An 
aliquot of this culture (2 ml) was then added to 1 l of LBS broth in 2 l conical flasks, 
which were also kept at 28 °C and shaken at 200 rpm until the culture reached an OD600 
of 1.0. For each membrane preparation, 5 l of culture was grown. 
 
2.1.5.5 Growing and sampling bacterial cells for ruthenium analysis (ICP-MS) 
Evans medium (200 ml) supplemented with glucose (4 ml of a 1 M stock solution) was 
transferred to a sterile 500 ml conical flask and inoculated with 10 µM starter culture of 
the appropriate strain, which had been grown for 8 h in LB and then pelleted and 
resuspended in double the volume of Evans medium. This was incubated overnight at 
37 °C with shaking at 200 rpm. When the cells reached an OD600 of approximately 0.4, 
a 20 ml sample was removed. Where appropriate, 40 µM CORM-3 or 20 µM CORM-2 
in combination with a 10 fold molar excess of NAC was added and the culture placed 
back in the incubator. Samples (20 ml) were taken at 2.5, 5, 10, 20, 40 and 80 min 
following the addition of CORM-3. The OD600 of the culture was read at each time-
point. Each sample was centrifuged for 20 min at 5,500 rpm at 4 °C. The supernatant 
was reserved. The cell pellet was resuspended in 0.5 ml nitric acid (0.5%) and this was 
centrifuged at 13,000 rpm for 5 min. This wash step was repeated twice more and the 
supernatant from each wash was retained along with the final pellet. This method was 
adapted from that described by (Davidge et al., 2009b; Graham et al., 2009). The 
protocol for ICP-MS is described in section 2.3.2.4. 
 
2.1.6 Culture turbidity measurements 
In order to measure the growth of a culture, the optical density was measured using a 
Klett-Summerson photoelectric colourimeter (Klett Manufacturing Co., New York) 
62 
 
with a number 66 red filter. A blank containing the sterile medium was used. Cultures 
were grown in conical side arm flasks, which allowed the optical density reading to be 
taken without removing any culture from the flask.  
 
2.1.7 Screening a library of E. coli transposon mutants 
2.1.7.1 The initial CORM-2 screen 
Cells treated with transposon (250 µl) were inoculated into 30 ml defined minimal 
medium in each of 3 Klett flasks. These cultures were incubated at 37 °C with shaking 
at 250 rpm until they reached approximately 25 Klett units (early exponential phase). 
CORM-2 (40 µM) or the equivalent concentration of the vehicle DMSO, was added, 
and the cultures incubated for a further 30 min at 37 °C with shaking at 250 rpm. The 
cultures were then washed by centrifugation at 4500 rpm for 4 min at 4 °C and then 
resuspended in 10 ml of defined minimal medium and then the centrifugation step 
repeated before finally resuspending in 500 µl defined minimal medium. This was then 
plated onto nutrient agar containing 30 µg ml-1 kanamycin.  
 
2.1.7.2 The second stage of the screen 
Each of the 288 kanamycin and putatively CORM-2 resistant colonies obtained in the 
initial CORM-2 screen was inoculated into 200 µl defined minimal medium in wells of 
a 96-well plate and grown for 8 h until a typical OD600 of between 0.1 and 0.3 was 
reached. CORM-2 (40 µM) was then added to each well and incubated at 37 °C with 
shaking for 16 h. OD600 was measured on a multilabel reader (VictorTM X3, Perkin 
Elmer). Mutants were regarded as interesting if they had an increase in OD600 > 0.2, 16 
h after treatment with CORM-2. 
 
2.1.7.3 CORM-2 susceptibility assay 
To measure the sensitivity of a strain to a range of CORM-2 concentrations (0-1.5 µM), 
starter cultures were prepared as described above (section 2.1.5.1) and a 20 µl inoculum 
added to 5 ml defined minimal medium in 20 ml Sterilin tubes with the appropriate 
volume of CORM-2. Cultures were incubated at 37 °C overnight with shaking at 200 
rpm and then OD600 measured using a spectrophotometer (Jenway). 
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2.1.7.4 The growth of transposon mutants of interest on plates containing CORM-2 
Overnight cultures of each transposon mutant of interest were grown in LB (10 ml). The 
cultures were harvested by centrifugation at 5000 rpm at 4 °C for 5 min, and the pellets 
resuspended in 10 ml defined minimal medium. An aliquot of each culture (50 μl) was 
added to 2.95 ml of molten defined minimal medium with 0.7% agar and maintained at 
50 °C, before the addition of various concentrations of CORM-2 (20 - 40 μM). This was 
mixed and poured onto a base layer of defined minimal medium with 1.5% agar and 
incubated overnight.  
 
2.1.7.5 Gradient plates 
Gradient plates consisting of two layers of agar were made as described by Gerhardt 
(1994) and used by Poole et al. (1989). The first layer consisted of defined minimal 
medium containing 1.5% agar, which was set at an angle (achieved by balancing the 
plate on the edge of a plate lid). The second layer consisted of defined minimal medium 
containing 0.7% agar, to which (after cooling to approximately 50 °C) 60 μM CORM-2 
was added. This agar containing CORM-2 was poured on to the first layer, resulting in a 
level agar plate, which had a maximal quantity of CORM-2 at one apex of the plate, 
which decreased gradually across the plate (for a diagrammatic representation of the 
construction of this plate, see Figure 6.5A and B). Cultures of each transposon mutant 
of interest, and the parent strain, were grown overnight in LB (10 ml) at 37 °C with 
shaking at 250 rpm; these cultures were then harvested by centrifugation at 5000 rpm at 
4 °C for 5 min, washed by resuspending in defined minimal medium, harvested once 
more and finally resuspended in 200 μl defined minimal medium. An aliquot of this 
suspension (50 μl) was streaked onto the CORM-2 gradient plates using a Gilson pipette 
to release the cell suspension along the concentration gradient, starting at the apex that 
had the least CORM-2. Care was taken to apply the suspension evenly and consistently 
between strains. The plates were then incubated at 37 °C overnight and then growth 
observed by eye. 
 
2.1.8 Viability Studies 
2.1.8.1 Viability Studies with E. coli 
Cultures were prepared as described above (section 2.1.5.1). In the case of CORM-3, 
samples were taken immediately prior to addition of CORM-3 or iCORM-3 (both at 30 
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μM) and at 10, 20, 30, 45, 60, 90 and 120 min thereafter, whereas in the case of CO-
RM-2, samples were taken immediately prior to addition of the CO-RM or 
RuCl2(DMSO)4 (20 - 50 μM) and after 30 min. Samples were diluted (10-5-10-8) and 
plated on to nutrient agar thus allowing the cfu ml-1 to be calculated. The experiments 
were performed with 3 independent cultures.  
 
2.1.8.1.1 Measuring the effect of photolysis on the viability of E. coli 
To evaluate the effect of photolysis of the haem-CO bond on bacterial viability, wild-
type MG1655 E. coli was grown to mid-exponential phase (50 Klett units) and 2 ml of 
culture transferred into each of two glass chambers (Strathkelvin instruments); one dark 
chamber (foil-wrapped) and one light chamber, on which a beam of light from a 150 W 
projector bulb was focused using a magnifying glass. Cultures were held at 37 °C and 
stirred magnetically at 260 rpm. Viable counts were performed as described above 
(section 2.1.8.1). 
 
2.1.9 Isolation of bacterial membrane particles  
Cells grown as described in section 2.1.5.1 and 2.1.5.2 were harvested by centrifugation 
at 12,000 g for 10 min at 4 °C. The pellets were then washed by resuspending in 8 ml of 
sonication buffer (for E. coli) or Vibrio phosphate buffer (for V. fischeri) and pelleting 
by centrifugation at 5500 rpm for 10 min at 4 °C. The cells were then resuspended in 4 
ml buffer to make a thick slurry and then broken by sonication at 12 µm ampliude for 5 
intervals of 30 s with a 15 s rest between each. The cells were kept on ice throughout 
this process. The sonicate was then centrifuged at 12000 g for 15 min at 4 °C in order to 
remove the unbroken cells. These unbroken cells were sonicated once more as above in 
order to ensure maximal cell breakage. The sonicate was centrifuged again at 12000 g 
for 15 min at 4 °C. The supernatant was then spun in an ultracentrifuge at 225,000 g for 
60 min at 4 °C in order to remove the membranes from the cytoplasm. The pellet 
obtained was resuspended in buffer using a glass homogeniser and the 
ultracentrifugation step repeated in order to wash the membranes. Finally, the pellets 
were resuspended in 3 ml buffer, frozen in liquid nitrogen and stored at – 70 °C in 200 
µl aliquots until required. This protocol is based on that of Poole (1993). 
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2.2 Biochemical Methods 
2.2.1 Carbon monoxide-releasing molecules (CO-RMs) 
2.2.1.1 Synthesis of CORM-3 
CORM-3 was either provided by Dr. Roberto Motterlini and Professor Brian Mann 
(Hemocorm), or synthesised by the following method as published by (Johnson et al., 
2007). CORM-2 ([Ru(CO)3Cl2]2, 0.129 g) and glycine (0.039 g) were placed under 
nitrogen in a round bottomed flask. Methanol (75 ml) and sodium ethoxide (0.034 g) 
were added and the reaction progressed for 18 h at room temperature while being 
magnetically stirred. The solvent was then removed under pressure and the residue 
redissolved in tetrahydrofuran. This was filtered and diethyl ether was added, followed 
by an excess of 40 - 60 light petroleum. The yellow solution was then evaporated under 
reduced pressure to give a pale yellow solid (typically 0.142 g, 96% yield). The purity 
of the CORM-3 preparation was assessed by infrared Anvel cell spectrophotometry 
performed by Dr. Robert Hanson and 1H NMR in methanol performed by Dr. Brian 
Taylor (both in the Chemistry Department of The University of Sheffield). CO-release 
by each CORM-3 preparation was measured spectroscopically by a myoglobin assay 
(Johnson et al., 2007) (see section 2.3.1.1). 
 
2.2.1.2  Preparation of CO-RM stock solutions and control compounds 
2.2.1.2.1 CORM-2 
CORM-2 was purchased from Sigma Aldrich. Fresh 10 mM stock solutions were made 
each hour by dissolving in DMSO and wrapped in foil to exclude light. 
 
2.2.1.2.2 CORM-3 
CORM-3 (tricarbonylchloro(glyinato)ruthenium(II)) was obtained from Professor Brian 
Mann (Alfama, previously Hemocorm). Stock solutions (10 mM or 100 mM) were 
made by dissolving in water and stored on ice. Stocks were used fresh or on the 
following day after overnight storage at 4 ºC. 
 
2.2.1.2.3 CORM-401 
CORM-401 [Mn(CO)4(S2CNMeCH2CO2H)], was obtained from Professor Brian Mann 
(Alfama, previously Hemocorm). Stock solutions (5 mM) were made by dissolving in 
PBS (pH 7.4, section 2.1.3.1). 
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2.2.1.2.4 Preparation of RuCl2(DMSO)4 
RuCl2(DMSO)4 was provided by Dr. Tony Johnson (Chemistry Department, University 
of Sheffield). A solution of this compound (100 mM) was prepared fresh for each 
experiment in distilled H2O. 
 
2.2.1.2.5 Preparation of iCORM-3 (inactive CORM-3) 
CORM-3 was dissolved in PBS to give a 5 mM solution. This was bubbled with 
nitrogen for 5 min immediately after it was made and then for 5 min every 2 h the 
following day (Clark et al., 2003; McLean et al., 2012). On the day of use, the solution 
was bubbled once more with nitrogen for 5 min. The lid was left off during the day, but 
closed overnight. Immediately prior to use, a myoglobin assay was performed (see 
section 2.3.1.1) to confirm that no CO was released from the iCORM-3. 
 
2.2.1.2.6 Preparation of miCORM-3  
miCORM-3 was prepared by treating CORM-3 twice with a 2-fold excess of ferrous 
myoglobin, reduced by adding sodium dithionite solution (2.2 mM final concentration 
in 0.1 M potassium phosphate, pH 7) to 1 mM metmyoglobin. Carbonmonoxy 
myoglobin was separated from the inactivated CORM-3 by centrifugation in a Vivaspin 
20 concentrator (Sartorius Stedim Biotech) with a molecular weight cut-off of 5 kDa 
(Wilson et al., 2013). Immediately prior to use, a myoglobin assay was performed (see 
section 2.3.1.1) to confirm that no CO was released from the miCORM-3. 
 
2.2.2 Determination of protein concentration 
The concentration of protein in whole cell and membrane samples was determined using 
the protocol established by Markwell et al. (1978). Cell and membrane samples were 
diluted as appropriate, typically by a factor of 20 initially, followed by 1 in 100, 5 in 
100, or 1 in 10 dilutions. Reagent A (100 parts) containing Na2CO3 (20 g l-1), NaOH (4 
g l-1), sodium tartrate (1.6 g l-1) and sodium dodecyl sulphate (SDS, 10 g l-1) was mixed 
with 1 part reagent B (CuSO4.5H2O, 40 g l-1); 3 ml of this was then added to each 
sample dilution. This was left to incubate at room temperature for 1 h, after which, 0.3 
ml Folin-Ciocalteau (Lowry) reagent (diluted 1:1 with H2O) was added to the samples 
and incubated at room temperature for a further 45 min. The absorbance of each sample 
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at 660 nm was then measured using a spectrophotometer (Jenway) against a H2O blank. 
The standard curve of protein amount against A660 was plotted and the equation of the 
line obtained. Protein concentrations (mg ml-1) were determined using a standard curve 
constructed using a range of dilutions of bovine serum albumin (BSA, 20 µg ml-1 to 200 
µg ml-1). 
 
2.2.3 DTNB thiol assay  
Ellman’s reagent (DTNB, 5,5’-dithiobis-[2-nitrobenzoic acid]) is reduced by free thiol 
groups causing the production of 5-thio-2-nitrobenzoic acid, which has a spectroscopic 
feature at 412 nm.  
 
2.2.3.1 The DTNB assay with variation of thiol concentration 
In an assay to investigate whether a range of CO-RMs and control molecules are able to 
react with thiol groups, various concentrations (10 – 200 μM) of NAC were incubated 
for 5 min with 100 μM of each of the following: CORM-3, CORM-2, iCORM-3, 
RuCl2(DMSO)4, CO-saturated solution or CORM-A1. DTNB (0.8 mM) was then added 
and incubated for 15 min. The OD412 was measured using a spectrophotometer 
(Jenway). 
  
2.2.3.2 The DTNB assay with variation of CO-RM concentration 
In an additional experiment, the thiol containing compounds cysteine, reduced 
glutathione and sodium hydrosulphide were incubated for 15 min with various 
concentrations (25 – 1000 μM)  of either CORM-3,  iCORM-3, or  CO-saturated 
solution in KPi (0.1 M pH 7.0). DTNB (0.5 mM) was then added and incubated for 15 
min. The OD412 was measured using a Jenway spectrophotometer. 
 
2.2.3.3 The DTNB assay to determine intracellular thiol concentration  
Starter cultures of wild type MG1655 E. coli and the gshA mutant in an MG1655 
background were grown for 8 h in 5 ml LB and 100 µl used to inoculate 20 ml LB in a 
250 ml conical flask, which was then incubated at 37 °C for 16 h with shaking at 200 
rpm. Cells were harvested by centrifugation at 5500 rpm for 5 min and then 
resuspended in 2 ml sonication buffer. Cells were broken by sonication at 12 µm 
amplitude for 5 intervals of 30 s with a 15 s rest between each, and the unbroken cells 
68 
 
removed by centrifugation (5500 rpm, 5 min). DTNB (0.8 M) was added to the cell free 
extract, which had been diluted by a factor of 4, and the A412 measured after 15 min 
incubation. Three technical and three biological replicates were performed. The 
concentration of thiol compounds in the sample was established by comparing the A412 
of the samples to a standard curve (0 – 0.1 mM NAC). This method is adapted from 
Goldman et al. (1996). 
 
2.2.4 Superoxide Assay 
Cytochrome c (20 μΜ) was added to the CO-RM or control molecule (1 mM), or 
CORM-3 pre-incubated for 5 min with NAC (1 mM) in KPi, pH 7.8. The OD550 was 
then read over a time course, as the reduction of cytochrome c causes an increase in 
absorbance at this wavelength. Superoxide dismutase (SOD, 250 units) was included as 
a control to determine whether the increase in absorbance detected is caused by 
superoxide. This method is adapted from Korshunov and Imlay (2006). 
 
2.2.5 Amplex red assay for hydrogen peroxide 
Hydrogen peroxide production by E. coli treated with CORM-3 was assayed using the 
Amplex Red Hydrogen Peroxide / Peroxidase Assay Kit (Invitrogen), which uses 10-
acetyl-3,7-dihydroxyphenoxazine to react with H2O2 in a 1:1 stoichometry to produce 
the fluorescent oxidation product resorufin, which has excitation and emission 
maximum of approximately 571 nm and 585 nm respectively. This assay is extremely 
sensitive and can detect as little as 10 picomoles H2O2 in 100 µl. 
 
A starter culture of wild type MG1655 E. coli was grown in 10 ml defined minimal 
medium for 17 h and then harvested by centrifugation (5500 rpm, 5 min, 4 °C) and then 
resuspended in 2 ml (1x) reaction buffer, which gave an OD600 of 9.2. This was then 
further diluted with reaction buffer to give a final OD600 of 0.09. The Amplex red 
reaction mixture was made up according to the manufacturer’s protocol and contained 
the amplex red reagent dissolved in DMSO, reaction buffer and horse radish peroxidase. 
An aliquot of this mixture (to give a final total volume of 50 µl) was added to wells of a 
96-well plate along with 5 µl cell suspension alone or with either CORM-3 (100 µM), 
CORM-3 with glycerol (5 mM) or glycerol alone. A standard curve was generated using 
a series of dilutions of H2O2 (0 – 10 µM). The absorbance at 560 nm was measured 
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spectrophotometrically (VictorTM X3, Perkin Elmer). Method adapted from Seaver and 
Imlay (2001). 
 
2.2.6 Oxygen electrode for measurement of respiration rates  
Respiration was measured using a Clark-type oxygen electrode (OXY041A, Rank Bros 
Ltd., Bottisham, CB25 9DA) operating at a polarising voltage of 0.6 V. This consists of 
a chamber separated from an electrode by an oxygen-permeable Teflon membrane. The 
oxygen is reduced at the cathode and creates a potential difference, which is recorded by 
a chart recorder (REC112, Amersham Pharmacia Biotech). The chamber is kept at a 
constant temperature by connection to a water bath, and the reaction mixture is 
constantly stirred magnetically (Gilberthorpe and Poole, 2008). The oxygen electrode 
was calibrated using air-equilibrated buffer appropriate for the sample type to establish 
maximal dissolved oxygen tensions; a few grains of sodium dithionite were added to 
remove all oxygen for the chamber to calibrate for 0% dissolved oxygen. A photograph 
of the oxygen electrode is shown in Figure 2.1. 
 
2.2.6.1 Closed electrode experiments 
A small amount of bacterial membrane suspension (adjusted to give a final protein 
concentration typically between 60 and 275 µg ml-1) was added to sonication buffer 
(used with E. coli membrane particles) or Vibrio phosphate buffer to a final volume of 2 
ml. The lid was then replaced and the system was left for several minutes to allow the 
amount of oxygen in the chamber to stabilise. Respiration was stimulated by the 
addition of 6.25 mM NADH, and then the compound of interest (for example CO-RM, 
CO-saturated solution, or control compound), was added at an oxygen tension of 
approximately 150 µM. The precise concentrations of compounds added are detailed in 
each experimental chapter. Where appropriate, thiol compounds, antioxidants or SOD 
were added to the chamber 1 min prior to the addition of CO-RM. Compounds were 
added through a hole in the lid using a Hamilton syringe to prevent additional oxygen 
from being added to the chamber. Respiration rates were calculated as nmol O2 
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Figure 2.1 Oxygen electrode for measurement of respiration rates.  
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consumed per min per mg of protein (measured using the Markwell assay described in 
section 2.2.2). 
 
2.2.6.2 Photolysis of the haem – CO bond 
Membranes were prepared from each E. coli single oxidase-containing strain as 
described in (Poole, 1993) and resuspended in 1.95 ml N2-saturated sonication buffer 
mixed with 50 µl air-saturated sonication buffer and placed in a glass chamber held at 
37 °C (Strathkelvin instruments) and stirred magnetically at a moderate speed. CORM-3 
(300 μM) was added and respiration was stimulated by addition of 12.5 mM NADH. A 
microcathode O2 electrode (SI130; Strathkelvin Instruments Limited) connected to an 
O2 meter (Model 781) was placed in the chamber. Prior to use, the electrode was 
calibrated using air-saturated buffer and by the addition of sodium dithionite (50 µl of a 
0.1 M solution, section 2.1.3.7) to remove all oxygen from the system. A 150 W 
projector bulb was used as a source of white light, and the beam focused on the wall of 
the glass chamber using a magnifying glass and an optical light guide. The intensity of 
light at the vessel surface was measured as 175,000 lux. The light was switched on and 
off at 1 or 2 min intervals. The oxygen level in the chamber was recorded using Data-
TraxTM software using a Lab-Trax-4/16 recorder (World Precision Instruments). A 
photograph of the apparatus used in this experiment is shown in Figure 2.2. 
 
2.2.6.3 Open electrode experiments 
2.2.6.3.1 Respiratory studies utilising membranes subjected to various oxygen 
tensions  
Membranes were prepared from wild-type E. coli, MG1655 as described previously 
(Poole, 1993). Membranes (175 μg ml-1, resuspended in 2 ml of sonication buffer) were 
transferred to an open, stirred chamber fitted with a Clark-type polarographic oxygen 
electrode (Rank Brothers) and held at 37 °C. Respiration was stimulated by the addition 
of 12.5 mM NADH. The speed of stirring was manipulated so that a steady state was 
achieved at either a high (approximately 75% of air saturation), low (approximately 
15% of air saturation) or very low (approximately 3% of air saturation) oxygen level. 
CORM-3 or RuCl2(DMSO)4 at 50 µM were added 2 min after the oxygen equilibrium 
had been reached. Respiration rates were calculated for both the CORM-3-inhibited and 
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Figure 2.2 Apparatus to measure oxygen consumption following photolysis.  
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control cultures (with either RuCl2(DMSO)4 or nothing added) at 10 and 20 min after 
the addition of compound. 
 
2.2.6.3.2 Measuring the time taken for the electrode chamber to reoxygenate 
The extent of respiratory inhibition of bacterial membrane particles was determined 
using an open electrode system in which the time taken for a sample to begin to re-
accumulate oxygen following a period of anoxia is measured as previously described 
(Hendgen-Cotta et al., 2008;(Shiva et al., 2007). In this experimental design, the sample 
is open to the atmosphere and is stirred magnetically allowing continuous O2 diffusion 
from the vortex surface into the sample with a typical KLa value of 0.35 min-1. KLa is 
the gas transfer coefficient from gas to liquid and is dependent on reaction volume, 
surface area and temperature (Pirt, 1985). The respiration of more sensitive strains will 
be inhibited to a greater extent and so will not be able to utilise the oxygen in the 
chamber as quickly, leading to a shorter time to reoxygenation.  
 
In order to compare the sensitivity of the terminal oxidase of E. coli to respiratory 
inhibition, membranes prepared from mutants containing only one of the three terminal 
oxidases of E. coli were added to the chamber to a final concentration of approximately 
370 μg ml-1 and stimulated to respire by the addition of 12.5 mM NADH. The stirring 
speed was set to 5 as, in the absence of compound, this maintained the oxygen level in 
the chamber at 0 for an extended period of time after the lid had been removed. Either 
CORM-3 or miCORM-3 (100 μM) was added 2 min after the oxygen in the chamber 
had reached 0, and the lid was then immediately removed. The time taken for the 
oxygen levels in the chamber to rise above 0 was recorded. 
 
In order to compare the sensitivity of the terminal oxidase of V. fischeri to respiratory 
inhibition, membranes prepared from wild type V. fischeri or mutants containing either 
AOX or cytochrome bd as the only terminal oxidase were resuspended in Vibrio 
phosphate buffer to a final concentration of approximately 40 mg ml-1, added to the 
electrode chamber, which was stirred magnetically at speed 5. The sample was 
stimulated to respire by the addition of 12.5 mM NADH. CORM-3 or iCORM-3 (both 
at 25 μM)  or CN- (100 μM) were added 1 min after the dissolved oxygen tension in the 
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chamber reached 0% and the lid removed 1 min later. The time taken for the oxygen 
levels in the chamber to rise above 0 was recorded. 
 
In order to assess whether NAC is able to protect bacterial respiration from inhibition 
by CORM-3, wild-type E. coli membrane particles were resuspended in sonication 
buffer (2 ml) to a final concentration of approximately 1.5 mg ml-1 and placed in an 
electrode chamber, which was stirred magnetically at speed 5. Respiration was initiated 
by the addition of NADH (6.25 mM). Where appropriate, NAC (400 µΜ) was added to 
the chamber 1 min before the addition of CORM-3 (400 µΜ); after a further minute, the 
lid was removed and the time taken for the chamber to reoxygenate was recorded. 
 
2.3 Spectroscopic methods 
2.3.1 Measurement of CO release from CO-RMs 
2.3.1.1 Myoglobin assay for the measurement of CO loss from CORM-3 
CO release from CORM-3 and control molecules to ferrous myoglobin was assayed as 
before (Clark et al., 2003), using an SDB4 dual-wavelength scanning spectrophotometer 
(The Johnson Foundation, University of Pennsylvania Biomedical Instrumentation 
Group and Current designs Inc., Philadelphia, PA, USA). This spectrophotometer scans 
samples from 400 to 700 nm in 0.5 nm increments. The data was analysed using 
SoftSDB software and then plotted using Sigma Plot (Systat Software Inc.). Horse heart 
Mb (10 µM) in 0.1 M KPi (pH 7.4) was reduced by the addition of a few grains of 
sodium dithionite, and this was scanned in triplicate as a baseline.  
 
In order to assess CO release from CORM-3 and control compounds, CORM-3 (8 µM) 
(pre-incubated for 5 min with various concentrations of NAC where appropriate) was 
added to the reduced myoglobin (10 μM), in a cuvette with 10 mm path length, and 
rapidly mixed before recording CO reduced minus reduced difference spectra in 
triplicate. Data were averaged and the spectrum of reduced myoglobin was subtracted 
from that of the CO-RM treated, reduced myoglobin. The change in absorbance was 
calculated as the difference between the peak and trough in the Soret region (426 – 441 
nm) of this difference spectrum, using Excel software. Where appropriate, the extinction 
coefficient of Mb-CO (177 mM-1 cm-1) was used to calculate the concentration of Mb-
CO formed over time (Wood, 1984).  
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2.3.1.2 Haemoglobin assay 
This assay measures the release of CO from CO-RMs without the presence of 
dithionite, which has been shown to facilitate CO loss from some CO-RMs including 
CORM-2 and CORM-3 (McLean et al., 2012).  
 
Haemoglobin (Sigma, grade P90%) was dissolved in 0.1 M KPi (pH 7.4) and reduced 
by the addition of a few grains of sodium dithionite. This was then passed down a PD 
MiniTrap G-25 column (GE Healthcare) to remove the excess dithionite and generate 
oxyferrous-haemoglobin. The concentration of reduced oxy-hamoglobin was measured 
spectrophotometrically using the known extinction coefficient for bovine muscle 
haemoglobin (133 mm-1 cm-1, at 430 nm). CORM-3 (8 µM) (pre-incubated for 5 min 
with 80 µM NAC when appropriate) was added to 10 µM oxyferrous-haemoglobin. 
Scans were taken every 30 s for 10 min, then every 1 min for the next 10 min and every 
5 min for the next 20 min using a scanning kinetics program (Cary 50). Difference 
spectra were then obtained by subtracting the oxyferrous-haemoglobin spectrum from 
the CORM-3 treated spectra in Excel, followed by plotting of the data in Sigma Plot. 
 
2.3.1.3 Measurement of CO binding to cytochromes 
For E. coli, membrane particles (prepared as described above, section 2.1.9) were 
suspended in sonication buffer to a final protein concentration of 8 – 33 mg ml-1 
whereas, for V. fischeri, samples were suspended in Vibrio phosphate buffer to a final 
protein concentration of 2 - 4 mg ml-1 for membrane particles, or 12 - 14 μg ml-1 for 
whole cell samples grown to OD600 1.0, as described above (section 2.1.5.4). Samples 
were transferred to a cuvette of 10 mm path length and reduced with sodium dithionite 
and spectra recorded in a Johnson Foundation SDB4 dual-wavelength 
spectrophotometer as detailed above (2.3.1.1) at room temperature (Kalnenieks et al., 
1998). This reduced sample spectrum was recorded in triplicate and assigned as the 
baseline, before the addition of CO-saturated solution, CORM-3 (pre-incubated with 1 
mM NAC where appropriate), iCORM-3 or RuCl2(DMSO)4 (each at 100μM). The CO 
treated samples were scanned in triplicate and spectra were viewed using SoftSDB 
software. Data were averaged and the spectrum of reduced myoglobin was subtracted 
from that of the CO-treated, reduced myoglobin to produce what is termed a CO 
reduced minus reduced, or CO difference spectra. Where appropriate, the change in 
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absorbance was calculated as the difference between the peak and trough in the Soret 
region (426 – 441 nm) of this difference spectrum, using Excel software, and then 
plotted in Sigma Plot. Where stated, data have been smoothed in Sigma plot graphing 
software with a sampling proportion of 0.1 and a polynomial degree of 9. 
 
2.3.1.4 ICP-MS 
Pellets were digested with 1 ml nitric acid (Aristar, 69% v/v) for 60 min and then 
diluted to 5 ml with 1% nitric acid. Analysis of ruthenium (mass 101) was done using 
an Agilent 7500CE ICP-MS (inductively coupled plasma-mass spectrometer) 
instrument using rhodium (mass 103) as an internal standard. Calibration standards 
were made up in 20% nitric acid to match the samples (blank, 25, 50 and 250 µg l-1 
ruthenium). With each batch of samples a sample blank was prepared comprising 1 ml 
nitric acid diluted to 5 ml with 1% nitric acid. This work was done at the Centre for 
Analytical Sciences (CAS, University of Sheffield) (Davidge et al., 2009b; Graham et 
al., 2009). 
 
2.3.1.5 Electron paramagnetic resonance (EPR) spectroscopy  
The spin trap BMPO (5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-oxide) (Enzo Life 
Sciences) was used to allow superoxide and hydroxyl radicals to be detected, identified 
and quantified. Superoxide and hydroxyl adducts of BMPO were generated to provide 
reference spectra for comparison with the CO-RM spectra. The components for each 
sample are described in the relevant figure legends. Samples were loaded into an AquaX 
cell and EPR spectra were recorded, at room temperature, on a Bruker EMX 
spectrometer at 9.47 GHz microwave frequency, 3.18 mW microwave power, 100 kHz 
modulation frequency and 9.54 G s-1 scan rate. Spectra were analysed using WINEPR, 
Version 2.11 (Bruker). This work was done in collaboration with Dr. Dimitri 
Svistunenko at the University of Essex. 
 
2.4 Genetic and molecular techniques 
2.4.1 Generalised transduction with bacteriophage P1 vir 
This was done to transfer the gshA mutation into an MG1655 background, and to 
transfer the mutated genes identified as important in the CORM-2 resistance screen 
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from independently sourced strains from the Keio collection (Simon Andrews, The 
University of Reading) into an MG1655 background. 
 
2.4.1.1 Preparation of lysates 
Donor cells were grown overnight at 37 °C in TY medium with CaCl2 (5 mM) with 
antibiotic where necessary. A P1 stock was diluted to 108, 107 and 106 PFU ml-1, and 
each was mixed with donor cells (100 µl) and incubated at 37 °C for 20 min. This phage 
/ cell mixture was then added to TB medium (1 ml) and TB soft agar (1.5 ml) both at 50 
°C, and then poured onto phage lysate plates, which were incubated in a wet atmosphere 
at 37 °C until plaques appeared giving the plates a ‘lacy’ appearance. The plates were 
then chilled at 4 °C for 20 min before cold phage dilution buffer was carefully added to 
the surface of the plates. These were then stored overnight at 4 °C, and then the overlay 
liquid was harvested using a Pasteur pipette and filtered through a 0.45 µm filter to 
exclude any bacterial cells. Phage lysates were stored over a drop of chloroform in 
sterile, screw capped tubes at 4 °C. 
 
2.4.1.2 P1 vir transduction of the recipient strain 
Recipient cells were grown overnight at 37 °C in 2.5 ml TY medium with CaCl2 (5 
mM). P1 lysates containing the DNA of the donor strain were diluted by 10- and 100-
fold and these dilutions as well as the neat lysate (100 µl) were mixed with the recipient 
cells (100 µl) and incubated at 37 °C for 20 min. The cells were then spread onto 
nutrient agar plates containing kanamycin (50 µg ml-1) and NaP2O7 (0.125 mM) and 
incubated at 37 °C overnight. A control plate with non-transformed recipient cells, and 
another with the phage lysate was also made. Surviving colonies from the transduced 
cultures were then re-plated on selective medium containing kanamycin (50 µg ml-1) 
and PCR carried out to confirm the mutaton. 
 
2.4.2 Transposon mutagenesis 
Transposon mutagenesis was performed using the EZ-Tn5™ <R6Kγori/KAN-2>Tnp 
Transposome™ Kit from Epicentre Biotechnologies, according to the manufacturer’s 
instructions. Briefly, the transposome complex (1 µl) was transformed into Iq Express 
chemically competent E. coli (50 µl) using the high efficiency transformation protocol 
(known as heat shock) as described in section 2.4.3.  
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2.4.3 High Efficiency Transformation Protocol  
A tube of NEB Express Iq Competent E. coli cells was thawed on ice for 10 min, then 
mixed gently and 50 µl of cells mixed with 1 µl transposon. The tube was flicked 4-5 
times to gently mix the cells and DNA. The mixture was placed on ice for 30 min and 
placed in a water bath at 42 °C for exactly 20 s, then placed on ice for 5 min. SOC (950 
µl) that had been heated to 37 °C was added and then the mixture incubated at 37 °C for 
60 min with shaking at 250 rpm. The cells were then mixed thoroughly but gently, then 
several 10-fold serial dilutions were performed in SOC. An aliquot (100 µl) of each 
dilution was spread onto a nutrient agar plate containing kanamycin (30 µg ml-1), which 
had been pre-warmed to 37 °C. The plates were then incubated overnight at 37 °C.  
 
2.4.4 Primer design and cloning 
Primers were designed based on the DNA sequences of the target genes using Primer 3 
software (V.0.4.0). Primers were designed to be 18 – 24 bp in length and to have a 
melting temperature (Tm) of 57 – 65 °C and a GC content of 20 – 80 %. Primers that 
had the potential to form secondary structures were eliminated and redesigned. Primers 
were synthesised by Sigma Aldrich and were supplied as desiccated oligonucleotides 
that were then resuspended in super-pure H2O to a final concentration of 100 µM. The 
primers used in this work are described in Table 2.2. 
 
2.4.5 Genomic DNA extraction 
The Blood and Tissue Kit (Qiagen) was used to extract genomic DNA according to the 
manufacturer’s protocol, from 1 ml culture grown to late-exponential phase in LB 
medium. Instructions for pre-treatment of Gram-negative bacteria, then those describing 
the purification of total DNA from animal tissues were followed. Super-pure water (50 
µl) was pipetted directly onto the membrane; this was incubated at room temperature for 
1 min, then spun for 1 min at 8000 rpm to elute the DNA. 
 
2.4.6 Restriction enzyme digestion 
Genomic DNA (17 µl) from mutants of interest was digested using the restriction 
enzyme RsaI (1 µl, NEB), which recognises the sequence 5’GTAC 3’ and cuts between 
the T and the A to generate blunt ends. The reaction mixture also included buffer 4 (2 
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µl, NEB). The digested DNA was purified using Qiaquick PCR purification kit 
(Qiagen) according to the manufacturer’s protocol. 
 
2.4.7 Ligation of Fragmented DNA 
Previously digested DNA (100 ng or 1 µl) was ligated by incubating with T4 DNA 
ligase (1 µl, NEB) and ligase buffer (1 µl, NEB) in super-pure water (7 µl) at room 
temperature for 6 h.   
 
2.4.8 PCR  
PCR was conducted in order to amplify the DNA adjacent to the transposon in the 
mutant strains. The primers used were KAN-2 FP1 Forward Primer (EZ-Tn5 
<R6Kγori/KAN-2>Tnp TransposomeTM Kit, Epicentre Biotechnologies) and a primer 
internal to the RsaI site of the EZ-Tn5 transposon (designed by Iain Kean), the 
sequences of which are given in Table 2.2 
 
The reaction mixture contained genomic DNA (0.5 µl) as a template, forward and 
reverse primers (0.1 µl of each), Dream Taq (2x) Green PCR mastermix (25 µl) 
(Thermo Scientific) and 24.3 µl super-pure water. 
 
A PCR machine was used to heat the mixture according to the following thermal cycle: 
 
95 °C            1 cycle 
95 °C 
55 °C            35 cycles 
68 °C 
72 °C            1 cycle 
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Primer name 
 
Primer Sequence Source 
KAN-2 FP1 
Forward Primer 
 
5’ ACCTACAACAAAGCTCTCTCATCAACC 3’ 
EZ-Tn5 <R6Kγori/KAN-
2>Tnp TransposomeTM 
Kit, Epicentre 
Biotechnologies  
 
Primer internal 
to the Rsa1 site  
of the EZ-Tn5 
transposon 
 
 
5' GTAACCATGCATCATCAGG 3' 
Designed by Iain Kean 
frvB forward 
primer 
 
5’ CAAACCCTCAGCTCATAAGGAAG 3’ Designed for this work 
using Primer3 Version 
0.4.0 
frvB reverse 
primer 
 
5’ GTTTATCAGAATGTCGCGAACTTC 3’ Designed for this work 
using Primer3 Version 
0.4.0 
manX forward 
primer 
 
5’ GTGTTAACGATAATAAAGGAGGTAGC 3’ Designed for this work 
using Primer3 Version 
0.4.0 
manX reverse 
primer 
 
5’ CTCCATTGTACTTCTCCTGTTTACG 3’ Designed for this work 
using Primer3 Version 
0.4.0 
sgaU forward 
primer 
 
5’ ATCGCTGAACTGTGGGGCTAAGGA 3’ Designed for this work 
using Primer3 Version 
0.4.0 
sgaU reverse 
primer 
5’ CCA TGT TGG CTT CAA ATA CCT GCT G 
3’ 
Designed for this work 
using Primer3 Version 
0.4.0 
 
gshA forward 
primer 
 
5’ CAGTTCGTTTTCCAATCTGCAAC 3’ 
 
Designed by Mariana 
Tinajero Trejo 
 
gshA reverse 
primer 
 
5’ ATTTTGACAGGCGGGAGGT 3’ 
 
Designed by Mariana 
Tinajero Trejo 
 
Table 2.2 List of Primers. Synthetic oligonucleotides used as primers for the 
sequencing of transposon insertion sites or PCR amplification of DNA fragments. 
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2.4.9 Agarose gel electrophoresis 
DNA samples were separated and visualised using agarose gel electrophoresis. Agarose 
(1 g) was dissolved in 100 ml 1 x TAE buffer by heating and then poured into a plastic 
mould containing a comb to form the sample wells. Hyperladder 1 (Bioline) was 
typically loaded alongside the DNA samples to provide a reference of the fragment size 
and concentration. The gel was covered with 1 x TAE buffer and 3 µl of 10 mg ml-1 
ethidium bromide solution (Promega) was added to the buffer in order to allow 
visualisation of the DNA. The gels were run at 100 V for approximately 45 min and 
then the DNA visualised under UV light using the GeneGenius Gel Imaging System 
(Syngene). 
 
2.4.10 Purification of DNA samples 
Following amplification of a region of DNA by PCR, samples were purified using 
Qiaquick PCR purification kit (Qiagen) according to the manufacturer’s protocol. 
 
2.4.11 DNA sequencing 
Samples were sent for nucleotide sequencing (Beckman Coulter Genomics) with the 
KAN-2 FP1 Forward Primer. 
 
2.4.12 Sequence and database analysis for identification of genes inactivated by 
transposon mutagenesis 
The sequence of the DNA adjacent to the transposon (sequenced using the KAN-2 FP1 
Forward Primer) was entered into a BLASTN search in the NCBI (The National Center 
for Biotechnology Information) database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
against the E. coli K12 genome sequence.   
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Chapter 3 
 
CO-RMs as inhibitors of the terminal oxidases of E. coli 
 
The haem-containing cytochromes of bacterial aerobic respiratory chains are thought to 
be important targets of CO from CORM-3, although there is mounting evidence that 
there are several other bacterial targets of this compound (as discussed in section 1.3.4 
and section 4.3). UV- visible spectroscopy of bacterial suspensions, including E. coli 
(Davidge et al., 2009b), P. aeruginosa (Desmard et al., 2009), and C. jejuni (Smith et 
al., 2011) show the formation of CO-bound cytochromes upon treatment with CORM-3. 
In E. coli, CO from CORM-3 binds rapidly to cytochrome d, followed by the slower 
formation of another CO-adduct, which is thought to be cytochrome bo’ (Davidge et al., 
2009b). Transcriptional analysis of E. coli treated with CORM-3 also implicates aerobic 
respiration as a major target of this compound. CORM-3 down-regulates the cyo 
operon, which encodes the terminal oxidase cytochrome bo’ and slightly up-regulates 
cydAB, which encodes cytochrome bd-I (Davidge et al., 2009b).  
 
While there have been many detailed studies of the interaction of CO gas with 
respiratory cytochromes (Borisov, 2008; Borisov et al., 2007; Borisov et al., 2001; 
Chance et al., 1953; Keilin, 1966), several key discrepancies between the effects of CO 
gas and CORM-3 on bacterial growth and respiration necessitate a thorough 
investigation of the nature of the interaction of CO from CORM-3 with the aerobic 
respiratory chain. These discrepancies include the finding that CO from CORM-3 is 
inhibitory to growth when present at concentrations equal to atmospheric oxygen levels 
(Davidge et al., 2009b), whereas historically, it has been understood that CO has a 
lower affinity for respiratory cytochromes than O2 and thus must be present in a 
significant excess, typically in a ratio of 19:1 (Poole et al., 1973), in order to be 
inhibitory. Nobre et al., (2007) have also reported that CO-RMs are more potent 
antibacterial agents than CO gas. More recent work has found that CORM-3 is more 
inhibitory to the respiration of E. coli cells than the equivalent concentration of CO gas 
(Wilson et al., 2013). 
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The work described in this chapter aims to compare the effects of CORM-3, and where 
appropriate CORM-2, on respiration in the model organism E. coli with the well-
established effects of CO gas. It was hoped that in doing so, a better understanding 
would be gained of the mechanism(s) by which CO-RMs inhibit respiration, and in turn, 
further our understanding of one of the key questions regarding the antibacterial 
properties of CO-RMs: to what extent does inhibition of respiration by CO-RMs 
contribute to the bactericidal properties of these compounds (see section 1.3.3). 
Specifically, it was investigated whether the three quinol oxidases of the aerobic 
respiratory chain of E. coli: cytochrome bd-I, cytochrome bd-II and cytochrome bo’ 
differ in their sensitivity to CO from CORM-3. Work was also done to investigate the 
photosensitivity of the CO-haem bond in CORM-3 treated bacterial membranes, and to 
assess whether the oxygen tension at which CORM-3 is added affects the extent of 
respiratory inhibition. 
3.2 Results CORM-2, CORM-3 and CO gas inhibit respiration in E. coli 
membrane particles  
When this work began, there were only two published reports of the effects of CORM-3 
on bacterial respiration. These reported incubation of CORM-3 with cultures of  E. coli 
for an extended period, followed by the measurement of oxygen consumption (Davidge 
et al., 2009b) and the treatment of P. aeruginosa cultures with CORM-3 prior to 
respiration rates being measured over a 40 min time-course (Desmard et al., 2009). 
Both pieces of work also provided spectroscopic evidence of the formation of CO-
adducts of cytochromes following treatment with CORM-3. Two papers have since 
been published on this subject, one of which demonstrates that CORM-3 inhibits 
respiration in C. jejuni without inhibiting growth (Smith et al., 2011), and the other 
presents a comprehensive study of the effects of CORM-3 on bacterial respiration in 
several bacteria and the yeast Saccharomyces cerevisiae (Wilson et al., 2013).  
 
The respiratory studies described in the present work differ from previous published 
reports as they study the effects of CO-RMs on bacterial membrane particles created by 
disrupting E. coli suspensions by ultrasonication (Poole, 1993). Measuring respiratory 
inhibition of E. coli membrane particles allowed the direct measurement of the effects 
of CORM-3 on respiratory components, without interference from other cellular 
components, or the effects of trans-membrane ion gradients. 
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The work described in this chapter predominantly used CORM-3 as a model CO-RM as 
it is chemically well characterised and is water soluble, a property that will be important 
in future therapeutically relevant CO-RMs. In some experiments, CORM-2, which is 
soluble only in organic solvents, was also used in order to confirm whether the effects 
observed with CORM-3 were shared by other CO-RMs. The chemical structure of both 
of these compounds can be seen in Table 1.2. It was important to begin by comparing 
the sensitivities of membrane particles to CORM-2, CORM-3 and equivalent 
concentrations of CO-saturated solution. E. coli membrane particles were suspended in 
fully aerated sonication buffer in a stirred Perspex chamber fitted with a Clark-type 
polarographic oxygen electrode (OXY041A, Rank Bros Ltd.) held at 37 °C, with a lid 
placed on the chamber to prevent the entry of additional oxygen into the sample 
(Gilberthorpe and Poole, 2008). NADH (6.25 mM) was added to stimulate respiration 
and the CO-RM compound or CO-saturated solution was added, through a small hole in 
the lid using a Hamilton syringe, when the dissolved oxygen tension in the chamber 
reached approximately 155 µM (75% of air saturation). 
 
Previous published reports had not studied the immediate effect of CORM-3 on 
bacterial respiration in the closed oxygen electrode, as inhibition could not be observed 
for intact E. coli cells in the limited time this experimental design allowed (Davidge et 
al., 2009b), however, the present study used fragmented membrane particles, which 
allowed an immediate inhibition of respiration to be observed when CORM-3 was 
added to the chamber. CO gas (100 µM) significantly inhibited respiration of membrane 
particles (by 38%), and to a greater extent than the equivalent concentration of CORM-3 
(12%; Figure 3.1A and B, blue short dash line). High concentrations of CORM-3 (400 
µM) were required to inhibit respiration in wild type membrane particles by 54.6%. 
CORM-2 was found to be more inhibitory to respiration than CORM-3 (100 µM 
inhibited respiration by 85%; Figure 3.1B and C). Importantly, the control compounds 
iCORM-3 (Figure 3.1B, red dot dash line) and RuCl2(DMSO)4 (Figure 3.1C, red dot 
dash line) caused little (6%) or no inhibition respectively. This confirms that CO is the 
85 
 
 
 
Figure 3.1 CO gas, CORM-3 and CORM-2 inhibit respiration in wild type E. coli 
membrane particles. Wild type E. coli membrane particles were added to an oxygen 
electrode chamber in sonication buffer (2 ml) to a final concentration of approximately 
60 μg ml-1 (in A), 170 µg ml-1  (in B) and 100 μg ml-1  (in C). A lid was placed on the 
chamber and respiration was initiated by the addition of 6.25 mM NADH. Traces show 
dissolved oxygen in the chamber as follows: (A) control (black solid line) and 100 μM 
CO (blue broken line); (B) control (black solid line), 100 μM iCORM-3 (red dot dash 
line), 100 μM CORM-3 (blue short dash line), 400 μM CORM-3 (blue long dash line); 
(C) control (black solid line), 100 μM RuCl2(DMSO)4 (red dot dash line), 50 μM 
CORM-2 (blue short dash line), 100 μM CORM-2 (blue long dash line). CO and CO-
RMs were added at approximately 75% of oxygen saturation (310 nmol O2). These data 
are representative of at least 3 technical and 2 biological replicates. Respiration rates 
(nmol min-1 mg-1 protein) 2 min following the addition of CO-RM are shown adjacent 
to each trace. This figure was published in Jesse et al. (2013).  
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causative agent of respiratory inhibition by CO-RMs, and that the inactive metal-
containing structure of the CO-RM does not contribute substantially to respiratory 
inhibition. Typical respiration rates for each of these conditions are given in Figure 3.1. 
 
3.2.2 The oxygen tension at which CORM-3 is added does not affect the degree of 
respiratory inhibition. 
It has been known for several decades that CO gas is a competitive inhibitor of the 
terminal oxidases of aerobic respiration as it binds to haem in place of oxygen, thereby 
preventing the reduction of oxygen to water (Wikstrom et al., 1981). Because of this, 
CO gas is a more potent inhibitor of respiration when oxygen concentrations are low 
(Poole et al., 1973). It has recently been reported that endogenously produced, but 
artificially induced CO can inhibit respiration, and that it does so more potently 
following a period of hypoxia (D'Amico et al., 2006). It is expected that CO from CO-
RMs inhibits aerobic respiration in the same way as CO gas; however this cannot be 
taken for granted as CO-RM-derived CO is known to elicit some strikingly different 
effects than CO gas, such as being inhibitory to growth (Davidge et al., 2009b) and 
respiration at substantially lower concentrations (Smith et al., 2011; Wilson et al., 
2013), even when present at concentrations much lower than surrounding oxygen 
tensions (Davidge et al., 2009b; Smith et al., 2011).  
 
It was therefore important to assess whether CO from CO-RMs inhibits aerobic 
respiration in a competitive manner. Wild type E. coli membranes were stimulated to 
respire in an open electrode using 12.5 mM NADH, and the speed of stirring was 
manipulated so that a steady state was achieved at either a high (approximately 75% of 
air saturation), or low (approximately 9% of air saturation) oxygen levels. 50 μM 
CORM-3 was then added two min after the oxygen equilibrium had been reached, and 
the respiration rates calculated 10 and 20 min after the addition of compound. 
Respiration rates at the corresponding time points in a control experiment in which no 
compound was added were also calculated. At both time points, there was no significant 
difference in the percentage inhibition induced by CORM-3 with regards to the oxygen 
level at which it was added (Figure 3.2). It was then investigated whether there was a 
difference in the degree of respiratory inhibition when CORM-3 was added at either low 
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Figure 3.2 The oxygen tension at which CORM-3 is added does not affect the 
degree of respiratory inhibition. Wild type membrane particles were added to 
sonication buffer to a final concentration of approximately 175 µg ml-1 in an open 
system oxygen electrode chamber. A magnetic stirrer bar was used to mix the 
suspension and to introduce oxygen into the sample. The rate of stirring was 
manipulated to achieve a constant dissolved oxygen tension for an extended time 
period. A stirrer speed of 9 achieved a plateau at high oxygen tensions (approximately 
75.0% of air saturation), shown in (A), while a stirrer speed of 5 achieved a plateau at 
low oxygen tensions (approximately 9.3% of air saturation), shown in (B). NADH (12.5 
mM) was added to initiate respiration and 50 μM CORM-3 (broken line) was added at 
the point indicated by the arrow (t = 0). No compound was added to the control (solid 
line). The numbers shown on the traces are the respiration rates (nmol min-1 mg-1 
protein) 10 and 20 min following the addition of compound, or at the equivalent point in 
the control. Data are from one representative experiment. (C) Respiration rates 10 and 
20 min following the addition of CORM-3, or the control compound RuCl2(DMSO)4 
(both at 50 µM) are expressed as a percentage of the respective rates at t=0. Data are the 
mean and standard deviations of 3 biological replicates. 
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(13%) or very low (3%) oxygen tensions. Again, no significant difference was found 
between these conditions (Figure 3.3). 
 
3.2.3 Cytochrome bd-I is the most resistant oxidase of E. coli to respiratory 
inhibition by CORM-3 and a strain containing only this oxidase is partially 
protected from growth inhibition by this compound. 
As mentioned previously, terminal oxidases are thought to be one of the major targets 
for CO-RM inhibition and may be important in determining sensitivity to CO-RMs in 
antimicrobial therapy. It was therefore important to study the interaction of CO from 
CORM-3 with each individual terminal oxidase of E. coli and to ascertain whether these 
differed in sensitivity to CORM-3. It could not be taken for granted that the oxidases 
would behave the same with CORM-3-derived CO as with CO gas due to the many 
differences in the effects of CO and CORM-3 described above (section 3.1). 
Additionally, there are no published reports of the interaction of CO or CORM-3 with 
the more recently identified cytochrome bd-II of E. coli. This work therefore constitutes 
the first comparison of the effects of a CO-RM on the individual terminal oxidases of a 
bacterial respiratory chain. 
 
The E. coli strains used in this work were each able to express only one of the three 
quinol oxidases of the aerobic respiratory chain of E. coli. For example, the strain 
containing only cytochrome bd-I had the phenotype Cyd+ App- Cyo- (see Table 2.1). To 
simplify the nomenclature in this work, this strain will be referred to by the phenotype, 
Cyd+, the strain containing only cytochrome bd-II will be referred to as App+ and the 
strain containing only cytochrome bo’ will be referred to as Cyo+. The single oxidase 
mutants also had a deletion in the nuo gene rendering them unable to produce NADH 
dehydrogenase-I, an electrogenic component upstream of the quinol oxidases in the 
respiratory chain of E. coli. The control strain used in this work was able to express all 
three oxidases, but had a nuo deletion and is referred to throughout this work as the 
parent strain. 
 
Growth of each of the single oxidase strains was monitored in the presence of 12.5 µM 
CORM-3, which was added during early exponential phase (at approximately 30 Klett 
units) (Figure 3.4 A-D). This concentration of CORM-3 had only a slightly deleterious 
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Figure 3.3 The degree of respiratory inhibition experienced by wild type E. coli 
membrane particles treated with CORM-3 is not exacerbated at very low oxygen 
tensions. Wild type membrane particles were added to sonication buffer to a final 
concentration of 175 µg ml-1 in an open system oxygen electrode chamber, as described 
in Figure 3.2. A stirrer speed of 7 achieved a plateau at low oxygen tensions 
(approximately 13.4% of air saturation), shown in (A), while a stirrer speed of 5 
achieved a plateau at very low oxygen tensions (approximately 3.1% of air saturation), 
shown in (B). NADH (12.5 mM) was added to initiate respiration and 50 μM CORM-3 
(broken line) was added at the point indicated by the arrow (t = 0). No compound was 
added to the control (solid line). The numbers shown on the traces are the respiration 
rates (nmol min-1 mg-1 protein) 10 and 20 min following the addition of compound, or at 
the equivalent point in the control. Data are from one representative experiment. (C) 
Respiration rates 10 and 20 min following the addition of CORM-3, or the control 
compound RuCl2(DMSO)4 (both at 50 µM) are expressed as a percentage of the 
respective rates at t = 0. Data are the mean and standard deviation of 3 biological 
replicates. 
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Figure 3.4. A strain containing only cytochrome bd-I is resistant to growth 
inhibition by CORM-3. CORM-3 (12.5 µM) was added at early exponential phase to 
cultures of E. coli: (A) parent strain; (B) expressing cytochrome bd-I only; (C) 
expressing cytochrome bd-II only and (D) expressing cytochrome bo’ only. Nothing 
was added to the controls. Data in (A) – (D) show growth in the absence (closed 
symbols) and presence (open symbols) of CORM-3. (E) Shows the doubling times of 
these strains, for the two hours before (black bars) and after (grey bars) the addition of 
CORM-3. All data are averages and standard deviations of three biological repeats. 
Student’s t-test was done in order to establish whether the doubling times before and 
after CORM-3 were significantly different for each strain. *, p = 0.0564, **, p = 0.0214. 
This figure was published in Jesse et al. (2013). 
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effect on the growth rate of the parent strain. The single oxidase mutants were all 
affected to a greater extent than the control strain, however, the doubling time of the 
Cyd+ mutant was inhibited much less than that of both App+ and Cyo+ (Figure 3.4 E). 
The doubling time of the parent strain was affected by a factor of 1.19 by 12.5 µM 
CORM-3, 1.16 for Cyd+, 1.98 for App+ and 1.81 for Cyo+. Student’s t-test was 
performed to establish whether the changes in doubling time following the addition of 
CORM-3 were statistically significant for each single oxidase containing strain. The 
doubling times of the parent strain and the strain containing cytochrome bd-I as the only 
oxidase were not significantly changed by the addition of 12.5 µM CORM-3, whereas 
that of the strains containing either cytochrome bd-II or cytochrome bo’ as the only 
oxidase were significantly decreased by this concentration of CORM-3. 
 
In order to further investigate this finding, membrane particles prepared from these 
single oxidase-expressing E. coli mutants were assessed for their susceptibility to 
respiratory inhibition by CORM-3. The extent of respiratory inhibition was determined 
by measuring the time taken for oxygen re-accumulation to begin after removal of the 
chamber lid, in the presence of CORM-3 or the control compound miCORM-3. 
miCORM-3 is a control compound developed by Jayne Louise Wilson (Wilson et al., 
2013), which is prepared by treating CORM-3 with dithionite and myoglobin in order to 
remove any labile CO from the compound. It has an advantage over another commonly 
used control compound iCORM-3, as it has been exposed to biological ligands. While 
both compounds have been used in published work, the precise chemical structure of 
neither is known. 
 
In this experimental design, the respiration of more sensitive strains will be inhibited to 
a greater extent and so will not be able to utilise the oxygen in the chamber as quickly, 
leading to a shorter time to reoxygenation. This is an established method for comparing 
the sensitivity of respiring samples to inhibitors (Hendgen-Cotta et al., 2008; Shiva et 
al., 2007). The chamber was initially closed and NADH (12.5 mM) was added to 
stimulate respiration. Compound(s) were added 1 min after the dissolved oxygen 
tension in the chamber reached 0 and the lid removed 1 min later. This allowed 
continuous O2 diffusion from the vortex surface into the sample with a typical KLa 
value of 0.35 min-1. KLa is the gas transfer coefficient from gas to liquid and is 
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dependent on reaction volume, surface area and temperature (Pirt, 1985), all of which 
were quantified and controlled. The extent of respiratory inhibition was determined by 
measuring the time to oxygen re-accumulation after removal of the chamber lid, as 
previously described (Shiva et al., 2007). This method has the advantage that prolonged 
measurements can be made without exhaustion of oxygen.  
 
When respiring membrane particles containing either cytochrome bd-II or all three 
oxidases (parent strain) were treated with 100 µM CORM-3, the time taken for the 
chamber to reoxygenate was significantly reduced (by 80 - 84%) (Figure 3.5A) 
compared to treatment with the control compound, miCORM-3 (Figure 3.5B). Thus, 
CORM-3 significantly inhibits respiration in these strains. However, when membrane 
particles prepared from a strain expressing only cytochrome bd-I were treated with 100 
µM CORM -3, the time to reoxygenation of the electrode chamber was reduced by only 
9% compared to that when miCORM-3 was present. Figures 3.5A and B show the 
electrode traces of one representative experiment. Figure 3.5C shows the means and 
standard deviations of 2 technical and 2 biological replicates of these data. Mean times 
to reoxygenation in min for each experimental condition were as follows: parent strain 
with miCORM-3 (65.8 ± 2.99) and with CORM-3 (13.2 ± 2.56); App+ with miCORM-3 
(55.5 ± 6.28) and with CORM-3 (9.42 ± 3.84); Cyd+ with miCORM-3 (65.7 ± 4.51) and 
with CORM-3 (59.8 ± 4.84). This confirms that cytochrome bd-I is the most resistant 
oxidase of E. coli to CORM-3.  
 
3.2.4 A spectroscopic study of the binding of CO from CORM-3 to each of the 
terminal oxidases of E. coli 
UV-visible spectroscopy was performed using a dual-beam spectrophotometer, in order 
to identify the haems present in membrane particles prepared from each single oxidase 
mutant and therefore confirm the oxidase composition of the mutants used in this work 
(Figure 3.6). CORM-3 difference spectra (i.e. the difference between the spectrum of a 
reduced sample treated with 100 µM CORM-3 minus the spectrum of a reduced sample 
(Wood, 1984)) were recorded for membrane particles prepared from the single oxidase-
expressing strains and resuspended in sonication buffer to a final concentration of 
between 8 and 16 mg ml-1. In each strain, the Soret feature consisting of a peak near 420 
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Figure 3.5 Cytochrome bd-I is resistant to respiratory inhibition by CORM-3. 
Membranes prepared from mutants containing only one of the three terminal oxidases 
of E. coli were added to an oxygen electrode chamber in sonication buffer (2 ml) to a 
final concentration of approximately 370 μg ml-1 and stimulated to respire by the 
addition of NADH (12.5 mM). The point at which either CORM-3 (shown in A) or the 
control compound miCORM-3 (shown in B, both at 100 µM) were added is indicated 
by the first, longer arrow in each panel. The lid was removed from the chamber 1 min 
later, indicated by the second arrow. These traces show dissolved oxygen in the 
chamber and indicate the times taken for the chamber to begin to reoxygenate for the 
strains containing cytochrome bd-I only (black lines), cytochrome bd-II only (blue 
dotted lines) and the parent strain (red dashed lines). The times taken for the chamber to 
reoxygenate (min) in each condition were as follows: parent strain with miCORM-3 
(70) and with CORM-3 (14); App+ with miCORM-3 (54) and with CORM-3 (7); Cyd+ 
with miCORM-3 (70) and with CORM-3 (63). These data are representative of 2 
technical and 2 biological replicates. (C) Shows the time to reoxygenation for each 
strain with CORM-3 (grey bars) or miCORM-3 (black bars). These data are the means 
and standard deviations of 2 technical and 2 biological replicates. This figure was 
published in Jesse et al. (2013). 
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Figure 3.6 Difference spectra of single oxidase membrane particles. Membranes 
were prepared from E. coli respiratory mutants and diluted with sonication buffer to a 
final protein concentration of 8 - 19 mg ml-1. Spectra were obtained 10 min after the 
addition of CORM-3 to membranes from the following strains: (A) wild type; (B) 
cytochrome bd-I only; (C) cytochrome bd-II only; (D) cytochrome bo’ only. Data were 
plotted using a scanning dual wavelength spectrophotometer as the difference between 
the spectrum of a dithionite reduced sample incubated with 100 μM CORM-3 minus the 
spectrum of a reduced sample. Data have been smoothed in Sigma plot graphing 
software with a sampling proportion of 0.1 and a polynomial degree of 9. This figure 
was published in Jesse et al. (2013). 
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nm and the trough near 445-459 nm demonstrate the binding of CO from CORM-3 to a 
mixture of cytochromes including cytochrome b, and in the case of Cyo+ cytochrome o’ 
(Figire 3.6D). The peak in the α-region, between 645 - 647 nm, is indicative of the 
binding of CO to cytochrome d (Figures 3.6A-C). Importantly, this feature is absent in 
the CORM-3 difference spectrum of Cyo+ (Figure 3.6D). 
 
Work was done to obtain CORM-3 difference spectra over a time-course in order to 
gain time-resolved data regarding the rate of CO binding to the respiratory cytochromes. 
Here, membrane particles prepared from wild type E. coli were resuspended in buffer to 
a final protein concentration of approximately 32 mg ml-1. The samples were reduced by 
the addition of a few grains of sodium dithionite and then treated with 100 μM CORM-
3. Spectra were recorded after 5 and 10 s, then every 10 s until 5 min, every 30 s until 
10 min, every 5 min until 40 min and then at 60 min. The main spectral features are 
shown in Figure 3.7A (the Soret region) and Figure 3.7B (the α-region). The magnitude 
of the peak at 423 nm and trough at 440 nm increase over time. These features are 
characteristic of CO binding to cytochrome b595. Cytochrome o’ bound to CO also has 
spectral features in this region, but this typically has a peak at 415 nm and a trough at 
430 nm (Wood, 1984). The absorbance minima of this feature (at 440 nm) was 
subtracted from the absorbance maxima (at 423 nm) and this difference in absorbance 
plotted against time (Figure 3.7C). This confirms that CO from CORM-3 binds rapidly 
to cytochrome b595 from E. coli, reaching saturation 10 min after CORM-3 treatment. 
The half-time of CO binding to cytochrome b595 was calculated as 0.44 min (± 0.13; 2 
biological replicates). The peak at 643 nm (Figure 3.7B) is indicative of CO-bound 
haem d. This change in intensity of this peak over time (calculated as the absorbance at 
643 nm minus the absorbance at 658 nm) is shown in Figure 3.7D. This shows that CO 
from CORM-3 binds extremely rapidly to haem d in E. coli membrane particles. The 
half-time of CO binding to this cytochrome was calculated as 0.17 min (± 0.011; 2 
technical replicates), although it should be noted that this spectroscopic method is not 
ideal for calculating accurate kinetic data for such a rapid process. 
 
For comparison, spectra of CO gas (from a saturated solution) bound to wild type 
membrane particles were also recorded over a time-course (Figure 3.8). The Soret 
region has a peak at 424 nm and a trough at 438 nm (Figure 3.8A), almost identical in 
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Figure 3.7. Binding of CO from CORM-3 to haem d and haem b595 of the terminal 
oxidases of E. coli. Membranes were prepared from wild type E. coli and diluted with 
sonication buffer to a final protein concentration of 32.6 mg ml-1. The samples were 
treated with 100 μM CORM-3. CORM-3 reduced minus reduced difference spectra 
were recorded. (A) shows the Soret region of the spectrum and (B) the α-region over a 
time course. (C) shows the change in absorbance in the Soret region (absorbance at 423 
nm minus the absorbance at 440 nm) plotted against time and (D) shows the change in 
the α-region (absorbance at 643 nm minus the absorbance at 658 nm plotted against 
time. In both cases, the absorbance at time 0 (ie. at the point of CORM-3 addition) has 
been assigned as zero, although technical limitations prevent a spectrum from being 
recorded at this point. The dashed horizontal lines in (C) and (D) indicate half the 
maximal absorbance change and the dashed vertical lines indicate the half time of CO 
binding to each cytochrome. The inset figure in (D) shows the same data as in the main 
figure, but without the data point for time zero allowing greater resolution of the data. 
Data are from one technical replicate but are representative of 2 technical replicates. 
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Figure 3.8 Binding of CO from a saturated solution to haem d and haem b595 of the 
terminal oxidases of E. coli. Membranes were prepared from wild type E. coli and 
diluted with buffer to a final protein concentration of 32.6 mg ml-1. The samples were 
treated with 100 μM CO from a saturated solution. CO reduced minus reduced 
difference spectra were recorded. (A) shows the Soret region of the spectrum and (B) 
the α-region over a time course. (C) shows the change in absorbance in the Soret region 
(absorbance at 423 nm minus the absorbance at 440 nm) plotted against time and (D) 
shows the change in the α-region (absorbance at 643 nm minus the absorbance at 658 
nm) plotted against time. In both cases, the absorbance at time 0 (ie. at the point of 
CORM-3 addition) has been assigned as zero, although technical limitations prevent a 
spectrum from being recorded at this point. The inset figure in (C) shows the same data 
as in the main figure, but without the data point for time zero allowing greater 
resolution of the data. The dashed horizontal lines in (C) and (D) indicate half the 
maximal absorbance change and the dashed vertical lines indicate the half time of CO 
binding to each cytochrome. Data are from one technical replicate but are representative  
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wavelength and magnitude to those in the difference spectra generated following 
treatment with CORM-3. However, this spectral feature formed much more rapidly 
following treatment with CO gas compared to CORM-3, with a half-time of CO binding 
of 0.020 min (Figure 3.8C), which is more than 5-fold lower than that for CORM-3. CO 
bound to haem d so rapidly, that almost no changes could be detected over time (Figure 
3.8B). 
3.2.5 Photolysis alleviates the inhibition of respiration by CO from CORM-3 and 
reduces killing by CORM-3 
Over 100 years ago, in 1896, Haldane and Smith noted that carbonmonoxy-
haemoglobin dissociates in the light, and reassociates in the dark (Keilin, 1966). Then in 
1926, Warburg demonstrated that a mixture of 95% CO and 5% O2 caused the 
respiration of yeast to be inhibited by 71% in the dark, but that this was greatly 
alleviated in the light, with respiration inhibited by only 14%. The photo-reversibility of 
CO inhibition of respiration was later used to identify terminal oxidases (Castor and 
Chance, 1955). In the early 1970s it was shown that the inhibition of respiration by CO 
in yeast, for example, Schizosaccharomyces pombe was light-reversible, confirming that 
CO was inhibiting respiration by binding to haem in the cytochromes of the terminal 
oxidases of this organism (Poole et al., 1973).  
 
The current work aimed to establish whether the binding of CO from CORM-3 to the 
terminal oxidases of the aerobic respiratory chain of E. coli could also be reversed by 
light in order to ascertain to what extent CO from CORM-3 mimics CO gas applied as a 
solution. Initially, work was done to confirm that photolysis of the haem-CO bond could 
be observed as a change in respiration rate upon illumination of respiring wild type 
membrane particles. White light from a 150 W bulb was focused on the wall of a glass 
chamber using a convex lens; the light was switched on and off at 1 min intervals. 
 
In the presence of a solution of CO gas, an increase in respiration rate was evident 
immediately following the application of light, followed by an instant decrease in 
respiration rate upon removal of the light (Figure 3.9A, respiration rates for the first two 
light / dark cycles are given in Table 3.1). This confirms that the experimental design 
used here is suitable for observing the effects on respiration caused by the photolysis of 
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Figure 3.9 Photolysis of CORM-3 treated membrane particles confirms that the heme-
CO bond is photolabile in each terminal oxidase of E. coli. Oxygen consumption of E. 
coli membrane particles prepared from (A) and (B) wild type, (C) cytochrome bd-I only, 
(D) cytochrome bd-II only and (E) cytochrome bo’ only strains in the presence of (A) a 
solution of CO gas and (B) – (E) 300 µM CORM-3. The membrane particles were 
resuspended in sonication buffer to a final protein concentration of approximately 0.1 
mg ml-1. Respiration was started by the addition of 12.5 mM NADH. White light focused 
on the glass chamber was switched on and off at 1 min intervals (A), and 2 min intervals 
(B-E); green arrows indicate where the light was switched on and red arrows where it 
was switched off. These traces are representative of at least 2 technical replicates. 
Respiration rates for the first 2 light / dark cycles for each condition can be found in 
Table 3.1.  
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 Respiration rates (nmol O2 min-1 mg-1) 
 
Wild type 
with CO * 
Wild type with 
CORM-3 
 
Cytochrome bd-I 
with CORM-3 
Cytochrome bd-II 
with CORM-3 
Cytochrome bo’ 
with CORM-3 
Rate 1 
(light on) 
157.5 82.0 88.5 52.7 15.0 
Rate 2 
(light off) 
51 13.7 12.3 10.5 4.0 
Rate 3 
(light on) 
78 31.9 36.8 21.0 8.6 
Rate 4 
(light off) 
21 7.18 6.1 3.6 2.5 
 
 
Table 3.1 The respiration rates calculated from the gradients of the traces at four 
different time points. For CORM-3 treated membranes, rate 1 refers to the rate of 
respiration between 1 min and 3 min when the light is on, rate 2 is that between 3 and 5 
min when the light is off, rate 3 between 5 and 7 min when the light is on and rate 4 
between 7 and 9 min when the light is off. This experiment was conducted three times 
for each oxidase, the data shown is from one representative experiment. *The rates for 
wild type membranes with CO gas were recorded between the following time intervals: 
rate 1: 1 and 2 min when the light is on, rate 2: 2 and 3 min when the light is off, rate 3 
3 and 4 min when the light is on and rate 4: 4 and 5 min when the light is off. 
  
101 
 
the bond between CO gas and the haem groups of the terminal oxidases of the 
respiratory chain of E. coli.  
 
In order to establish whether CO from CORM-3 binds to CO in a ‘classical’ photolabile 
manner, this experiment was repeated with membranes prepared from wild type E. coli 
and from each single oxidase strain in the presence of 300 μM CORM-3. Membrane 
particles were suspended in sonication buffer, which had been bubbled with nitrogen 
gas for 15 min in order to reduce the amount of dissolved oxygen in the buffer to 
between 60 - 90 µM, to obtain a dissolved oxygen tension similar to that in the 
experiment with CO-saturated solution described above. The light was switched on and 
off at 2 min intervals. Addition of CORM-3 inhibited respiration significantly in all 
strains, but this inhibition was immediately alleviated during illumination of the sample, 
and these effects were observed repeatedly over several light dark cycles (Figure 3.9B-
E). 
 
Table 3.1 shows the rates of respiration for each strain after the first four light changes. 
The initial inhibited rate is very similar for both wild type and Cyd+ membranes treated 
with CORM-3, and in both cases there is approximately a 3-fold increase in the rate of 
respiration when the light is switched on (between rate 2 and rate 3). In contrast, the 
respiration rates for both the App+ and the Cyo+ membranes increased by approximately 
2-fold in the presence of white light compared to the CORM-3 inhibited rate in the dark 
(between rates 2 and 3).  
 
Following the demonstration that respiratory inhibition by CORM-3 could be reversed 
by white light, it was hypothesised that light may also be able to rescue E. coli cultures 
from killing by CORM-3. To investigate whether this was the case, wild type cultures 
of E. coli were grown to an optical density of 50 Klett units and then a 2 ml aliquot of 
this culture was placed into a glass chamber wrapped in foil so that no light could enter, 
while a second 2 ml aliquot was placed in an identical glass chamber on which a beam 
of light was focused. The cultures in each chamber were stirred magnetically and 
samples were taken before the addition of 30 μM CORM-3 and at 10, 20, 30, 45 and 60 
min after. These samples were diluted and plated out on to nutrient agar, incubated 
overnight and then counted. The cfu ml-1 values of the cultures grown in the light were 
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calculated and compared to those of the dark cultures. The light incubated CORM-3 
treated culture experienced approximately 70% killing in the first hour following 
treatment, however, the viability loss was significantly greater in the dark; 95% of the 
population was killed in 60 min. Statistical analysis of the data was done using a 
Student’s t test, which revealed that survival of the CORM-3 treated cultures grown in 
the light was significantly higher than that of the cultures grown in the dark at 30 (P < 
0.001), 45 (P = 0) and 60 min (P = 0) following CORM-3 addition (Figure 3.10).     
 
3.3 Discussion                
3.3.1 CORM-2, CORM-3 and CO gas inhibit respiration in E. coli membrane 
particles 
Inhibition of bacterial respiration by CORM-3 had been reported when the work 
described in this thesis was undertaken, including preliminary evidence that CORM-3 
treated E. coli cells contained CO-bound cytochromes (Davidge et al., 2009b; Desmard 
et al., 2009). However the details of respiratory inhibition by CORM-3 remained 
elusive and it was uncertain as to what extent inhibition of the terminal oxidases by CO 
from CORM-3 contributed to the bactericidal nature of these compounds. As outlined in 
the Introduction to this chapter (section 3.1) several key differences between the 
behaviour of CO gas and CORM-3 were evident, which necessitated a thorough 
investigation into the similarities and differences between respiratory inhibition by CO-
RMs with the established knowledge of the mechanisms by which CO gas inhibits 
respiration, in order to ascertain to what extent CO from CORM-3 mimics CO applied 
as a saturated solution. The work presented in this chapter investigated the nature of the 
inhibition of the terminal oxidases of E. coli with the aim of better understanding the 
mechanism of respiratory inhibition by CORM-3 
 
The respiratory studies presented in this thesis utilize bacterial membrane particles 
rather than whole cells. This was done to allow the investigation of respiration alone, 
without interference from other cellular components. The utilization of membrane 
particles allowed the immediate inhibitory effect of CO-RMs on the terminal oxidases 
to be observed without interference from the phenomenon of respiratory stimulation 
seen in whole cells treated with CORM-3, which is thought to arise from the transport 
of K+ and Na+ ions across the cell membrane as described in section 1.3.3.  
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Figure 3.10 Light can reduce the toxic effect of CORM-3 by photolysing the haem 
– CO bond. E. coli was grown aerobically to an OD of 50 Klett units, and 2 ml culture 
was added to both a light and dark chamber. Samples were taken before addition of 30 
μM CORM-3 and at regular intervals after and viability counts performed.  The mean 
percentage survival of 5 technical replicates at 30, 45 and 60 min compared to the 
viability before the addition of CORM-3 is shown. Asterisks indicate statistically 
significant decreases in viability of cultures grown in the dark compared to cultures 
grown in the light as measured using Student’s t test (*, P < 0.001; **, P < 0). These 
data are representative of 3 biological replicates. 
 
These data have been published in Wilson et al. (2013)  
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(Wilson et al., 2013). Indeed the demonstration that respiration rates are not stimulated 
in fragmented membrane samples is evidence that CORM-3 does not directly stimulate 
oxidase activity as has been reported with cytochrome c oxidase activity in 
mitochondria, in which low doses of CO (10 µM) transiently stimulate respiration 
(Queiroga et al., 2011).  
 
The use of membrane particles in respiratory studies also has the advantage of providing 
a more stable sample, whereas when whole cells samples were prepared their ability to 
respire deteriorated over several hours. It also allowed rapid measurements to be made 
in the closed system of the oxygen electrode, which is not possible with whole cell 
samples.  
 
While inhibition of respiration of E. coli membranes particles by CORM-3 is reported 
in this work as occurring on a faster time scale than that of whole cells as reported in 
Wilson et al. (2013), much higher concentrations of CORM-3 (400 µM) were required 
in order to give substantial inhibition (55%, Figure 3.1B). In the current work, 100 µM 
CORM-3 added at 75% of air saturation inhibited respiration by only 12%, while this 
concentration of CORM-3 inhibited intact E. coli cell suspensions by approximately 
40% (Wilson et al., 2013). While it would be unwise to try to make quantitative 
comparisons between these two findings, due to several inherent differences in the 
methodology used in each study, including differences in the amount of protein used, 
the oxygen tension at which the CO-RM compound was added and the use of the 
closed, compared to the open electrode system, it can be qualitatively concluded that 
over an extended time period, CORM-3 is more inhibitory to respiration in whole cells 
than in membrane particles. This is particularly evident when the effects of CORM-3 
are compared to those of CO gas in each system. CO gas (100 µM) administered as a 
solution has been shown not to inhibit bacterial respiration in whole cells Wilson et al. 
(2013), whereas work presented in this chapter shows CO gas to be more inhibitory to 
respiration of E. coli membrane particles than the equivalent concentration of CORM-3 
(38% inhibition following treatment with 100 µM CO gas, Figure 3.1A).   
 
Although it may initially seem counterintuitive that CORM-3 would be more inhibitory 
to whole cells than to membrane particles, as it could be expected that CO from CORM-
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3 would be better able to access its respiratory targets in fractured membrane particles 
compared to intact cells (as indeed it appears to with regards to exhibiting immediate 
inhibition upon addition of CORM-3), it may be that the low levels of cellular 
components available with washed membrane particles may reduce the rate or extent of 
CO release from CORM-3. This hypothesis is consistent with the findings of  (McLean 
et al., 2012) who showed that CORM-3 requires the presence of compounds such as 
sulfites in order to release CO. It is thought that CORM-3 releases CO once it has 
entered the cell, but not when in buffer, due to the presence of intracellular species 
similar to sulfites, which trigger this release.  
 
CORM-2 was used in addition to CORM-3 in these initial experiments to provide a 
comparison with CORM-3 and to ascertain the effects of this compound on respiration 
of E. coli membrane particles as a precursor to other work using this compound 
throughout this thesis. The finding that CORM-2 was more inhibitory to respiration than 
the same concentration of CORM-3 is in agreement with the findings of Nobre et al., 
(2007) who found that higher concentrations of CORM-3 than CORM-2 were required 
to decrease viability in E. coli and S. aureus cultures. 
 
3.3.2 The oxygen tension at which CORM-3 is added does not affect the degree of 
respiratory inhibition. 
An interesting finding of the current work is that the oxygen tension at which CORM-3 
is added does not determine the extent of respiratory inhibition experienced by E. coli 
membrane particles. This is contrary to our established knowledge that CO gas is 
preferentially inhibitory to respiration when present in concentrations in excess of 
dissolved oxygen (Keilin, 1966) and therefore provides additional evidence that CO 
from CORM-3 does not merely mimic CO gas. It is known from the work described in 
this thesis (section 3.2.1) and from the published work of others (Davidge et al., 2009b; 
Wilson et al., 2013), that  CO is the agent of CORM-3 that causes inhibition of 
respiration, as control molecules, including the CORM-2 precursor RuCl2(DMSO)4, 
inactive iCORM-3 and myoglobin inactivated miCORM-3, do not perturb respiration. 
Therefore it is hypothesised that the differing effects of CORM-3 and CO applied as a 
saturated solution are caused by the ability of CO-RMs such as CORM-3 to deliver CO 
into the cell, perhaps directly to the micro-domain of the respiratory chain resulting in 
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concentrations of CO at these sites that exceed concentrations applied outside the cell, 
and consequently, that greatly exceed the local oxygen concentrations (Davidge et al., 
2009b). Further evidence in support of this hypothesis is that ruthenium from CORM-3 
is known to accumulate inside cells to concentrations approximately 8-fold that applied 
to the culture medium (McLean et al., 2013), and results described in Chapter 5).  
 
The finding that CORM-3 is not more inhibitory to respiration of E. coli membrane 
particles when applied at low oxygen tensions differs from the findings of Wilson et al. 
(2013) who found that incubation of whole cell suspensions of E. coli and CORM-3 
under anoxic conditions for an extended period of time resulted in a shorter period of 
respiratory stimulation and a greater degree of inhibition when oxygen was allowed to 
re-enter the system. These differences may result from differences in experimental 
design between the two studies, particularly variations in the behaviour of CORM-3 
with whole cells and membrane particles. It is also possible that the greater inhibition 
seen when CORM-3 is incubated with whole cells under extended conditions of anoxia 
is in part due to the longer time period in which the cells were exposed to CORM-3, 
rather than a specific consequence of the oxygen tension at which this incubation 
occurred.  
 
A limitation of the experimental design used in this work is that the oxygen tension 
achieved may not have been sufficiently low considering the very high affinity of 
respiratory cytochromes for oxygen. In the ‘very low’ oxygen condition, the oxygen 
tension will have been approximately 6.2 µM, however, the km of cytochrome bo’ for 
oxygen is reported to be between 0.2 and 0. 46 µM, depending on the globin used in the 
measurement (D’mello et al., 1996), while that for cytochrome bd-I is between 3 – 8 
nM (D’mello et al., 1996). Furthermore, the cytochrome composition of the wild type 
membranes used in this work was not quantified. It is likely therefore likely that even in 
the very low oxygen condition, the cytochromes were able to bind oxygen efficiently, 
therefore out competing CO from the CO-RM.  
 
3.3.3 Cytochrome bd-I is the most resistant oxidase of E. coli to CORM-3 
The data presented in Figure 3.3 and 3.4 clearly demonstrate that cytochrome bd-I is 
significantly more resistant to inhibition by CO from CORM-3 than the other two 
107 
 
quinol oxidases of E. coli and that when expressed as the sole respiratory oxidase it is 
able to partially protect this organism from growth inhibition caused by CORM-3. The 
notion that cytochrome bd-I may have a role as a cellular protector against stressors is 
well established in the literature. This oxidase is known to protect bacteria from various 
environmental stresses such as azide and divalent metal ions. Moreover, cytochrome bd-
I null mutants are more sensitive to hydrogen peroxide than wild type E. coli (Poole and 
Cook, 2000). Cytochrome bd-I is more resistant to haem group inhibitors than haem-
copper oxidases such as cytochrome bo’, including cyanide (Pudek and Bragg, 1974), 
NO and CO (Poole et al., 1989). 
 
 More recently, cytochrome bd-I has been shown to protect E. coli cultures from NO-
induced growth inhibition by virtue of the fast dissociation rate of NO from this oxidase 
(Mason et al., 2009). Evidence for this stems from the findings that cydA and cydB, the 
genes that encode cytochrome bd-I, are up-regulated by exposure to NO (Pullan et al., 
2007). It was found that there was greater inhibition of respiration by NO of a strain 
containing cytochrome bo’ as the only terminal oxidise, and that the growth of this 
strain was also more restricted during NO stress. The authors concluded that these 
negative effects were not caused by a reduction in the amount of terminal oxidase in this 
strain (caused by the down-regulation of cytochrome bo’ in response to NO) but that 
cytochrome bo’ is more sensitive to NO than cytochrome bd-I. Measuring the O2- and 
NO-binding kinetics of each terminal oxidase allowed the authors to conclude that it is 
the rapid rate at which NO dissociates from cytochrome bd-I (5 times faster than that of 
cytochrome bo’) that causes this resistance (Mason et al., 2009). The resistance of 
cytochrome bd-I to NO may confer an advantage to pathogenic bacteria such as M. 
tuberculosis (Shi et al., 2005) and S. aureus (Richardson et al., 2006), both of which 
increase expression of this oxidase in response to low concentrations of NO. In support 
of this hypothesis, cytochrome bd mutants of several pathogenic bacteria are 
significantly less virile than their wild type counterparts (Endley, 2001; Shi et al., 2005; 
Way, 1999).  
 
Cytochrome bd-I also has a very high dissociation constant for CO (Kd = 70 nM for 
membrane bound enzyme (Borisov, 2008) compared to 1.7 μM for cytochrome bo’ 
(Cheesman et al., 1993)), which could explain the resistance of this oxidase to CO from 
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CORM-3. That the genes encoding cytochrome bd-I are up-regulated upon exposure to 
CORM-3 (Davidge et al., 2009b; McLean et al., 2013), provides further evidence that 
this oxidase provides a modest cellular defence against this compound. The increased 
transcription of cydAB was shown using a gene profiling microarray and then confirmed 
spectroscopically; a mutant containing only cytochrome bd-type oxidases exhibited 
increased levels of this oxidase following treatment with CORM-3 (Davidge et al., 
2009b). The published work also found a 10 - 22-fold reduction in the transcription of 
the genes in the cyo operon that encode cytochrome bo’. This is consistent with the 
finding in the current work that a strain expressing this cytochrome as the only terminal 
oxidase is the most sensitive to growth inhibition following treatment with CORM-3.  
 
3.3.4 Time-resolved spectra of CO from CORM-3 binding to each of the terminal 
oxidases of E. coli 
The data presented in Figure 3.7 confirm that CO is released rapidly from CORM-3 in 
the presence of E. coli membrane particles and sodium dithionite, and that it binds 
rapidly to  haem b595 and even more so to haem d. This is consistent with the findings of 
Davidge et al. (2009b), which provided evidence of the binding of CO from CORM-3 
to cytochromes in E. coli whole cells, however, the current work provides more detailed 
and time-resolved data. The substantially longer half-time of CO (from CORM-3) 
compared to that of a CO-saturated solution, binding to the respiratory cytochromes of 
E. coli membrane particles is consistent with CO needing to dissociate from the CORM-
3 molecule before it can bind to the oxidases.  
 
It is acknowledged that kinetic data cannot be accurately determined for such fast 
processes using this experimental technique. The use of stopped-flow spectroscopy 
would allow much more accurate kinetic data to be collected, although this is not trivial 
due to limitations with regards to the optical density of the samples used in this method. 
The data reported here do however confirm that, like CO gas (Figure 3.8), CO from 
CORM-3 binds most rapidly to haem d and that the majority of haem d becomes CO-
bound within the first 5 seconds following the addition of CORM-3. 
 
A limitation of both studies is the use of dithionite, which is added in order to reduce 
the haem proteins, thereby allowing CO binding, as this compound is now known to 
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promote CO release from several CO-RMs including CORM-3 (McLean et al., 2012). 
Therefore, while this method allows the relative rates of binding of CO from CORM-3 
to be measured, it does not allow conclusions to be drawn as to the un-facilitated rate of 
CO release from CORM-3 to the respiratory cytochromes. For this to be achieved, 
whole cell, or membrane particles should be treated with glucose, or another respirable 
substrate, to promote respiration to render the sample anoxic prior to the addition of 
CORM-3. This would allow in vivo measurements of CO release from CORM-3 to the 
terminal oxidases to be made.  
 
Cytochrome bd-I from E. coli has a Km (O2) value of 3-8 nM, which is the highest 
reported oxygen affinity for a respiratory oxidase. In this oxidase, it is haem d that binds 
O2 and reduces it to H2O, and it is known that this is also the site of CO binding 
(Borisov, 2008). Studies of the binding of CO gas to cytochrome bd from Azotobacter 
vinelandii have shown that haem d has an affinity for CO approximately 20-fold higher 
than that of haem b595 (Borisov et al., 2001). 
 
3.3.5 Photolysis alleviates the inhibition of respiration by CO from CORM-3 and 
reduces killing by CORM-3. 
When this work began, one of the major questions surrounding the bactericidal activity 
of CO-RMs was to what extent the inhibition of respiration is the major cause of killing 
by these compounds. The work described in this chapter aimed to investigate the 
mechanism by which CO from CORM-3 binds to respiratory cytochromes, and to 
answer this question by investigating the relationship between the alleviation of 
respiratory inhibition and the effect this has on the viability of CORM-3 treated 
cultures.  
 
It is shown here for the first time that CO from CORM-3 inhibits respiration in a 
‘classical’ photo-sensitive manner. This is an important finding and confirms that, 
despite having many properties distinct from CO gas (Davidge et al., 2009b; Nobre et 
al., 2007; Wilson et al., 2013), the mechanism of respiratory inhibition is similar. 
 
Most significantly, this work has directly demonstrated that, by alleviating CORM-3 
induced inhibition of respiration through photolysis of the haem-CO bond, the viability 
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of CORM-3 treated cultures can be preserved. This provides strong evidence that the 
binding of CO to haem proteins, including those in respiratory cytochromes, is a key 
contributor to the bactericidal properties of CORM-3. This is in agreement with the 
work of Desmard et al. (2009), who showed that inhibition of respiration precedes the 
loss of viability of P. aeruginosa caused by CORM-3, but is in contrast to the findings 
of Wilson et al. (2013), who measured respiration rates and viability concurrently in 
CORM-3 treated E. coli cultures and found a significant loss of viability of E. coli 
cultures before respiratory inhibition began. The conflicting evidence suggests that 
respiration is a significant target of CO from CORM-3, and that, by relieving this 
inhibition by photolysing the CO-haem bond in CORM-3-treated cultures, viability can 
be significantly protected. However, this does not exclude other important mechanisms 
by which CORM-3 exerts its toxicity. Such mechanisms may include the binding of CO 
from CORM-3 to other non-respiratory haem proteins, which based on the findings of 
this work, would be expected to be relieved by light, or indeed the effects of CORM-3 
on non-haem proteins (as described in section 4.3). 
 
Further evidence that inhibition of respiration is not the main mechanism by which CO-
RMs exert their bactericidal effects is provided by the work of Desmard et al. (2012), 
which compared the effects of two fast CO-releasing, ruthenium based CO-RMs 
(CORM-2 and CORM-3) with those of the slow releasing CO-RMs, CORM-371, which 
is manganese based, and CORM-A1, which does not contain a metal moiety. This work 
found that CORM-2, CORM-3 and CORM-371 decreased oxygen consumption to a 
similar extent, but that CORM-371 had a more transient effect on loss of viability. 
Furthermore, CORM-A1 only had a slight effect on O2 consumption and no adverse 
effect on viability. These differences in bactericidal effect suggest that it is unlikely that 
inhibition of respiration, is the cause of viability loss, but rather that the metal 
component of CO-RMs may have a larger effect on the toxicity of these compounds 
than was previously thought. 
 
The greater increase in respiration rate when light is applied to wild type and Cyd+ 
membranes treated with CORM-3 compared to that of App+ and Cyo+ membranes could 
suggest that CO is either bound more strongly to cytochrome bd-II and cytochrome bo’ 
or that it associates more rapidly with these oxidases reducing the stimulatory effects of 
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photolysis in these strains. This is consistent with the data presented earlier in this 
chapter, which suggest that cytochrome bd-II and cytochrome bo’ are more sensitive to 
respiratory inhibition by CORM-3. The data also support the work of Borisov (2008), 
which shows CO to dissociate more rapidly from cytochrome bd-I than from 
cytochrome bo’. 
 
Overall, this work provides the first evidence that the biological consequences of CO 
release from a CO-RM can be reversed by light and has been published in part in 
Wilson et al., (2013). There is much current work developing CO-RMs that release CO 
upon irradiation; see section 1.2.4 and the recent review by Schatzschneider (2011). The 
findings of the current work have important implications for future therapeutic 
applications of CO-RMs, particularly regarding photoCO-RMs. 
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Chapter 4 
The non-haem oxidase AOX from Vibrio fischeri 
is sensitive to inhibition by CORM-3 
 
4.1 Introduction  
Vibrio fischeri is a bioluminescent bacterium, which is able to live freely in fresh or salt 
water or to live symbiotically in the light organ of the Hawaiian bobtail squid Euprymna 
scolopes. This bacterium is of interest to the present work as it encodes the non-haem 
alternative oxidase AOX (Visick and Ruby, 2006), haems being prime targets of CO. 
 
4.1.1 Respiration in V. fischeri 
V. fischeri is able to conserve energy by aerobic and anaerobic respiration (Ruby et al., 
2005) and by mixed acid fermentation (Doudoroff, 1942). Anaerobically, it is able to 
use several terminal electron acceptors, including trimethylamine N-oxide (TMAO), 
nitrate, nitrite and fumarate (Dunn and Stabb, 2008; Ruby et al., 2005). Aerobically, V. 
fischeri can express three terminal ubiquinol oxidases; cytochrome bd-I, encoded by 
cydAB, a cbb3 type oxidase, encoded by ccoNOQP and an alternative oxidase, encoded 
by aox. Cytochrome bd-I and the cbb3 type oxidase are both haem-based oxidases, 
whereas AOX is unique as it does not contain haem, but instead possesses a di-iron 
catalytic center (Berthold et al., 2002). Figure 4.1 shows a diagrammatic representation 
of the respiratory chain of V. fischeri. 
 
4.1.2 Alternative oxidase 
Alternative oxidase was originally discovered in the mitochondria of plants and is also 
found in some fungi, bacteria and protozoa (Vanlerberghe and McIntosh, 1997). Most 
of the knowledge of the structure, regulation and function of AOX comes from studies 
of the plant oxidase, although it is not known whether bacterial AOX shares all of these 
properties. Bacterial homologs of plant aox were discovered by genome sequencing 
(McDonald and Vanlerberghe, 2005; Stenmark and Nordlund, 2003) and it is notable 
that many bacteria that possess aox, including V. fischeri, are marine organisms 
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(Rusch et al., 2007). As a functioning ubiquinol oxidase, AOX catalyses the four 
electron reduction of oxygen to water in aerobic respiratory chains, with oxygen binding 
to the di-ferrous form of the enzyme (Berthold and Stenmark, 2003). In plants, AOX 
does not directly contribute to the generation of a proton motive force, but may 
contribute indirectly when coupled to proton-pumping by NADH dehydrogenase 
(reviewed by Vanlerberghe and McIntosh, 1997).  
 
4.1.2.1. Structure of plant AOX 
Relatively little is known about the structure of AOX due to difficulties in purifying this 
protein. Work investigating the plant AOX indicates that it is a monotopic integral 
membrane protein (Berthold and Stenmark, 2003) with a dicarboxylate di-iron active 
site (Berthold et al., 2002). Recent work by Moore et al. (2008) used EPR spectroscopy 
to confirm that this is also true of trypanosomal AOX. The iron atoms are located within 
a bundle of 4 helices (Andersson and Nordlund, 1999; Berthold and Stenmark, 2003) 
and are bound by four carboxylate groups and two histidine residues (Berthold and 
Stenmark, 2003).  
 
4.1.2.2 Regulation of AOX activity and expression 
In V. fischeri aox is not expressed under normal laboratory conditions (Dunn, 2012). 
AOX activity is regulated at both the gene and protein levels. The expression of AOX is 
regulated by many stressors including low temperature, oxidative stress, pathogens and 
by inhibitors of cytochrome-mediated respiration (Slayman, 1977). Reduced sulfur 
compounds such as cysteine and methionine are known to induce AOX expression in 
the yeast Hansenula anomala (Minagawa et al., 1990). 
 
AOX activity is also regulated by post-transcriptional and post-translational 
modifications. The activity of plant AOX has been shown to increase when levels of 
reduced ubiquinone are high, implicating it as a useful respiratory pathway when the 
cytochrome oxidases are saturated (Lambers, 1982). However, AOX does not merely 
constitute an ‘overflow’, as it is known to compete with cytochrome oxidases for 
electrons (Hoefnagel et al., 1995). In plants, AOX activity is known to depend on direct 
interaction of a key cysteine residue, Cys I (Berthold et al., 2000) with certain alpha-
keto acids, particularly pyruvate (Day et al., 1994; Millar et al., 1993). High levels of 
115 
 
pyruvate occur with rapid glycolytic flux and when ADP levels are high, ensuring AOX 
is not active when respiratory substrates are limited. Recent studies in the plant Arum 
maculatum have elucidated the mechanism of AOX activation by pyruvate, which has 
been shown to stabilise the active conformation of AOX, directly increasing Vmax (Carre 
et al., 2011). AOX can exist as a monomer or dimer linked by disulfide bonds, with the 
dimer being the less active form (Umbach and Siedow, 1993). AOX must be in the 
reduced monomeric form in order to be activated by pyruvate and this reduced, 
activated form of AOX has a higher affinity for ubiquinone (Umbach et al., 1994). 
Figure 4.2 summarises factors that affect AOX activity. 
 
4.1.2.3 The role of AOX 
In themogenic plants, AOX is involved in heat generation, which is important for 
pollination and temperature regulation (Meeuse, 1975); however the specific role of this 
oxidase in other species is less well understood. There is some evidence that AOX is 
involved in the maintenance of metal homeostasis (Rasmusson et al., 2009), protection 
from oxidative stress (Gupta et al., 2009; Wagner and Moore, 1997) and in virulence 
(Akhter et al., 2003). Plant AOX is not directly involved in the generation of the proton 
motive force, and is therefore not subject to back pressure from this force, however, 
AOX may be important in maintaining turnover of the Krebs cycle and allowing 
synthesis of carbon skeletons (Lambers, 1982). 
 
AOX may also confer a selective advantage to V. fischeri, enabling it to exclusively 
colonise the squid Euprymna scolopes. This symbiotic relationship is well studied as a 
model for beneficial host - microbe interactions. V. fischeri readily colonises the light 
organ of E. scolopes, where it receives a plentiful supply of nutrients, while the squid 
benefits from the bioluminescence produced by the bacteria in a process called 
‘counterillumination’, which reduces the visibility of the squid to predators (Jones and 
Nishiguchi, 2004). V. fischeri produces light via the enzyme luciferase, which requires 
oxygen in order to convert a reduced flavin mononucleotide and an aldehyde to a 
carboxylic acid. The reaction forms an excited hydroxyflavin intermediate, which emits 
blue-green light of λmax 490 nm upon dehydration (Fisher et al., 1996). Strains unable to 
generate light have a colonisation defect (McFall-Ngai et al., 2012; McFall-Ngai and 
Ruby, 2000; Visick et al., 2000). Luciferase has an affinity for oxygen in the nanomolar 
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Figure 4.2 Factors that affect the activity of plant AOX. Major factors that control 
the partitioning of respiratory electrons to the non-energy-conserving alternative 
oxidase may include coarse control of the amount of AOX enzyme present as well as 
fine metabolic control of the activity of pre-existing AOX enzyme. The information 
used to generate this figure was obtained from (Vanlerberghe and McIntosh, 1997). 
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range (Lloyd et al., 1985), therefore the process of light generation is in competition 
with aerobic respiration, which may be problematic at later stages of colonisation when 
oxygen may be limited (Ruby and McFall-Ngai, 1999). The low oxygen affinity of 
AOX (see below) may enable it to continue catalysing aerobic respiration, without 
compromising essential luciferase activity. 
 
4.1.2.4 Interaction of AOX with gaseous ligands 
The affinity of AOX for oxygen has long been known to be lower than that of 
cytochrome based oxidases (Kano and Kageyama, 1977). Studies of cytochrome 
oxidases similar to those encoded by V. fischeri suggest that cytochrome bd has a 
Michaelis constant of between 3 – 8 nM (D'mello et al., 1996), while CcoNOQP is 
thought to have a Km value of 7 nM (Preisig et al., 1996). These oxidases have 
considerably higher affinities for oxygen than plant AOX, which has a Km in the 
micromolar range (Ribas-Carbo et al., 1994).  
 
It is well established that AOX from plants is a cyanide-resistant oxidase (reviewed by 
(Laites, 1982) due to the absence of haem, which is at the center of the catalytic 
mechanism of traditional cytochrome oxidases. Indeed, the existence of cyanide-
resistant respiration in plants such as that in potato tubers, has been known since before 
the discovery of AOX (Hanes and Barker, 1931). The ability to undergo cyanide-
resistant respiration is an important property in plants as approximately 800 species of 
plant are known to produce cyanide when wounded or attacked by pathogens 
(Mansfield, 1983). 
 
It has recently been shown that a strain of V. fischeri containing AOX as the sole 
terminal oxidase was significantly less sensitive to the respiratory inhibitor NO than a 
strain containing cytochrome bd as the only terminal oxidase (Dunn et al., 2010). As 
AOX is up-regulated by NO via the negative regulator NsrR, it has been suggested that 
AOX is important in protecting V. fischeri from host-derived NO during colonisation, 
enabling the symbiotic relationship between the bacterium and squid to be established. 
Contrary to this, aox mutants have been shown to be capable of colonizing squid with 
the same efficiency as wild type, which may suggest that AOX has a role at later stages 
of symbiosis (Dunn et al., 2010).  
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There is currently no literature describing the relationship between CO and AOX, but 
this oxidase is assumed to be CO insensitive by analogy with cyanide and NO, which 
inhibit haem-based oxidases, but not AOX (Dunn et al., 2010; Lambers, 1982).  
 
4.1.3 The aim of this work 
The aim of the work in this chapter was to assess the effects of CO-RMs on the non-
haem oxidase AOX from V. fischeri through respiratory studies and spectroscopic 
methods. It was hypothesised that this oxidase would be resistant to respiratory 
inhibition by CO-RMs, as it lacks haem, which is believed to be a major target of CO 
from CO-RMs.  
 
4.2. Results 
4.2.1 The growth of V. fischeri in rich medium 
In this work, mutants were obtained that were each able to express only one of the 
terminal oxidases of V. fischeri. AKD788 has the genotype Δaox ΔccoNOQP and 
therefore expresses CydAB (cytochrome bd-I) as the only ubiquinol oxidase; AKD789 
has the genotype ΔcydAB ΔccoNOQP and expresses AOX (alternative oxidase) as the 
only terminal oxidase (Dunn et al., 2010). CydAB is known to be essential for aerobic 
growth; however, when such mutants were switched from anaerobic to aerobic growth, 
many developed suppressor mutations, which often affected AOX expression and 
allowed these mutants to grow normally in aerobic conditions (Dunn et al., 2010). 
AKD789 contains the suppressor mutation OG1-10, which disrupts the putative NsrR 
binding site and results in NO-independent AOX expression (Dunn et al., 2010). The 
wild type V. fischeri strain used as a control in this work was ES114 (Boettcher and 
Ruby, 1990), from which the mutant strains and were derived. 
 
Initially, the growth of these strains was assessed in rich LBS medium (Figure 4.3). The 
strain AKD789 (AOX-only) grew at a much slower rate than both the wild type and 
AKD788 strains, which had similar growth rates.  
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Figure 4.3 The growth of three strains of V. fischeri in LBS medium. The growth of 
wild type V. ficheri ES114 (closed circles), the mutant expressing only cytochrome bd 
(AKD 788, open circles) and the mutant expression only AOX (AKD 789, closed 
triangles) was measured spectroscopically using a Klett meter. Data are the means and 
standard deviations of 2 technical replicates and are representative of 2 biological 
replicates. 
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 4.2.2 The effects of CO gas and CO-RMs on the terminal oxidases of V. fischeri 
In order to investigate the effects of CO-RMs on the terminal oxidases of V. fischeri, 
oxygen consumption of membrane particles prepared from cultures of each of the 
strains introduced in section 4.2.1 was measured using an oxygen electrode. Respiration 
was initially studied in a closed oxygen electrode (ie. a lid was placed on the electrode 
chamber to prevent the entry of oxygen into the system). The closed system allows 
oxygen consumption to be studied simply and directly for a short duration. A small 
amount of membrane preparation (typically 275 µg ml-1) was added to the chamber and 
the respiratory substrate NADH (6.25 mM) was added to initiate respiration. As 
respiration proceeded, oxygen levels within the chamber rapidly decreased in a linear 
fashion. When the oxygen levels in the chamber reached 75% of air saturation 
(approximately 150 µM), the compound of interest (CO, CORM-401, CORM-3 or 
iCORM-3) was added to the chamber through a narrow hole in the lid, using a Hamilton 
syringe. 
 
The addition of CORM-3 (50 µM) to both wild type and AKD788 (cytochrome bd-I-
only) membranes reduced the rate of respiration to 84% and 74% respectively of the 
control rates in which no compound was added (data are the mean of at least 2 technical 
and 2 biological replicates). In contrast, the addition of CORM-3 (50 µM) to AKD 789 
(AOX-only) membrane particles had a larger effect on the respiration rate, which was 
reduced to 27% of the control rate (Figure 4.4A and Figure 4.5).  
 
The finding that membranes containing AOX as the sole terminal oxidase were 
hypersensitive to CORM-3 was contrary to expectations, as it was hypothesised that an 
oxidase without haem would be insensitive to respiratory inhibition by CO from 
CORM-3. In order to further investigate this finding, the above experiment was 
repeated with a CO-saturated solution used in place of CORM-3. CO reduced the rate of 
oxygen consumption by wild type, AKD788 and AKD789 membrane particles to 50, 60 
and 79% of the control rates respectively (Figure 4.4B and Figure 4.5).The experiment 
was then repeated using the control compound iCORM-3. This had a minimal effect on 
the rates of oxygen consumption, altering respiration rates to 101, 94 and 90% of the 
control for wild type, AKD 788 and AKD 789 respectively (Figure 4.4C and Figure 
4.5). Finally, the experiment was repeated using the manganese based CO-RM, CORM- 
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Figure 4.4 AOX from V. fischeri is resistant to respiratory inhibition by CO-
saturated solution, but hypersensitive to CORM-3 and CORM-401. Membrane 
particles resuspended in 2 ml Vibrio phosphate buffer to a final protein concentration of 
approximately 275 µg ml-1, and added to the closed oxygen electrode chamber. NADH 
(6.25 mM) was added to initiate respiration. Traces show oxygen consumption of 
membrane particles from wild type (black lines), cytochrome bd-I-only (red lines) and 
AOX-only (blue lines) in the presence of (A) CORM-3 (50 μM), (B) CO-saturated 
solution (100 μM), (C) iCORM-3 (50 μM) and (D) CORM-401 (50 μM), all added at 
approximately 150 µM O2, as indicated by the arrow. Traces (E - H) show the 
corresponding controls for the above experiments. Variations in respiration rate between 
control experiments are due to variation in the use of different batches of membrane 
preparation and variations of the quantity of protein added for different strains. The 
numbers on the traces are respiration rates 2 min following the addition of compound 
(nmol O2 min mg-1 protein-1). These traces are representative of at least 2 technical and 
2 biological replicates. 
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Figure 4.5 Respiration rates of V. fischeri membrane particles treated with CO, 
CORM-3, iCORM-3 or CORM-401 as a percentage of the control rate. This figure 
summarizes graphically the data shown in Figure 4.4. Respiration rates were calculated 
2 min after the addition of compound, and at the corresponding point in the control 
experiment in which no compound was added. Rates were expressed as a percentage of 
the control rate and means and standard deviations calculated from at least 2 technical 
replicates of at least 2 biological replicates. Brown bars represent the control rate, which 
was set as default at 100%, orange bars show the data for iCORM-3 (50 µM), yellow 
bars for CORM-3 (50 µM), green bars for CO (100 µM) and blue bars for CORM-401 
(50 µM). 
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401. This compound is able to release up to 3 CO equivalents from each CO-RM 
molecule under biological conditions (1.2.3.3). CORM-401 inhibited respiration to a 
lesser extent than CORM-3, consistent with the effects of this compound on E. coli 
membranes (Lauren Wareham, unpublished work). Oxygen consumption rates of wild 
type and AKD788 membranes were both increased by 116% in the presence of 50 µM 
CORM-401 compared to the control in which no compound was added, whereas that of 
AKD789 was inhibited to 79% of the control (Figure 4.4D and Figure 4.5). Figures 
4.4E – F show the oxygen consumption rates of the control experiments in each case. 
Numbers shown on each trace represent the respiration rates calculated at 2 min 
following the addition of compound (or the equivalent time point in the control 
experiments). In some cases, these numbers appear misleading; for example the 
respiration rate calculated for AKD789 membranes in Figure 4.2F is 58.4 nmol O2 min-1 
mg-1 protein, however it appears to have a faster rate of oxygen consumption than 
AKD788 membranes in the same figure, which have a respiration rate of 333 nmol O2 
min-1 mg-1 protein. This is because a larger amount of protein was added to the chamber 
in the case of AKD789 in order to achieve similar apparent rates of oxygen 
consumption for all three strains prior to the compound of interest being added. 
Variation between the various control respiration rates occurred between each 
preparation of membrane particles; however, the trends seen when the various 
compounds were added to the chamber were consistent between biological replicates as 
reflected by the small standard deviations of the percentage inhibition data (Figure 4.5). 
 
Due to the unexpected nature of the results described above, work was also done to 
compare the sensitivities of the oxidases to inhibition by CORM-3 in the open oxygen 
electrode, by measuring the time taken for the chamber to reoxygenate, as described in 
Chapter 3. This method allows a comparison between the sensitivity of various strains 
to the inhibitor to be made; the respiration of more sensitive strains will be inhibited to a 
greater extent and so will not be able to utilise the oxygen in the chamber as quickly, 
allowing oxygen to accumulate in the chamber and be detected by the electrode.  
 
In this experiment, conditions were established that allowed respiration to proceed at a 
sufficient rate to maintain an oxygen level of 0 in the chamber for an extended period of 
time. Eventually, the substrate NADH became exhausted, leading to reoxygenation of 
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the chamber. In the absence of an inhibitor, the time to reoxygenation of membranes 
from all three strains (wild type, AKD788 and AKD789) was very similar (between 40 
and 48 min; Figure 4.6A). However, when CORM-3 (25 μM) was added, while the time 
to reoxygenation of wild type and AKD789 was largely unaffected (wild type: 81% of 
control, AKD788: 87% of control), the chamber containing AKD789  membranes began 
to reoxygenate almost immediately, confirming that this oxidase is extremely sensitive 
to respiratory inhibition by CORM-3 (Figure 4.6B). Importantly, the control experiment 
using iCORM-3 gave times to reoxygenation for each membrane type similar to that of 
the control (Figure 4.6C; wild type: 93% of control, AKD788: 103%, AKD789: 94%).   
 
Plant AOX is known to be resistant to cyanide (reviewed by Lambers, 1982). In order to 
validate the experimental design, the experiment was repeated using potassium cyanide 
(KCN) (Figure 4.6D). Indeed, it was found that the time taken for membranes 
containing AOX or cytochrome bd-I as the only terminal oxidase to begin to 
reoxygenate was largely unaffected by 50 µM cyanide (with times to reoxygenation of 
96% and 119% of the control times respectively). AKD788 membranes were able to 
maintain anoxia in the chamber for a significantly longer duration than wild type 
membranes, which is consistent with cytochrome bd-I having some cyanide resistance 
(Borisov et al., 2011a; Voggu et al., 2006) The control traces for this experiment, in 
which no cyanide was added, are shown in Figure 4.6E. The data described thus far in 
this chapter confirm that AOX is resistant to cyanide and CO, but hypersensitive to CO-
RMs. 
 
4.2.3 The effects of CORM-2 and CORM-3 on the growth of V. fischeri 
Next, it was investigated whether the sensitivity of the AOX protein to respiratory 
inhibition by CORM-3 led to an increased sensitivity of a strain of V. fischeri 
expressing AOX as the only ubiquinol oxidase to growth inhibition by this compound. 
Aliquots of CORM-2 or CORM-3 were added to 5 ml ASW medium in sterilin tubes 
with a small inoculum of primary culture (40 µl of wild type and 120 µl of AKD789), 
which had been grown in 5 ml LBS for 6 h.   
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Figure 4.6 AOX is the most sensitive oxidase of V. fischeri to respiratory inhibition 
by CORM-3. Membranes prepared from either wild type V. fischeri or from mutants 
containing either AOX (AKD 789) or cytochrome bd-I (AKD 788) as the only terminal 
oxidase were added to the chamber to a final concentration of approximately 40 mg ml-1 
and stimulated to respire by the addition of 12.5 mM NADH. The black lines show the 
traces for the wild type strain, red lines show the traces for the strain containing 
cytochrome bd-I only and blue lines for the strain containing AOX only. (A) shows the 
control in which no compound was added for the CORM-3 experiment, (B) CORM-3 
(25 μM) added at the long arrow, (C) iCORM-3 (25 μM) added at the long arrow,  (D) 
CN- (100 μM) added at the long arrow, (E) shows the control in which no compound 
was added for the cyanide experiment. In each case, the lid was removed from the 
chamber at the time point indicated by the short arrow. The numbers with each trace 
show the time taken for the chamber to reoxygenate, following the removal of the lid, in 
minutes. Data are representative of at least 2 biological and 2 technical repeats. 
 
 
 
  
CN- 
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These cultures were then incubated at 28 °C with shaking for 17 h and then the OD600 
measured using a spectrophotometer. One difficulty that arose when comparing the 
growth of AKD 789 with that of wild type V. fischeri in the presence of CO-RM, is that 
in the absence of an inhibitor, the former grows significantly slower than the later. In 
the absence of CO-RM, AKD789 reached an optical density (OD600) approximately 
40% lower than that of wild type after 16 h (Figure 4.7A and C). For this reason, it was 
considered that the optical density values expressed as a percentage of the growth for 
each strain in the absence of CORM-3 (Figure 4.7B and D) gave more meaningful 
information than the raw optical density data (Figure 4.7A and C).  The growth of 
AKD789 was inhibited by a lower percentage than that of wild type V. fischeri over a 
range of CORM-3 concentrations. CORM-2 had a more potent effect on the growth of 
V. fischeri than CORM-3, consistent with observations in other organisms (see Chapter 
3 of this work and Nobre et al. (2007)). CORM-2 (50 µM) reduced the growth of wild 
type V. fischeri by 93%, whereas 50 µM CORM-3 reduced the growth of V. fischeri by 
only 65% (Figure 4.7B and D). At three of the four CORM-2 concentrations tested 
(12.5, 50 and 100 µM), the growth AKD789 appeared to be slightly less affected in 
terms of percentage than that of the wild type strain. Importantly, the control compound 
RuCl2(DMSO)4, a CORM-3 precursor that is also structurally similar to CORM-2, did 
not have any effect on the growth of either strain under the same experimental 
conditions (data not shown). 
 
4.2.4 Spectroscopic studies of V. fischeri cell suspensions and membrane 
preparations treated with CORM-3 
The haem content of the membrane particles used in the respiratory studies in this 
chapter was confirmed by generating reduced minus oxidised difference spectra (Figure 
4.8). V. fischeri membrane particles were suspended in buffer to a final concentration of 
approximately 2 - 4 mg ml-1. The ‘oxidised’ sample was scanned in triplicate using a 
dual wavelength spectrophotometer (Kalnenieks et al., 1998) using a 10 mm path 
127 
 
 
 
 
Figure 4.7 The effect of various concentrations of CORM-2 and CORM-3 on the 
growth of V. fischeri. Cultures of V. fischeri; wild type (black bars) and AKD 789 
(grey bars) were grown overnight in the presence of various concentrations of CORM-2 
or CORM-3 (0 – 100 μM). OD600 was then recorded for each strain (A and C) and 
expressed as a percentage of the OD600 in the absence of CO-RM (B and D). Data are 
the means and standard deviations of 3 biological repeats.  
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Figure 4.8 Reduced minus oxidised spectra of V. fischeri membrane particles. (A) 
wild type, (B) AKD788 (cytochrome bd-I only) and (C) AKD789 (AOX only) 
membranes were analysed using a dual-beam spectrophotometer to generate reduced 
minus oxidised difference spectra. Membrane preparations were diluted with vibrio 
buffer to a final concentration of 2 - 4 mg ml-1. These spectra are representative of 2 
technical and 2 biological replicates. 
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length. Samples were then reduced by the addition of a few grains of sodium dithionite 
and spectra were again recorded in triplicate. Data were averaged in Excel and plotted 
as reduced minus oxidised difference spectra. The spectrum of each strain had a peak 
between 438 and 448 nm, which is indicative of various cytochromes, a trough at 
approximately 470 nm, which is probably attributable to flavin and a peak at 
approximately 560 nm caused by haem b (Jones and Poole, 1985). Importantly, there is 
a peak at approximately 634 nm in the wild type and cytochrome bd-I-only-containing 
cells that is not present in the AOX only cells confirming the absence of haem d. 
 
CORM-3 difference spectra for V. fischeri whole cells (Figure 4.9) were then generated 
for each strain to further investigate their interaction with CO from CORM-3. Samples 
were suspended in buffer to a final concentration of approximately 12 - 14 mg ml-1, 
reduced by the addition of a few grains of sodium dithionite and then scanned in 
triplicate using a dual wavelength spectrophotometer as described above. Samples were 
then treated with CORM-3 (300 µM). Spectra were recorded in triplicate, averaged and 
plotted as a CO reduced minus reduced difference spectra. The whole cell CORM-3 
difference spectra confirmed that CO from CORM-3 binds to components of all three 
strains, including AKD789, which expresses AOX as the only terminal oxidase. 
 
In order to investigate more directly the interaction of CO from CORM-3 with the 
terminal oxidases of V. fischeri, CO difference spectra were also generated as described 
above by treating membrane particles (final concentration 2 - 4 mg ml-1) prepared from 
wild type V. fischeri (Figure 4.10A, C, E), or the strain expression AOX as the only 
terminal oxidase (Figure 4.10B, D, F) with CO (Figure 4.10A, B, bubbled for 5 min) 
CORM-3 (Figure 4.10C, D; 300 µM) or iCORM-3 (Figure 4.10E, F; 300 µM), or by 
bubbling with CO for 5 min. The spectra produced from the whole cell samples and the 
membrane preparations were very similar, confirming that membrane-based 
components are interacting with CO in all cases. CO and CORM-3 treatment also led to 
very similar spectra, indicating that CO released from CORM-3 was responsible for the 
spectral changes seen when the membrane particles were treated with this compound 
(Figure 4.10A and C, B and D). An important spectral difference between the two 
membrane types is the absence of a peak at 648 nm in the AOX only membranes. This  
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Figure 4.9 CORM-3 difference spectra of V. fischeri whole cells. A dual wavelength 
spectrophotometer was used to generate difference spectra (CORM-3 reduced minus 
reduced) of (A) wild type, (B) AKD788 (cytochrome bd-I-only) and (C) AKD789 
(AOX only membranes). Cell suspensions were added to Vibrio phosphate buffer to a 
final concentration of between 12 - 14 μg ml-1 and treated with CORM-3 (100 μM). 
These spectra are representative of 2 technical and 2 biological replicates. 
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Figure 4.10 CORM-3 difference spectra V. fischeri membrane particles (reduced 
plus CORM-3 minus reduced) were recorded in a dual wavelength spectrophotometer. 
V. fischeri membrane particles from wild type (A, C, E) and AOX-only (B, D, F) 
strains were added to Vibrio buffer to a final concentration of between 2 - 4 μg ml-1 and 
treated with either CO-saturated solution (A and B), CORM-3 (300 μM) (C and D) and 
iCORM-3 (300 μM) (E and F).   
iCORM-3CORM-3 
CORM-3CO 
CO 
Wild type Wild type Wild type 
AOX-only AOX-only AOX-only 
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confirms that haem d is not present in these membranes (Figure 4.10B and D). It is clear 
however that there are some spectral features in the CO and CORM-3 difference spectra 
of the AOX-only membranes (Figure 4.10B and D), some of which are also present in 
the wild type membranes (Figure 4.10A and C). Difference spectra were produced for 
each membrane type treated with the control compound iCORM-3, which was verified 
to release very little CO to myoglobin (less than 1% compared with CORM-3, data not 
shown). The addition of iCORM-3 to wild type membranes resulted in oxidation of the 
membrane particles (seen by a trough at 436 nm, Figure 4.10E) as well the formation of 
a small peak at 648 nm indicating the binding of a small amount of CO to haem d. 
Interestingly, while the addition of iCORM-3 to AOX-only membranes appears to cause 
slight oxidation (shown by a small trough at 424 nm), no other distinct features are seen, 
suggesting that membranes devoid of haem are less able to trap the small amount of 
residual CO from iCORM-3. 
 
4.3 Discussion 
The work in this chapter constitutes the first investigation of the effects of CO and CO-
RMs on a non-haem oxidase. Contrary to the expectation that AOX would be resistant 
to respiratory inhibition by CO-RMs, membranes containing only this oxidase were 
found to be hypersensitive to these compounds. Two different methods were used to 
measure respiration in membranes treated with CO-RMs because of the unexpected 
findings. These included closed electrode experiments, which measure respiration rates 
directly, and an open electrode method, used to compare the sensitivities of various 
strains to a respiratory inhibitor. Both methods experienced the same difficulty; that the 
respiration rate of AKD789 was significantly slower than that of AKD788 or wild type, 
which had similar oxygen consumption rates to one another (Dunn et al., 2010). This 
necessitated a greater quantity of membrane preparation be used for AKD789 than the 
other two strains in order to achieve similar oxygen consumption rates. It is therefore 
possible that CORM-3 could be titrated by the additional membrane in this sample, 
thereby dampening the effects of the compound; however, the finding that CORM-3 is 
in fact more inhibitory to respiration in this strain negates this potential problem. 
Another concern caused by the differing respiration rates of the strains used was the 
possibility that the weak oxygen consumption rates of AKD 789 would render this 
strain sensitive to potent respiratory inhibition by any inhibitor. This led to the control 
133 
 
experiment in which cyanide (to which AOX is known to be resistant) was added to 
respiring membrane particles in the open electrode chamber (Figure 4.6D). The ability 
of AKD789 membrane particles to respire in the presence of cyanide acts as a positive 
control and confirms the validity of the finding that these membranes are hypersensitive 
to CORM-3. The experiment to measure time to reoxygenation is also validated by the 
finding that membranes containing only cytochrome bd-I were more resistant to CN- 
than wild type membranes, as is reported in the literature (Borisov et al., 2011a). 
 
The finding that the control compound iCORM-3 does not significantly inhibit 
respiration in any of the strains (Figure 4.4C and 4.6C) supports the conclusion that CO 
is the agent causing the inhibition, rather than the ruthenium-containing CO-RM 
backbone; however, the uncertain nature of iCORM-3, which was not fully apprecieated 
at the time this work was carried out, complicates the interpretation of these results. 
This hypothesis is further supported by the finding that CORM-401, which contains 
manganese instead of ruthenium at its centre, is also more inhibitory to respiration in 
AKD789 membranes (Figure 4.4D). However, in contrast to this, AOX was shown to be 
resistant to CO delivered as a saturated solution (Figure 4.4B), suggesting that CO is not 
the causative agent of the inhibition of the enzymatic activity of this oxidase (Figure 
4.4B).  
 
Despite the finding that AOX oxidase activity is extremely sensitive to respiratory 
inhibition by CORM-3, the strain AKD 789 was less sensitive to growth inhibition by 
CORM-3. One difficulty in assessing the contribution of AOX to growth sensitivity in 
the presence of an inhibitor is that the strain AKD 789 grows at a much slower rate than 
wild type, which may affect the growth response to CORM-3. It should also be noted 
that the percentage of the optical density in the presence of CORM-3 compared to that 
in the absence of CORM-3 is quoted, and this will be affected to a different magnitude 
by an inhibitor because of the differing growth rates of the two strains. Another 
difficulty with the strain AKD789 is that the expression of AOX has been uncoupled 
from control by the NO response regulator NsrR and so AOX is being expressed under 
conditions in which it might not otherwise be, and perhaps in the absence of other 
proteins or conditions that are associated with its normal function. It is also possible that 
the V. fischeri cultures were able to ferment the carbon source in the medium (N-acetyl 
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glucosamine). As elucidating the effects of CO-RMs on the respiratory components of 
V. fischeri is the aim of this work, further studies should be done using a non-
fermentable carbon source, such as glycerol to force the bacteria to respire. 
 
It was considered important to investigate further the nature of the interaction between 
CO from CORM-3 and the terminal oxidases of V. fischeri. This process was hampered 
by the inherent difficulties of studying AOX, which, in plants, is notoriously difficult to 
purify and has no characteristic spectral features and no specific EPR signals (Laites, 
1982).   
 
Both the reduced minus oxidised and CO and CORM-3 difference spectra show that 
haem d is absent from both whole cell and membrane samples of the strain ADK789. 
Importantly though, CO applied as a saturated solution, or as CORM-3, was found to 
bind to components of membranes from all three strains of V. fischeri. The CO bound 
features of AKD789 membranes cannot yet be positively identified, however it is 
possible that they contribute to the sensitivity of this strain to CORM-3. 
 
The peaks at 631 - 634 nm in the wild type and cytochrome bd-only reduced minus 
oxidised spectra (Figure 4.8A and B) are characteristic of cytochrome d as shown by 
Haddock et al. (1976) in E. coli and A. vinelandii, Jones and Redfearn (1966) in P. 
aeruginosa and Miller and Gennis (1986) in E. coli. This feature is absent from the 
AOX-only spectrum as expected (Figure 4.8C). The peaks between 561 and 565 nm are 
due to multiple b type cytochromes, with a contribution from cytochrome c (a 
component of ccoNOQP) in the case of the wild type and cytochrome bd-only 
membranes (Figure 4.8A and B). In the Soret region, the bands between 438 and 448 
nm are again due to a composite of signals from cytochromes b and d. In Figure 4.8B, 
there is a greater contribution from cytochrome bd, shown by the shift of the peak to 
448 nm. The features from the c-type cytochromes in the cco type oxidase would be 
expected at shorter wavelengths, but these are masked by other features. 
 
These conclusions are supported by the CO and CORM-3 difference spectra in Figure 
4.9 and 4.10, which show the presence of haem d, indicated by a peak at 645 – 648 nm 
(Jones and Poole, 1985) in the wild type and cytochrome bd-only strains, but not in the 
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AOX-only strain. In the Soret region of Figure 4.9A and B, the peak and trough can be 
attributed largely to CO binding cytochrome b (ie. cytochrome b595) and haem d. The 
identity of the spectral features seen in the CO spectra of AKD 789 is much less clear; 
the only oxidase reported in this strain is AOX and it has been reported that this oxidase 
has no spectral features (Laites, 1982). 
 
Haemoproteins other than respiratory oxidases are capable of giving rise to spectral 
features. Indeed, a peak at approximately 420 nm can indicate CO binding to 
cytochrome P-420, while a peak at approximately 440 – 445 nm can be caused by CO 
binding to cytochrome a1 or a3 (Jones and Poole, 1985). There is no evidence that V. 
fischeri contains either of these cytochromes; however, it is known to contain 
cytochromes c551 and c554 (Petushkov and Lee, 1997), which have reduced absorption 
spectra similar to c-type cytochromes from P. aeruginosa and Azotobacter with a strong 
peak at 416 nm. There are other components of V. fischeri that absorb in the UV-visible 
region; blue fluorescence protein also has an absorption maximum at 417 nm and 
thioredoxin reductase has absorption features between 400 – 500 nm (Petushkov and 
Lee, 1997).  
 
The binding of CO from CO-RMs to haem proteins and the subsequent inhibition of 
these proteins was initially considered to be a major cause of the bactericidal nature of 
these compounds. While this is still considered to be an important mechanism of CO-
RM action, there is mounting evidence that CO-RMs have much wider reaching cellular 
effects. Transcriptomic profiling indicates that the metabolism and transport of many 
ions are greatly affected by CORM-3, as well as several global regulators of 
transcription (Davidge et al., 2009b). There is also evidence that E. coli cultures treated 
with CORM-3 (100 µM) lose significant viability prior to the onset of respiratory 
inhibition (Wilson et al., 2013). In addition, anaerobic cultures have been shown to be 
susceptible to killing by high concentrations of CO-RMs (Davidge et al., 2009b; Nobre 
et al., 2007). Recent work from this laboratory has found that both naturally occurring 
haem-deficient bacteria (Lactococcus lactis) and a strain of E. coli, which had been 
genetically modified to be haem-deficient, were both susceptible to growth inhibition 
and killing by CORM-3 (Wilson, 2012). 
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These findings, and the results presented in this chapter, suggest that there are 
significant targets of CORM-3 other than the haem-containing respiratory oxidases. 
There are examples of CO directly affecting the activity of non-haem proteins. CO is 
known to activate large-conductance Ca2+- and voltage-gated K+ (Slo1 BK) channels, 
which are involved in oxygen sensing, vasodilation and the activation of signalling from 
neurones (Wang et al., 1997). The interaction of CO with such channels is thought to 
involve sulfur from cysteine and nitrogen from histidine residues within the cytoplasmic 
domain of the channel. CO is thought to act as a partial agonist for the divalent cation 
sensor in the Slo1 BK channel (Hou et al., 2008).  
 
As yet, the mechanism of AOX inhibition by CO-RMs cannot be envisaged as there is 
no structural information available for the active site of bacterial AOX. CO is able to 
bind to iron in iron, iron-iron and iron-nickel hydrogenases (Armstrong, 2004) and to 
the iron-iron hydrogenases of Chlamydomonas (Stripp et al., 2009), which could 
provide a precedent for the binding or CO to the di-iron active site of AOX.  
Furthermore, a cyanide-resistant but CO-sensitive hydrogenase has been reported 
(Lamrabet et al., 2011). As some hydrogenases have di-iron centres that coordinate to 
both CO and cyanide in order to activate hydrogen, this may be a starting point for 
understanding the CO-RM sensitivity of the di-iron centre of AOX. 
 
CO-RM has been reported to have activities distinct from those of CO gas; for example, 
CORM-2, but not CO gas, has been shown to obstruct ATP-gated human P2X4 
receptors involved in the sensing of pain in mammalian systems (Wilkinson and Kemp, 
2011). CORM-2 is thought to behave as an antagonist, reversibly inhibiting these 
receptors in a competitive manner independent of its CO releasing properties. 
Furthermore, CORM-3, but not CO gas or iCORM-3, has recently been shown to 
facilitate the transport of K+ and Na+ ions across the bacterial membrane, causing a 
stimulation of respiration (Wilson et al., 2013). These findings could be analogous to 
the results obtained in the current study, in which it is possible that the whole CO-RM 
molecule is binding to and interfering with the activity of AOX, compatible with the 
finding that both CO gas and the control compound iCORM-3 do not inhibit the activity 
of AOX. It should be noted that the structure and redox properties of iCORM-3 are not 
well characterised, which poses difficulties in drawing firm conclusions from the results 
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gained when using this control compound (see section 7.2). CORM-3 has recently been 
reported to bind to proteins (Santos-Silva et al., 2011; Santos et al., 2012). It would 
therefore be interesting to investigate this hypothesis further by purifying AOX 
(although this would not be trivial) and then investigating whether CORM-3 is able to 
bind to this protein. 
 
CO-RMs are known to be more potent than CO gas at inhibiting growth (Davidge et al., 
2009b), viability (Nobre et al., 2007), and respiration (Wilson et al., 2013). However, in 
such cases, it is assumed that CO-RMs deliver CO into the cell, dramatically increasing 
the concentration of this gas at the target sites (Davidge et al., 2009b). In the case of 
AOX, CORM-3 is inhibitory, while CO is not, and there is no conceivable mechanism 
for how CO could inhibit this enzyme, even at high concentrations.  
 
Although regulation of AOX activity is not well understood, it is known that in plants, 
certain carboxylic acids such as pyruvate and glyoxylate stabilize the active 
confirmation of AOX and are essential for the activity of this oxidase (Carre et al., 
2011). Pyruvate is a fundamental component of metabolism. It is produced by 
glycolysis and is also converted into acetyl-coenzyme A, which is essential for the 
Krebs cycle. It could therefore be investigated whether CORM-3 interferes with the 
binding of pyruvate to AOX, thereby adversely affecting the activity of this oxidase. 
 
The lack of detailed structural or sequence information for bacterial AOX, as well as the 
unavailability of the purified protein, have limited efforts to explain the unexpected 
finding that AOX is hypersensitive to respiratory inhibition by CORM-3. Ideally, 
Infrared or Resonance Raman spectroscopy would be performed to investigate whether 
CO interacts with AOX directly, or with another component of these membranes. There 
has been some success elucidating the nature of the active site of plant and 
trypanosomal AOX using EPR spectroscopy (Moore et al., 2008), and so this technique 
could be used to investigate the binding of CO to this oxidase. 
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Chapter 5 
 
The effects of thiol-containing compounds and antioxidants 
on the activities of CO-RMs 
 
5.1 Introduction  
Almost a decade ago, it was noted that N-acetylcysteine (NAC) abolished the activities 
of CORM-2 and CORM-3 (Sawle et al., 2005 and Taille et al., 2005). Since then, 
several papers have been published describing this phenomenon, but none have 
comprehensively explained the mechanism by which these compounds exert their 
effects. It was initially shown that while CORM-2 and CORM-3 increased HO-1 
expression and haem oxygenase activity in murine macrophages, these effects were 
abolished by NAC (Sawle et al., 2005). NAC was also found to partially prevent the 
inhibitory effects of CORM-2 on the mitochondrial respiratory chain and NAD(P)H 
oxidase (Taille et al., 2005). It was then reported that NAC (1 mM), reduced glutathione 
(GSH) (50 μM) and cysteine (100 μM) all completely prevent the effects of CORM-3 
on the growth and oxygen consumption of P. aeruginosa. The authors concluded that 
this was not due to NAC preventing the liberation of CO from CORM-3, or causing the 
activation of the cysteine - glutathione pathway leading to increased levels of free 
glutathione. Instead, they hypothesised that NAC may interfere with the interaction of 
CO liberated from CORM-3 and the cytochromes of the bacterial respiratory chain, or 
that inhibition of oxygen consumption by CORM-3 may involve cysteine moieties 
strategically located in the enzymes of the respiratory chain (Desmard et al., 2009). It 
was later reported that only the activity of metal-containing CO-RMs (especially those 
containing ruthenium) are affected by thiol compounds; therefore it is unlikely that 
NAC interferes with the binding of CO to terminal oxidases, as this is assumed to be a 
target of all CO-RMs (Desmard et al., 2012). It was hypothesised that thiol compounds 
may favour a very rapid rate of CO release from transition metal carbonyls (Desmard et 
al., 2012), causing them to mimic the application of CO gas (ie. CO release prior to the 
CO-RM entering the cell), and that this could abrogate the intracellular delivery 
capacity of CO-RMs. In support of this, there is some evidence that thiol-containing 
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compounds such as cysteine, can promote CO release from CO-RMs (Hasegawa et al., 
2010). 
 
An alternative hypothesis suggests that thiol-containing compounds quench the activity 
of CO-RMs by virtue of their antioxidant properties (Tavares et al., 2011). It was found 
that GSH was able to prevent the antibacterial effects of CORM-2 by approximately 
95% and that cysteine prevented the growth inhibitory effects of the CO-RM ALF062 
by approximately 85%. Evidence is presented that high concentrations of CORM-2 
cause an increase in reactive oxygen species (ROS) as measured by the fluorescent 
probe 2’,7’-dichlorofluorescien diacetate, and that application of exogenous glutathione 
reduces the amount of ROS detected, leading the authors to conclude that the 
antioxidant properties of GSH are responsible for this activity. It was also shown that 
CO is necessary for ROS production, as cultures treated with RuCl2(DMSO)4 or with 
CORM-2 in media supplemented with haemoglobin, which scavenges CO, did not 
experience an increase in ROS (Tavares et al., 2011).  
 
It is important to note that another group had previously investigated the possibility that 
CORM-3 mediates its bactericidal effects by the production of ROS and concluded this 
was unlikely as not all antioxidants (for example ascorbic acid) were able to abolish the 
effects of CO-RMs and hydrogen peroxide production was not detected when P. 
aeruginosa was treated with 10 µM CORM-3, despite this concentration of CORM-3 
significantly decreasing the viability of this organism (Desmard et al., 2009).  
 
In light of the uncertainty in the published literature as to how thiol compounds 
abrogate the effects of CO-RMs, and whether the production of ROS contributes to the 
deleterious effects of CO-RMs, the work presented in this chapter aimed to address the 
following questions. (1) Do thiol compounds affect the rate or amount of CO released 
from CORM-3? (2) If not, by what mechanism do thiol compounds abrogate the effects 
of CO-RMs? (3) Do endogenous thiol compounds protect bacterial cells from the 
deleterious effects of CO-RMs? (4) To what extent does the production of ROS by CO-
RMs contribute to the bactericidal effects of these compounds? 
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5.2 Results 
5.2.1 Thiol-containing compounds completely prevent the inhibitory effects of 
CORM-2 and CORM-3 on respiration 
It was important to begin by establishing that under the standard experimental 
conditions used in this laboratory, thiol-containing compounds could prevent the 
inhibitory effects of CORM-3 on bacterial respiration as has been reported by others 
(Desmard et al., 2009). Initially, a closed oxygen electrode system was used to measure 
the rate of respiration of wild type E. coli membrane particles in the presence of 
CORM-3 and the thiol-containing compounds NAC, cysteine and reduced glutathione. 
Membrane particles were added to 2 ml sonication buffer to a final concentration of 
between 60 and 100 μg ml-1 and respiration was initiated by the addition of 6.25 mM 
NADH. The thiol compound was added when the dissolved oxygen tension in the 
chamber reached approximately 155 µM (75% of air saturation) and the CO-RM was 
added 1 min later.  
 
The respiration rate of membrane particles 2 min after the addition of CO-saturated 
solution to a final concentration of 100 μM was 177 nmol min-1 mg-1 compared to 287 
nmol min-1 mg-1 in the control in which no compound was added. NAC was unable to 
abrogate the inhibition caused by CO gas: respiration in the presence of both NAC and 
CO was inhibited to the same extent as when CO-saturated solution was added alone 
(Figure 5.1A). 
 
This experiment was then repeated with CORM-3. The respiration rate of membrane 
particles 2 min after the addition of 400 μM CORM-3 was 167 nmol min-1 mg-1 
compared to 442 nmol min-1 mg-1 in the absence of inhibitor. However, in the presence 
of CORM-3 and an equimolar concentration of NAC, the respiration rate was restored 
to 418 nmol min-1 mg-1 (Figure 5.1B). NAC also reduced respiratory inhibition of E. 
coli membrane particles by CORM-2; however a 10-fold excess of NAC was required 
in order to reduce the inhibitory effect of CORM-2 by approximately 45% (Figure 
5.1C). The respiration rate of membrane particles 2 min after the addition of 50 μM 
CORM-2 was 139 nmol min-1 mg-1 compared to 452 nmol min-1 mg-1 in the absence of 
inhibitor, and 276 nmol min-1 mg-1 in the presence of CORM-2 and NAC. Figure 5.1D 
shows the oxygen consumption profile of E. coli membranes in which NAC was added 
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Figure 5.1 NAC prevents CORM-2 and CORM-3 - dependent inhibition of 
respiration in E. coli membrane particles. Wild type E. coli membrane particles were 
added to sonication buffer (2 ml) to a final concentration of approximately 60 μg ml-1 
(A) or 100 μg ml-1 (B, C, D) and respiration was initiated by the addition of NADH 
(6.25 mM). In (A) arrows indicate the addition of 100 μM NAC, or 100 μM CO as a 
saturated solution; in (B), arrows indicate the addition of NAC or CORM-3 (both at 400 
μM); in (C) arrows indicate the addition of NAC (500 μM) or CORM-2 (50 μM) and in 
(D), the arrow shows the addition of 400 mΜ NAC. The traces show dissolved oxygen 
in the chamber for uninhibited respiration (black solid lines) or oxygen consumption in 
the presence of CO or CO-RM (blue dashed lines) or CO-RM and NAC (red dotted 
lines). Respiration rates (nmol min-1 mg-1 protein) 2 min following the addition of CO 
or CO-RM are shown adjacent to each trace. These data are representative of at least 3 
technical and 2 biological replicates. This figure was published in Jesse et al. (2013).
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alone when the oxygen in the chamber reached approximately 80%. The respiration rate 
here (445 nmol min-1 mg-1) was very similar to that when no compound was added, 
confirming that NAC alone has no effect on the rate of respiration. This investigation 
was extended to confirm that the thiol-containing compounds glutathione and cysteine 
were also able to abrogate the inhibitory effects of CORM-3. The respiration rate of 
wild type E. coli membrane particles 2 min after the addition of 400 μM CORM-3 was 
91.8 nmol min-1 mg-1 compared to 197 nmol min-1 mg-1 in the absence of inhibitor and 
123 nmol min-1 mg-1 in the presence of CORM-3 and 200 μM reduced glutathione 
(Figure 5.2A). Similarly, in the case of GSH, the respiration rate of the membrane 
particles 2 min after the addition of 400 μM CORM-3 was 72.6 nmol min-1 mg-1 
compared to 117 nmol min-1 mg-1 in the absence of inhibitor and 115 nmol min-1 mg-1 in 
the presence of CORM-3 and 400 μM cysteine (Figure 5.2B). It is important to note that 
the addition of these thiol compounds alone did not affect significantly the rate of 
respiration (Figure 5.2 C and D). 
 
The open electrode system in which the time taken for the oxygen electrode chamber to 
begin to reoxygenate is measured (as described in section 3.2.3 and 4.2.2) was also used 
to confirm that NAC protects respiration from inhibition by CORM-3. In this 
experiment, the balance between the oxygen entering the stirred system and the oxygen 
consumed by respiration is manipulated (by adjusting the speed of stirring) so that the 
oxygen detected by the electrode remains at 0 for an extended period of time. The 
presence of a respiratory inhibitor will reduce the rate at which oxygen is consumed, 
therefore allowing oxygen to be detected by the electrode leading to an upward 
deflection of the electrode trace (Figure 5.3).  
 
The addition of 400 μM CORM-3 caused the chamber to reoxygenate immediately, 
indicating that respiration was inhibited (Figure 5.3, blue dashed line). However, when 
400 μM NAC was added prior to CORM-3, respiration was protected so that the time 
taken for the chamber to reoxygenate was restored to 87% of the control time in which 
no inhibitor was added (Figure 5.3, red dotted line). NAC was added to the chamber in 
the absence of CORM-3 and found to cause reoxygenation in 74% of the time taken 
under control conditions. However, previous measurements in the closed oxygen 
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Figure 5.2 Reduced glutathione and cysteine prevent CORM-3 dependent 
inhibition of respiration in E. coli membrane particles. E. coli membrane particles 
were added to sonication buffer to a final concentration of ~ 60 μg ml-1 inside an 
oxygen electrode chamber. A lid was placed on the chamber and respiration was 
initiated by the addition of 6.25 mM NADH. The first arrow in each panel indicates the 
addition of either 200 μM reduced glutathione (A) and (C), or 400 μM cysteine (B) and 
(D), while the second arrow in (A) and (B) indicates the addition of 400 μM CORM-3. 
In (A) and (B) the black solid lines indicate respiration in the absence of these 
compounds, the blue dashed lines show oxygen consumption in the presence of CORM-
3 and the red dotted lines show oxygen consumption in the presence of CORM-3 and 
the thiol-containing compound. In (C) and (D) the black lines show oxygen 
consumption in the presence of 200 μM reduced glutathione and 400 μM cysteine 
respectively. Respiration rates (nmol min-1 mg-1 protein) 2 min following the addition of 
CO or CO-RM are shown adjacent to each trace. These data are representative of 3 
technical and 2 biological replicates for each condition. This figure was published in 
McLean et al. (2013). 
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Figure 5.3 NAC prevents CORM-3-dependent inhibition of respiration in E. coli 
membrane particles. Wild type E. coli membrane particles were added to sonication 
buffer (2 ml) to a final concentration of approximately 1.5 mg ml-1 and respiration was 
initiated by the addition of NADH (6.25 mM). Arrows indicate the addition of NAC or 
CORM-3 (both at 400 µΜ). The trace shows dissolved oxygen in the chamber for 
uninhibited respiration (black solid lines) or oxygen consumption in the presence of 
CORM-3 (blue dashed lines), CORM-3 and NAC (red dotted lines) or NAC alone (red 
dot-dash line). The lid was removed from the chamber 1 min after the addition of 
CORM-3 and the time taken for the chamber to reoxygenate (given in min in 
parentheses) was measured for the various conditions: with no additions (35); with 
CORM-3 (0); with NAC and CORM-3 (33); with NAC alone (28). These data are 
representative of at least 3 technical and 2 biological replicates. This figure was 
published in Jesse et al. (2013). 
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electrode had shown that the respiration rate of E. coli membrane particles was not 
affected when NAC was added on its own to the chamber (Figure 5.1D). These results 
confirm that NAC, in a 1:1 ratio with CORM-3, is able to protect the respiration of E. 
coli from inhibition by this CO-RM. 
 
5.2.2 Investigating the hypothesis that thiol-containing compounds affect the rate 
or amount of CO released from CORM-3. 
In order to elucidate the mechanism by which thiol-containing compounds prevent the 
effects of CO-RMs, several hypothesis were considered. Initially it was investigated 
whether NAC affects the rate at which CO is released from CORM-3. The rate of CO 
release from CORM-3 was measured spectroscopically by assaying the rate of 
formation of carbonmonoxy-myoglobin (CO-Mb) in the presence and absence of NAC. 
A dual-beam spectrophotometer was used to record the spectra of a 10 µM solution of 
myoglobin in phosphate buffer (pH 7.4) reduced with sodium dithionite. This was then 
subtracted from the spectra of this sample treated with either 8 µM CORM-3, or 8 µM 
CORM-3 pre-treated with a 10-fold molar excess of NAC.  
 
The rate of CO release was slower and 21% less CO was released from CORM-3 in the 
presence of a 10:1 molar excess of NAC (Figure 5.4, open circles). The half-life of CO 
release from CORM-3 to dithionite-reduced myoglobin was calculated to be 2.5 min, 
whereas the half-life of CO release in the presence of NAC in a 10:1 molar excess was 
2.8 min. It was then investigated whether higher ratios of NAC:CORM-3 led to 
diminished CO loss from CORM-3 to myoglobin. There was no concentration-
dependent difference in the amount or rate of CO loss from CORM-3 when a 20-fold 
excess of NAC (Figure 5.4, closed triangles) was used instead of a 10-fold excess. 
However the use of both a 50-fold excess (Figure 5.4, open triangles) and a 100-fold 
excess (Figure 5.4, closed squares) of NAC did slightly reduce the rate and amount of 
CO release compared to the lower concentrations; however there was no difference 
between these higher concentrations. 
 
The finding that the total amount of CO released to myoglobin was reduced in the 
presence of NAC, could imply that NAC acts by either preventing some CO loss from 
CORM-3, or by promoting the loss of CO, which could then be lost from solution prior 
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Figure 5.4 Increasing the ratio of NAC to CORM-3 to some extent reduces the 
amount of CO lost to myoglobin up to a 50-fold NAC excess. The change in 
absorbance in the Soret region induced by the binding of CO from 8 μM CORM-3 to 10 
μM of dithionite-reduced myoglobin was measured spectroscopically and plotted 
against time. This was done for CORM-3 alone (closed circles) and for CORM-3 
preincubated for 5 min with NAC in either a 10:1 (open circles), 20:1 (closed triangles), 
50:1 (open triangles) or 100:1 (closed squares) ratio. These data are representative of 2 
technical replicates. 
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to the application of CORM-3 to myoglobin. Recent work from this laboratory has 
greatly advanced our understanding of the mechanisms by which CO is released from 
CORM-3 (McLean et al., 2012). It is now known that sulfite species including 
dithionite (a necessary component of the myoglobin assay, which has been widely used 
to determine the rate of CO loss from CO-RMs (Atkin et al., 2011; Davidge et al., 
2009b; Desmard et al., 2012) cause CO loss from CO-RMs. The myoglobin assay is 
therefore not an ideal method by which to measure of the rate of CO release from these 
compounds. Haemoglobin has been proposed as an alternative to reduced myoglobin for 
this purpose (McLean et al., 2012), as CO binds to oxyhaemoglobin much more avidly 
than oxygen (Sirs, 1974). In this assay, sodium dithionite is used to reduce the haem 
groups of haemoglobin, but is then removed by chromatography, producing 
oxyhaemoglobin, which, unlike oxymyoglobin, is stable in air. The spectroscopic 
changes that occur when oxyhaemoglobin is converted to carbonmonoxy-haemoglobin 
in the presence of CO-RMs can therefore be used as a measure of the rate of CO loss 
from these molecules in the absence of sodium dithionite (McLean et al., 2012). In 
particular, the peak at 422 nm in the CO difference spectrum is indicative of CO 
binding to the haem in oxyhaemoglobin (see Figure 5.5B). 
 
Haemoglobin was reduced with dithionite, then desalted on a PD-10 column, producing 
oxyferrous haemoglobin with no residual dithionite. This was diluted in phosphate 
buffer (100 mM, pH 7.4) to 10 μM and the spectrum of this sample recorded in an OLIS 
spectrophotometer as described above (section 2.3.1.2). CO was added to the 
oxyhaemoglobin by bubbling the contents of the cuvette with CO from a cylinder for 2 
min, and the spectrum of this sample was recorded. The absolute spectra of the 
oxyhaemoglobin and carbonmonoxyhaemoglobin are shown in Figure 5.5 A, while the 
difference spectrum of these samples (CO - treated oxyhaemoglobin minus 
oxyhaemoglobin) is shown in Figure 5.5B. The shift in the peak of the Soret region of 
the absolute spectra, from 414 nm to 419 nm (Figure 5.5A) and the corresponding peak 
at 422 nm in the difference spectrum confirms that CO has bound to haemoglobin; 
however, when oxyhaemoglobin is treated with CORM-3 (8 μM), this shift was not 
seen (Figure 5.5C) and therefore, no peak was seen at 422 nm in the CORM-3 
difference spectrum (Figure 5.5D). This confirms that when CORM-3 is exposed to a 
biological ligand in buffer, no CO loss occurs (McLean et al., 2012). This experiment 
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Figure 5.5 The haemoglobin assay: NAC does not promote CO loss from CORM-3. 
Haemoglobin was reduced with sodium dithionite, then desalted on a PD-10 column, 
producing oxyferrous-haemoglobin with no residual dithionite. (A, C and E) show the 
absolute spectra (B, D and F) show the CO difference spectra (ie. the oxyhaemoglobin 
spectra minus the spectra of oxyhaemoglobin treated with CO (B), CORM-3 (D) or NAC 
and CORM-3 (F). The various coloured lines represent the spectra taken at time points from 
0 to 40 min). In (A, C and E), the absolute spectrum of oxyhaemoglobin (10 μM) is shown 
in burgundy, while the orange lines show the absolute spectrum in the presence of (A) CO 
(applied by bubbling the contents of the cuvette with CO from a cylinder for 2 min), (C) 
CORM-3 (8 μM) and (E) CORM-3 (8 μM) preincubated with NAC (80 μM) for 5 min 
before the assay was begun.  
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was then repeated with CORM-3 pre-incubated for 5 min with a 10-fold excess of NAC 
(80 μM) in order to investigate whether NAC was able to promote CO loss from 
CORM-3. As can be seen from the absolute spectra (Figure 5.5E) and the difference 
spectra (Figure 5.5F), CO does not bind to oxyhaemoglobin in the presence of NAC and 
CORM-3. This confirms that NAC does not cause CO loss from CORM-3. The troughs 
seen in the difference spectra (Figure 5.5D and F) indicate a small loss of the reduced 
form of oxyhaemoglobin, which may suggest that CORM-3 can act as an oxidising 
agent, as discussed in section 7.1.2. 
 
5.2.3 NAC does not prevent the interaction between CO from CORM-3 and the 
terminal oxidases of the aerobic respiratory chain of E. coli 
In order to assess whether NAC prevented the interaction of CO from CORM-3 with the 
terminal oxidases of the aerobic respiratory chain, difference spectra were recorded of 
wild type E. coli membrane particles treated with CORM-3 alone (Figure 5.6A) or with 
CORM-3 pre-incubated for 5 min with a 10-fold excess of NAC (Figure 5.6B). Both 
spectra show a peak at approximately 420 nm and a trough at approximately 446 nm in 
addition to a peak at approximately 644 nm. The later indicates the presence of CO-
bound cytochrome d of E. coli (Wood, 1984), while the features in the Soret region can 
be attributed to CO binding to a mixture of haems, including haems d and b595. 
Importantly, there was no reduction in the magnitude of these features in the presence of 
NAC, confirming that this compound does not interfere with the binding of CO released 
from CORM-3 with the terminal oxidases of E. coli.  
 
5.2.4. A glutathione-deficient E. coli mutant is more resistant to killing than a wild 
type strain 
As thiol-containing compounds have been shown to protect bacteria from the 
deleterious effects of some CO-RMs (Desmard et al., 2009; Desmard et al., 2012; 
Tavares et al., 2011), it was hypothesised that endogenous glutathione may constitute a 
cellular defence against CORM-3. It was therefore investigated whether a mutant strain 
of E. coli that was unable to produce glutathione was hypersensitive to killing by 
CORM-3. 
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Figure 5.6 Reaction of the terminal oxidases in wild type E. coli membrane 
particles with CORM-3. Wild type E. coli membrane particles were added to 
sonication buffer to a final concentration of approximately 10 mg ml-1 and incubated 
with (A) CORM-3 (100 μM) and (B) CORM-3 (100 μM) pre-incubated for 5 min with 
NAC (1 mM). Spectra were obtained 5 min after the addition of CORM-3 to 
membranes using a scanning dual-beam spectrophotometer. Data were plotted as the 
difference between the spectrum of a dithionite-reduced sample incubated with CORM-
3 minus the spectrum of a reduced sample. Data have been smoothed in Sigma plot 
graphing software with a sampling proportion of 0.1 and a polynomial degree of 9. This 
figure was published in Jesse et al. (2013). 
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A mutation in the glutathione gene gshA was moved into a wild type MG1655 
background by P1 vir phage transduction. The successful transduction was verified by 
an absence of a PCR product generated using primers specific to the gshA gene 
(described in Table 2.2) in the mutant, but the presence of an appropriately sized 
product in the MG1655 wild type. A 64.4% (± 4.41) reduction in intracellular thiol 
content in the gshA mutant was confirmed by the DTNB assay (section 2.2.3.3). The 
viability of this mutant was then studied in the presence and absence of CORM-3 and 
compared to that of wild type. Treatment with 30 µM CORM-3 reduced the viability of 
wild type E. coli cultures to 56% of the initial viable cell count at 45 min, and 2.8% at 
90 min, whereas the viability of the gshA mutant had only decreased to 68% of the 
initial viable cell count at 45 min, and 75% at 90 min (all percentages given are the 
means and standard deviations of 5 technical and 3 biological replicates). Figure 5.7A 
shows data from one representative biological replicate in which the gshA mutant is 
statistically significantly more resistant to killing than the wild type strain at 30, 45, 90 
and 120 min (p < 0.02). In each biological replicate, the gshA mutant had statistically 
greater viability than wild type 120 min following CORM-3 treatment (as determined 
by a Student’s t test). In order to confirm that the effects seen in this experiment were 
due to CO released from CORM-3, the experiment was repeated using the control 
compound iCORM-3, which does not release CO. This compound did not reduce the 
viability of either strain within 120 min (Figure 5.7B). 
 
5.2.5 CORM-2 and CORM-3 react with thiol groups  
A recently published paper suggests that CORM-2 and the molybdenum-based CO-RM 
ALF062 generate ROS, specifically hydroxyl radicals, which are able to oxidise thiol 
groups (Tavares et al., 2011). The authors propose that CO-RMs are bactericidal 
because of this ROS, and that thiol compounds are protective against the effects of CO-
RMs because they quench these damaging species. The DTNB assay was used to show 
that in the presence of CORM-2, but not RuCl2(DMSO)4, the amount of thiol groups 
detected in a solution of glutathione was diminished. DTNB (5,5'-dithiobis-2-
nitrobenzoic acid) reacts quantitatively with thiol groups releasing 5-sulfido-2-
nitrobenzoic acid which absorbs light at 412 nm (Ellman, 1959).   
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Figure 5.7 A glutathione deficient E. coli mutant is more resistant to killing than a 
wild type strain. The viability of wild type (closed circles) and a gshA mutant (open 
circles) in the presence of (A) CORM-3 and (B) iCORM-3, both at 30 µM. Data are the 
means and standard deviations of 5 technical replicates and are representative of 3 
biological replicates. Asterisks denote the degree of statistical significance for the data 
as determined by a Student’s t test (*, p<0.02), (**, p<0.001). 
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In order to determine whether NAC is able to react with other CO-RMs, various 
concentrations (10 – 200 μM) of NAC were incubated for 5 min with CORM-3, 
CORM-2 and CORM-A1 or the control compounds iCORM-3, RuCl2(DMSO)4 or CO-
saturated solution, all at 100 μM. DTNB (0.8 mM) was then added and incubated for 15 
min before the OD412 was measured using a Jenway spectrophotometer. This assay 
revealed that CORM-3 reacts with 16% of the thiol groups of NAC (Figure 5.8A) when 
present in equimolar amounts, while CORM-2 reacts with approximately 80% of the 
thiol groups in NAC when present at equimolar amounts. In contrast, the control 
compounds iCORM-3, RuCl2(DMSO)4 and CO gas did not react to a significant degree 
with thiol groups. The non-metal CO-RM, CORM-A1 reacted with only 4% of the thiol 
groups in NAC when present in a 2-fold excess. 
 
It was then investigated whether CORM-3 could react with a range of thiol compounds, 
specifically cysteine, reduced glutathione and sodium hydrosulfide. Cysteine and 
glutathione were investigated as they are abundant within the cellular milieu, and 
sodium hydrosulfide in order to determine whether CORM-3 had different effects on an 
inorganic sulfide compound compared with organic thiol compounds. The DTNB assay 
was employed again, but here the concentration of thiol compound was kept constant 
(100 µM), while the concentration of CORM-3, iCORM-3 or CO-saturated solution was 
varied (0 – 100 µM). The presence of CORM-3 reduced the number of thiol groups in 
solution for each thiol compound (Figure. 5.9). The control compound iCORM-3 
caused a less pronounced, yet still significant, decrease in the amount of free thiol 
groups, whereas exposure of the thiol compounds to CO-saturated solution had no 
significant effect on the free thiol groups (Figure 5.9). 
 
5.2.6 Superoxide is generated by CORM-2 and CORM-3 in solution 
As there are conflicting data in the literature as to whether CO-RMs generate ROS and 
therefore whether the protective effect of thiol compounds against CO-RMs is due to 
their antioxidant properties, superoxide production by CORM-2, CORM-3, the non-
metal CO-RM, CORM-A1 and the control compounds RuCl2(DMSO)4 and iCORM-3 
was assayed in vitro. Cytochrome c (20 μΜ) was added to a solution of each CO-RM (1 
mM) in potassium phosphate buffer (pH 7.8). Spectrophotometric changes at 550 nm, 
which are indicative of the reduction of cytochrome c (Winterbourn, 1982),  
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Figure 5.8 CORM-2 and CORM-3, but not CORM-A1 or control compounds react 
with NAC. Various concentrations (10 – 200 μM) of NAC were incubated for 5 min 
with each of the following, all at 100 μM: (A) CORM-3, (B) CORM-2, (C) iCORM-3, 
(D) RuCl2(DMSO)4, (E) CO-saturated solution or (F) CORM-A1. DTNB (0.8 mM) was 
then added and incubated for 15 min. The OD412 was measured using a Jenway 
spectrophotometer. (G) Shows the structure of DTNB (5,5'-dithiobis-(2-nitrobenzoic 
acid)). The red line shows the site of cleavage when DTNB reacts a thiol group.
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Figure 5.9 CORM-3 reacts with glutathione, cysteine and sulfide. Various 
concentrations (0 – 100 µM) of CORM-3 (closed circles), iCORM-3 (open circles) or 
CO-saturated solution (closed triangles) were incubated with 100 μM (A) cysteine, (B) 
reduced glutathione or (C) sodium hydrosulfide in phosphate buffer for 15 min at room 
temperature. 500 μM DTNB was added and the solution incubated for a further 15 min 
before the absorbance was measured at 412 nm. These data are the means and standard 
deviations of three separate experiments. This figure was published in McLean et al. 
(2013).  
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were then monitored over a time course. The abolition of the signal by superoxide 
dismutase (SOD) confirmed that the reduction of cytochrome c is caused by superoxide. 
CORM-3 (Figure 5.10A), CORM-2 (Figure 5.10B) and CORM-A1 (Figure 5.10C), all 
at 1 mM, were found to produce low levels of superoxide (equivalent to ~ 1% of the 
CO-RM concentration). CORM-2 produced superoxide at an initial rate approximately 
10-fold faster than CORM-3 (1.9 μM O2- min-1 and 0.17 μM O2- min-1 respectively); 
however the overall amounts of superoxide produced from CORM-2 and CORM-3 were 
similar. CORM-A1 generated a similar amount of superoxide as CORM-3 and did so at 
a similar rate. Interestingly, iCORM-3 was found to produce slightly more superoxide 
than CORM-3 over 2 h (Figure 5.10D), and at a slightly faster initial rate (0.624 μM O2- 
min-1), whereas the control compound for CORM-2, RuCl2(DMSO)4, produced only a 
very small amount of superoxide (0.0971 μM O2- in one hour; Figure 5.10E).  
 
It was then investigated whether NAC altered the kinetics of superoxide production 
from CORM-3 (Figure 5.10F). Contrary to the expectation that this antioxidant would 
reduce the amount of superoxide detected, the rate of superoxide production from 
CORM-3 in the presence of NAC was greatly increased (1.17 μM O2 min-1). 
 
5.2.7 Antioxidants do not consistently prevent the inhibitory effects of CORM-3 on 
respiration 
As mentioned previously, recent work has presented evidence that CORM-2 generates 
ROS, specifically hydroxyl radicals (OH·), leading the authors to conclude that this 
accounts for the antibacterial properties of this CO-RM (Tavares et al., 2011). However, 
it is important to note that very high concentrations of CORM-2 are used in these assays 
(up to 2 mM). This group had also previously reported the up-regulation of oxidative 
stress response genes such as soxS and oxyR when E. coli was subjected to 250 µM 
CORM-2. Other groups have not seen the up-regulation of oxidative stress response 
genes in transcriptomic studies using low concentrations (30 μM) CORM-3 (Davidge et 
al., 2009b). It is therefore unlikely that the generation of ROS by CO-RMs is able to 
account for all of the deleterious effects that occur when bacteria are stressed with low 
concentrations of CORM-3. 
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Figure 5.10 Both CORM-2 and CORM-3 generate superoxide. Cytochrome c (20 
μΜ) was added to the CO-RM (1 mM) in KPi, pH 7.8. The OD550 was then read over a 
time course. Graphs show superoxide generated by (A) CORM-3 (solid line) and 
CORM-3 in the presence of SOD (250 units) (broken line), (B) CORM-2 (solid line) 
and CORM-2 in the presence of SOD (250 units) (broken line), (C) CORM-3 (open 
circles) and CORM-A1 (closed circles), (D) CORM-3 (open circles) and iCORM-3 
(closed circles) (E) CORM-2 (closed circles) and RuCl2(DMSO)4 (open circles), 
CORM-3 (open circles) and (F) CORM-3 in the presence of  NAC (1mM) (closed 
circles). Part A of this figure was published in McLean et al. (2013).  
A B 
C D
E F 
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Figure 5.11 Antioxidants and superoxide dismutase (SOD) do not prevent CORM-
3-dependent inhibition of respiration to the same extent as thiol compounds. Wild 
type E. coli membrane particles were added to the oxygen electrode in sonication buffer 
(2 ml) to a final concentration of approximately 60 μg ml-1. A lid was placed on the 
chamber and respiration was initiated by the addition of 6.25 mM NADH. The first 
arrows in each panel indicate the addition of the antioxidant or enzyme: (A) ubiquinol 
(100 μM); (B) ascorbate (1 mM); (C) ferredoxin (200 μg ml-1) and (D) SOD (250 units) 
to the chamber, while the second arrows indicate the addition of CORM-3 (400 μΜ). 
The black solid lines show the uninhibited respiration rate, the blue dashed lines show 
oxygen consumption in the presence of CORM-3 and the red dotted lines show oxygen 
consumption in the presence of CORM-3 and the antioxidant (A, B and C) or SOD (D). 
In (A and C), the red dot dash line shows oxygen consumption in the presence of (A) 
ubiquinol or (B) ferredoxin alone. Respiration rates (nmol min-1 mg-1 protein) 2 min 
following the addition of CO-RM are shown adjacent to each trace. Traces are 
representative of 2 biological replicates, each with 3 technical replicates. This figure 
was published in Jesse et al. (2013).  
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In order to examine this further, it was investigated whether non-thiol-containing 
antioxidants were capable of abolishing the inhibitory effects of CORM-3 on respiration 
(Figure 5.11). While the antioxidant ubiquinol (100 μM) was capable of partially 
decreasing the degree of respiratory inhibition caused by CORM-3 (Figure 5.11A), 
ascorbic acid (1 mM) had no effect on respiratory inhibition by CORM-3 (Figure 
5.11B). Interestingly, in the presence of CORM-3 and the antioxidant ferredoxin, 
respiration was inhibited more than it was in the presence of CORM-3 alone (despite 
ferredoxin having no significant effect on the respiration rate of these membranes when 
added alone (Figure 5.11C, red dot dash line). These results suggest that it is not the 
antioxidant nature of compounds such as NAC, reduced glutathione and cysteine that 
enable them to prevent metal-based CO-RMs from exerting their effects but, more 
likely, the chemical interaction of the thiol groups with the CO-RM. Additionally, when 
superoxide dismutase (SOD) was added to the electrode with CORM-3 (Figure 5.13D), 
there was no significant change in the degree of inhibition suggesting that superoxide 
plays no role in the inhibition of respiration by CORM-3. 
 
5.2.8 The use of EPR spectroscopy and the spin trap BMPO to assess whether 
reactive oxygen species are generated from solutions of CORM-2 and 
CORM-3 
Electron Paramagnetic Resonance (EPR) spectroscopy is a sensitive method able to 
detect species with unpaired electrons and therefore has the potential to identify ROS. 
However, ROS are transient, which causes difficulties when recording EPR spectra; 
consequently, nitrone spin traps are often used to stabilize these species (Frejaville et 
al., 1995). 
 
The spin trap BMPO (5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-oxide) has the 
advantage over other spin traps that it is able to distinguish between hydroxyl radicals 
and superoxide anions (Zhao et al., 2001). In comparison, the spin trap DMPO forms a 
superoxide adduct, which then decomposes to form the hydroxyl adduct (Finkelstein et 
al., 1982).  
 
Tavares et al., (2011) recently reported the use of a BMPO spin trap with EPR 
spectroscopy to detect ROS generated from CORM-2, RuCl2(DMSO)4 and CORM-2 
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incubated with reduced haemoglobin. They claim that the species detected is hydroxyl 
radicals (OH.), yet they show a hyperfine splitting constant around both nitrogen and 
hydrogen of 1.1 mT or 11 gauss (G) (Figure 5.12). This does not match the EPR 
spectrum of the hydroxyl-BMPO adduct seen in Zhao et al. (2001), which has aN 
values of 13.37 G and 13.4 G and aH values of 9.42 G and 12.1 G. Therefore, 
independent EPR spin trapping measurements were undertaken to investigate whether 
hydroxyl radicals could be detected in solutions of CORM-2. This work was then 
extended to investigate whether CORM-3 was able to produce such species. 
 
Initially, superoxide and hydroxyl adducts of BMPO were generated to provide 
reference spectra for comparison with the CO-RM spectra. Samples were loaded into an 
AquaX cell and EPR spectra were recorded, at room temperature, on a Bruker EMX 
spectrometer at 9.47 GHz microwave frequency, 3.18 mW microwave power, 100 kHz 
modulation frequency and 9.54 G/s scan rate. Spectra were analysed using WINEPR, 
Version 2.11 (Bruker).  
 
Xanthine and xanthine oxidase were reacted in order to generate superoxide. Figure 
5.13A shows the EPR spectrum of a mixture of 1 mM xanthine, 5 milliunits xanthine 
oxidase, the chelator DTPA (0.1 mM) and 25 mM BMPO, 2 min after mixing, while 
Figure 5.13B shows the spectrum of this mixture 80 min after mixing. This spectrum 
has a nitrogen hyperfine coupling constant (aN) of 11 G and a hydrogen hyperfine 
coupling constant (aH) of 13.4 G. This spectrum is similar to that for superoxide 
reported by Zhao et al., (2001). Two values are given as there are two diastereomers of 
each spin adduct (Zhao et al., 2001), each with their own hyperfine coupling constants 
for both nitrogen and hydrogen. There are however some slight differences between the 
spectra obtained in this work and those reported by Zhao et al., (2001): the features 
circled in green in Figure 5.13B were slightly broader than expected when compared to 
the published spectrum and the feature circled in red was not as broad as that presented 
in Zhao et al., (2001); this suggests that there are two contributions to this feature in the 
present work.  
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Figure 5.12 EPR spectra of samples containing (A) 2 mM CORM-2, (B) iCORM-2 
and (C) CORM-2 plus hemoglobin (Hb,) acquired in the presence of the spin trap, 
BMPO.  
 
This figure was originally published in The Journal of Biological Chemistry. Tavares, 
A.P.N., Teixeira, M., Romao, C.C. Seixas, J.D., Nobre, L.S. and Saraiva, L.M. Reactive 
Oxygen Species Mediate Bactericidal Killing Elicited by Carbon Monoxide-releasing 
Molecules. The Journal of Biological Chemistry. (2011) 286 (30):26708-26717. © The 
American Society for Biochemistry and Molecular Biology. 
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Attempts were then made to generate the hydroxyl-BMPO adduct using Fenton 
chemistry. This involves hydroxyl radicals being produced from H2O2 in the presence of 
either Fe2+ or Cu+ according to the reactions below: 
 
Fe2+ + H2O2              Fe3+ + ·OH + OH-                             (1) 
Cu+ + H2O2                Cu2+ + OH- + ·OH                  (2) 
 
When 1 mM FeSO4 was mixed with 1 mM H2O2 in the presence of 8 mM BMPO, an 
EPR spectrum typical of the BMPO-hydroxyl adduct was observed (Figure 5.13 C; see 
also Zhao et al., (2001)). The hyperfine splitting around nitrogen was 13.3 G, while that 
for hydrogen was 14.0 G; these values are consistent with those reported by Zhao et al., 
(2001). However, when CuSO4 was used to generate hydroxyl radicals, a different EPR 
spectrum was observed. CuSO4 (1 mM) was mixed with 1 mM ascorbic acid (included 
to reduce the copper in CuSO4 to Cu+) and 1 mM H2O2 with 8 mM BMPO (Figure 
5.13D; see also Zhao et al., (2001)) and gave a spectrum that appears to be a doublet of 
overlapping triplets, i.e. the first, second and fourth features comprise the first triplet 
and the third, fifth and sixth features comprise the second. The hyperfine splitting for 
nitrogen was 15 G, while aH was measured as 21.4 G. When both hydrogen and 
nitrogen, interact with an electronic spin, the EPR line splits into a 1:1:1 triplet (on IN = 
1, with a distance between the lines being the aN value), then each line splits into a 1:1 
doublet (on IH = 1/2, with a distance between the lines being the aH value). Now, a 
spectrum exhibiting a quartet pattern 1:2:2:1 can be observed if aN ≈ aH, or, to be more 
precise, if the difference │aN - aH│ is not notably greater than the individual line width 
(see below). 
 
The FeSO4 generated hydroxyl-BMPO spectrum (Figure 5.13C) is approximately a 
1:2:2:1 spectrum, while that generated by CuSO4 (Figure 5.12D) shows a well resolved 
1:1 doublet of 1:1:1 triplets giving 6 lines in intensity 1:1:1:1:1:1. Both spectra seem to 
show the presence of two isomers. 
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The EPR spectrum generated from CuSO4, ascorbic acid and H2O2 (Figure 5.13D) 
shows a larger than expected aH, which indicates a slightly higher spin density on the 
hydrogen. It is possible that the BMPO molecule has either been oxidised or reduced as 
a result of the attack of the oxygen radical, leaving the O-N=CH fragment planar rather 
than the -CH existing in a tetrahedral conformation. The planar O-N=CH would allow a 
higher unpaired electron density at the H and therefore an increased aH. However, the 
CuSO4-generated spectrum (Figure 5.13D) appears to show a small quantity of a second 
isomer is present, which would rule out the existence of a planar structure. An 
alternative possibility is that Cu or Ru could coordinate at either the NO or the 
OH/OOH oxygen of BMPO, which would modify the unpaired electron density 
distribution, resulting in a larger than expected aH (Brian Mann, personal 
communication). 
 
The EPR spectrum of 4 mM CORM-2 in DMSO mixed with 10 mM BMPO was then 
recorded (Figure 5.14A). The resulting spectrum was not identical to either the 
superoxide or hydroxyl BMPO adducts reported in the literature (Zhao et al., 2001), nor 
to the EPR spectrum reported by Tavares et al. (2001) for CORM-2 mixed with BMPO. 
The spectrum does however overlay the spectrum generated by a mixture of CuSO4, 
ascorbic acid and H2O2 mixed with BMPO and has a hyperfine splitting value for 
nitrogen of 15.2 G, while that for hydrogen is 21.2 G (Figure 5.14B). This suggests the 
EPR spectrum obtained for CORM-2 in this work could indicate the presence of 
hydroxyl radicals, although it is not clear why this spectrum differs from those reported 
in the literature for both the BMPO hydroxyl radical (Zhao et al., 2001) and CORM-2 
with BMPO (Tavares et al., 2011). The EPR spectrum of RuCl2(DMSO)4 mixed with 
BMPO was generated, and no features were detected, suggesting that this control 
compound does not generate any ROS (Figure 5.14C). The relative intensity of the EPR 
spectrum generated by CORM-2 and BMPO was plotted against time (Figure 5.14D) 
and revealed that the BMPO adduct was short lived, with a maximum intensity 
occurring within the first 2 min following mixing. 
 
EPR spectra were then recorded for a solution of CORM-3 (4 mM) with BMPO (8 mM) 
over time. Initially, no clear features could be seen, (Figure 5.15A and B); however, by 
recording multiple spectra and averaging the signals, the signal to noise ratio was  
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Figure 5.13 Reference spectra of superoxide (A and B) and hydroxyl (C and D) 
radicals bound to BMPO. EPR spectra were generated from the following samples 
including the spin trap BMPO (5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-oxide). 
(A) and (B) xanthine (1 mM), xanthine oxidase (5 milliunits), DTPA (0.1 mM) and 
BMPO (25 mM), A) 2 min after mixing and (B) 80 min after mixing, (C) hydroxyl-
BMPO adduct generated by FeSO4 (1 mM), H2O2 (1 mM) and BMPO (8 mM) and (D) 
hydroxyl-BMPO adduct generated by CuSO4 (1 mM), ascorbic acid (1 mM), H2O2 (1 
mM) and BMPO (8 mM) 10 min after mixing. The features circled in green were 
slightly broader than expected when compared to the spectrum published by Zhao et al., 
(2001), and the feature circled in red was not as broad. 
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Figure 5.14 CORM-2 EPR spectra. Spectra were generated from the following 
samples including the spin trap BMPO (5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-
oxide). (A) shows the spectrum generated by CORM-2 (4 mM) in DMSO with BMPO 
(10 mM) 2 min after mixing, (B) shows an overlay of the copper generated hydroxyl 
radical bound to BMPO in green (Figure 5.12D) and the CORM-2 with BMPO spectra 
(red), (C) shows the spectrum of RuCl2(DMSO)4 (4 mM) with BMPO (8 mM) and (D) 
shows the intensity of the CORM-2 adduct of BMPO over time. 
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Figure 5.15 CORM-3 EPR spectra. (A) and (B) Spectra were generated from CORM-
3 (4 mM) with the spin trap BMPO (5-tert-butoxycarbonyl 5-methyl-1-pyrroline N-
oxide) (8 mM) (A) 2 min after mixing, (B) 6 min after mixing, (C) shows the average of 
4 spectra generated from this sample and (D) shows an overlay of the iron-generated 
hydroxyl radical bound to BMPO and the averaged CORM-3 with BMPO spectrum. 
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improved allowing a distinct spectrum to be produced (Figure 5.15C). This spectrum 
bares great resemblance to the hydroxyl-BMPO spectrum generated from FeSO4 in this 
work, with similar values for aH (14.5 G) and aN (13.8 G); however it is of very low 
intensity suggesting that only a small amount of hydroxyl radical is formed. Figure 
5.15D shows an overlay of the CORM-3 - BMPO spectrum with the FeSO4 generated 
hydroxyl-adduct of BMPO. 
 
5.2.9 Assay of H2O2 production in vitro by CORM-3 treated E. coli 
It was also considered important to assess whether CORM-3 produced hydrogen 
peroxide in vivo; therefore an Amplex red assay (Invitrogen) was performed in CORM-
3 treated cells. This assay uses 10-acetyl-3,7-dihydroxyphenoxazine, which reacts with 
H2O2 in a 1:1 stoichometry to produce the fluorescent oxidation product resorufin, 
which has excitation and emission maxim of approximately 571 nm and 585 nm 
respectively, and can also be detected spectrophotmetrically at 560 nm. This assay is 
extremely sensitive and can detect as little as 10 picomoles H2O2 in 100 µl.  
 
H2O2 production was assayed in a suspension of wild type MG1655 E. coli cells alone 
(resuspended to a final OD600 of 0.09) and with either CORM-3 (100 µM), CORM-3 
with glycerol (5 mM) or glycerol alone. Glycerol was added to ensure the samples were 
respiring. A standard curve was generated using a series of dilutions of H2O2 (0 – 10 
µM). The absorbance at 560 nm was measured spectrophotometrically. No hydrogen 
peroxide was detected in any of the samples (data not shown). This could suggest that 
the cell concentration used was too dilute; however it is similar to that used by Seaver 
and Imlay (2001) who detected elevated H2O2 production by E. coli mutants unable to 
express both alkyl hydroperoxide reductase and catalase. It therefore seems reasonable 
to conclude that a dilute E. coli cell suspension (OD600 = 0.09) treated with 100 µM 
CORM-3 produces less than 10 picomoles H2O2 irrespective of whether the cells are 
respiring or not. 
 
5.2.10 NAC significantly reduces CORM-2 and CORM-3 uptake of E. coli cells  
Finally, it was investigated whether the presence of NAC affects the uptake of CO-RMs 
into bacterial cells (Figure 15.16). ICP-MS is a technique that measures with great 
sensitivity the concentration of individual metals within a sample, and therefore was 
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Figure 5.16 NAC significantly reduces the uptake of CORM-2 and CORM-3 into 
bacterial cells. Cultures of wild type E. coli were grown to mid-log phase (OD600 ~0.5) 
prior to the removal of 20 ml samples both before and at regular intervals after the 
addition of CORM. In (A) ruthenium uptake as CORM-3 (40 μM) in the absence 
(closed symbols) or presence (open symbols) of 400 μM NAC is shown. In (B) 
ruthenium uptake as CORM-2 (20 μM) in the absence (closed symbols) or presence 
(open symbols) of 200 μM NAC is shown. Cell pellets were assayed for ruthenium 
content by inductively coupled plasma-mass spectrometry. Data are the means and 
standard deviations of 3 biological replicates. This figure was published in Jesse et al. 
(2013). 
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ideal for comparing the uptake of both CORM-2 and CORM-3 (measured as ruthenium) 
in the presence and absence of NAC. As ruthenium is not present in bacteria under 
normal conditions, it can be assumed that any ruthenium detected in the cell pellets 
following CO-RM treatment has come directly from the CO-RM.  Bacteriostatic 
concentrations of each CO-RM were added to cultures of wild type E. coli grown in 
Evans medium to early exponential phase (OD600 = 0.5) either alone, or in the presence 
of a 10-fold excess of NAC. Samples (20 ml) were taken before the addition of CORM-
3 and at 2.5, 5, 10, 20, 40 and 80 min thereafter. Cells were harvested by centrifugation 
at 5500 rpm for 5 min in polypropylene tubes (50 ml). Culture supernatants were 
retained for analysis. Cell pellets were washed three times in 0.5% HNO3 (0.5 ml; 
Aristar nitric acid (69%, v/v)) to remove loosely bound elements. Supernatants collected 
from the washes were also retained for analysis. Samples were analyzed using a Spectro 
CirosCCD (Spectro Analytical) inductively coupled plasma-mass spectrometer (ICP-MS). 
The percentage of ruthenium recovered from these samples was calculated to monitor 
the precision of this technique and revealed that between 74 to 90% of the ruthenium 
added to the culture was recovered in the cell pellet, wash steps or medium. To calculate 
intracellular ruthenium concentrations, published values for individual cell dry mass and 
volume were used (Graham et al., 2009).  
 
Treatment of cultures of E. coli with 40 µM CORM-3 led to a rapid accumulation of 
ruthenium within the cells to approximately 8 times the concentration of ruthenium 
applied to the culture (Figure 5.16A). The striking discovery was made that in the 
presence of 400 µM NAC, ruthenium from CORM-3 accumulated inside E. coli cells 
approximately 8-fold less, i.e. to a similar concentration to that applied to the culture. 
 
A similar effect was true of CORM-2 treated E. coli: in the absence of NAC, ruthenium 
from CORM-2 (20 µM) accumulated inside the cells to concentrations approximately 
30-fold higher than that applied to the culture, however in the presence of 200 µM 
NAC, intracellular ruthenium concentrations were 5-fold lower, confirming that NAC 
dramatically reduces the uptake and intracellular accumulation of ruthenium-based CO-
RMs.  
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5.3 Discussion 
As detailed in the introduction to this chapter (section 5.1), this work aimed to ascertain 
the mechanism by which thiol compounds are able to prevent the inhibitory effects of 
CO-RMs, and specifically, to what extent the negation of the deleterious effects of ROS 
are responsible for these effects. 
 
The finding presented in this chapter that an excess of NAC, cysteine or reduced 
glutathione is able to abolish the effects of CORM-3 on respiration is in agreement with 
the literature (Desmard et al., 2009, Desmard et al., 2012). However, the work 
presented here is the first demonstration that NAC is able to completely abolish the 
inhibitory effects of CORM-3 on respiration when present at an equimolar 
concentration to CORM-3 (Figure 5.1B). Furthermore, it is shown that thiol compounds 
are able to prevent or greatly reduce the inhibition of respiration induced by ruthenium 
based CO-RMs in E. coli membrane particles (Figure 5.1B and C, and Figure 5.2A and 
B), but have no effect on inhibition caused by CO gas (Figure 5.1A).  
 
Importantly, it was shown that thiol compounds do not interfere with binding of CO 
from CORM-3 to the terminal oxidases (Figure 5.6). This concurs with the conclusions 
of Desmard et al. (2012), who found that only the activity of certain CO-RMs, 
specifically those containing metal, are affected by thiol-containing compounds such as 
NAC. They concluded that if thiol compounds elicited their effects by interfering with 
the downstream effects of CO-RMs, such as the binding to the terminal oxidases, they 
would affect all CO-RMs similarly. 
 
5.3.1 The effect of thiol compounds on the release of CO from CORM-3 
The hypothesis that the rate of CO release from CORM-3 may be affected (either 
increased or decreased) by thiol compounds was investigated. CO release from CORM-
3 was assayed by performing myoglobin assays in the presence of varying 
concentrations of NAC. The data obtained suggest that the rate of CO release from 
CORM-3 is slightly diminished and that the final amount of CO release is slightly less 
(21%) in the presence of a 10-fold excess of NAC (Figure 5.4), and that these effects are 
greater as the ratio of NAC to CORM-3 increased. However, as the majority of CO can 
still be released to Mb following incubation with NAC, these differences do not seem 
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sufficient to completely abolish the effects of CO-RMs on bacteria. In light of our 
current understanding of the ability of sulfite species, such as dithionite, to promote CO 
release from many CO-RMs, it is possible that thiol compounds do greatly reduce the 
ability of CO to be released from CO-RMs in cellular conditions, but that the ability of 
dithionite to promote CO loss then overrides this, resulting in relatively normal CO 
release kinetics to myoglobin (Figures 5.4). 
 
The haemoglobin assay (Figure 5.5) was used as a measure of CO release from CORM-
3 in the absence of dithionite, and in accordance with the findings of McLean et al. 
(2012), no CO release from CORM-3 was observed. Furthermore, CO release was not 
observed from CORM-3 pre-incubated with an excess of NAC, confirming that this 
compound does not promote CO loss from CORM-3.  
 
These findings suggest that NAC stabilizes the CO-bound CORM-3 structure. It is 
possible that interaction between thiol compounds and CORM-3 causes a 
conformational change in the latter, thereby decreasing the rate of CO loss from 
CORM-3. It is known that CORM-3 and other fac-[Ru(CO)3]2+ compounds are able to 
bind to hen egg white lysozyme resulting in a conformational change in the CO-RM 
that may decrease the rate of CO-release (Santos-Silva et al., 2011; Santos et al., 2012).  
 
The finding that CORM-3 may cause slight oxidation of oxy-ferrous haemoglobin is 
interesting and is in agreement with observations of other researchers in this laboratory 
(Lauren Wareham, unpublished). Conversely, another researcher, Salar Ali 
(unpublished) has found some evidence that some CO-RMs are able to reduce 
tetrazolium dyes. It is becoming increasingly clear that the redox potential of CO-RMs, 
of which very little is currently known, may have important biological effects, and 
therefore should be a key area for future investigation. 
 
There is a published report of thiol compounds promoting the release of CO from 
CORM-3 and carbon monoxide-releasing micelles (Hasegawa et al., 2010); cysteine (10 
mM) was found to cause the release of 0.12 equivalents of CO per molecule of CORM-
3. However, lower concentrations of cysteine (100 µM) did not have this ability. These 
effects were also observed for glutathione. It is important to note that CO release was 
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measured using a CO detector that measured the CO concentration in the gas phase, and 
that only very low levels of CO were detected and the CO release occurred slowly 
(Hasegawa et al., 2010). 
 
It has been suggested that if thiol compounds promoted the release of CO from CO-
RMs, it would cause the CO-RM to ‘act like CO gas’ (Desmard et al., 2012) and 
therefore be less effective at inhibiting respiration in whole cells than CORM-3. The 
data presented in this chapter show that CO gas, at a concentration of 100 μM, causes 
substantial inhibition of respiration in E. coli membranes particles (Figure 5.1A). 
Therefore, with regards to the inhibition of respiration of membrane particles, thiol 
compounds do not cause CORM-3 to behave like CO gas. Moreover, when CO is 
released from CORM-3 prior to a myoglobin assay being conducted, a characteristic 
jump in the myoglobin spectrum is seen upon addition of the CORM-3 mixture to the 
myogobin (McLean et al., 2012). This is not seen in the case of CORM-3 pre-treated 
with NAC (Figure 5.4).  
 
Desmard et al. (2009) reported that NAC did not affect the rate of CO release from 
CORM-3 as measured by the myoglobin assay; however, while specific details were not 
provided in that paper, it is likely that they added NAC directly to the CORM-3 and 
myoglobin, without allowing a 5 min pre-incubation period as was done in the present 
work. In addition, the presence of dithionite in that study and in the present work adds a 
variable that contributes to CO release in a manner that was not understood when both 
pieces of work were undertaken. 
 
5.3.2 The influence of endogenous thiol compounds on the bactericidal effects of 
CORM-3  
Glutathione is present in a wide variety of organisms including bacteria, yeast, plants 
and animals (Hopkins, 1921). It was shown to undergo reversible oxido-reduction and 
was believed to have an important role in respiration (Hopkins, 1923), for a recent 
review see Masip et al. (2006). Viability studies presented in the current work found 
that an E. coli mutant unable to produce endogenous glutathione was significantly more 
resistant to killing by CORM-3 than wild type cultures, particularly at 90 and 120 min 
following treatment (Figure 5.7). This provides further evidence that ROS is not a 
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significant cause of bacterial killing by this CO-RM. These findings are contrary to the 
expectation that glutathione would protect against damage from CORM-3. However the 
finding that CORM-3 is able to react with thiol groups (Figure 5.8 and 5.9) and that 
superoxide is generated from CORM-3 at a substantially faster rate in the presence of 
NAC (Figure 5.10F), could suggest that there are deleterious consequences of CORM-3 
in the presence of glutathione. An alternative possibility is that the glutathione mutant 
has an altered redox potential, which may affect the ability of CORM-3 to release CO 
inside the cell. It is also important to note that there are many other endogenous proteins 
that stabilize the redox potential of a cell such as glutaredoxins and thioredoxins 
(Aslund et al., 1997). In contrast, Tavares et al. (2011) found that exogenous 
glutathione protects against killing by CORM-2 and ALF062, while Nobre et al. (2009) 
found that E. coli mutants unable to synthesize methionine are hypersensitive to 
CORM-2.  
 
The expression of several genes involved in the transport and metabolism of thiol-
containing compounds are affected by treatment of E. coli with CORM-3 (McLean et 
al., 2013). Genes affected include cysPUWA, which encodes the sulfate-thiosulfate 
transport system, metQIN, which are involved in methionine metabolism and transport 
and ssuABCDE and tauABCD, which respond to sulfur starvation. This indicates that E. 
coli cultures treated with CORM-3 have enhanced requirements for sulfur. 
 
5.3.3 Could ROS account for the bactericidal effects of CO-RMs? 
As mentioned above, it has been suggested that the main mechanism by which CORM-
2 induces bacterial cell death is by the generation of ROS, specifically hydroxyl radicals 
(Tavares et al., 2011). There is a large body of evidence suggesting that CO (and in 
some cases CO-RMs) lead to increased ROS due to inhibition of respiration (Queiroga 
et al., 2011; Smith et al., 2011; Zuckerbraun et al., 2007). Such ROS are thought to play 
an important role in mediating some of the downstream effects of CO, particularly in 
eukaryotic systems (Zuckerbraun et al., 2007) (see section 1.2.8.2.4). However, there is 
evidence that low concentrations of CO can actually protect against oxidative stress in 
models of mouse lung hypoxia (Otterbein et al., 1999) and that CO can actually 
decrease ROS production by NADPH oxidase (Taille et al., 2005).  
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Tavares et al. (2011) suggest that, in addition to ROS produced by the inhibition of 
respiration, CORM-2 and ALF062 can also generate hydroxyl radicals directly. It is 
known that some transition metal carbonyls e.g. Na[Mo(CO)3(histidinate)] and 
Na3[Mo(CO)3(citrate)] can cause hydroxyl radical formation (Seixas, 2010). It is 
proposed that ALF062 produces hydroxyl radicals by reaction of the electron dense 
metal with H2O and O2, as ROS did not form in anoxic conditions (Tavares et al., 2011). 
They propose that hydroxyl radicals are formed by CORM-2 via the reduction of 
oxygen by ruthenium species that are generated by the water gas shift reaction, which 
occurs when water reacts with one of the CO ligands of this CO-RM. They show that 
the control molecule RuCl2(DMSO)4, which they refer to as iCORM-2, did not produce 
ROS, and neither did CORM-2 in the presence of haemoglobin, as in these conditions, 
CORM-2 forms RuII(CO)2, which is stable and does not react with water to form OH 
radicals. It is also important to remember that EPR is very sensitive and the radicals 
detected in the current work and in Tavares et al. (2011) may be the products of a minor 
side reaction, or even a contaminant in the CO-RM preparation. 
 
The data collected in this current work, by biochemical assays (Figure 5.10) and EPR 
spectroscopy (Figure 5.14 and 5.15) indicate that while small amounts of ROS (both 
superoxide and hydroxyl radicals) are produced by high concentrations (1 - 4 mM) of 
both CORM-2 and CORM-3, this does not explain all of the effects of CO-RMs on 
bacteria. Indeed, neither CORM-2 nor CORM-3 (both at 100 μM) produced sufficient 
superoxide to be detected by the superoxide assay (data not shown). This is close to the 
concentration of CO-RMs used in biological studies and therefore it is unlikely that 
superoxide is responsible for the deleterious effects induced by low concentrations of 
these CO-RMs. Furthermore, no H2O2 was detected in vivo by relatively high 
concentrations of CORM-3 (100 µM) in a dilute suspension of E. coli cells (data not 
shown). This concurs with the findings of Desmard et al. (2012) that 100 µM of 
CORM-2, CORM-3, CORM-371 and CORM-A1 did not cause any ROS production in 
P. aeruginosa within 1 h of treatment as measured by DCFH-DA, which measures 
oxidation of DCFA by ROS. This is in agreement with previous work from this group, 
which showed that CORM-3 did not produce ROS (Desmard et al., 2009). Furthermore, 
while CORM-2 treatment has been shown to increase the production of ROS by P. 
aeruginosa biofilms, this increase did not correlate with bacterial cell death and addition 
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of the thiol compound and antioxidant L-cysteine in combination with 100 µM CORM-
2 reduced biofilm formation, but did not affect ROS production, suggesting that 
CORM-2 is preventing biofilm formation by a different mechanism (Murray et al., 
2012).  
 
Therefore, our data support the previous observations that ROS production is not the 
major mechanism by which CORM-2 disrupts P. aeruginosa growth. There is, however, 
some evidence that inhibition of respiration by CORM-3 leads to ROS production in C. 
jejuni (Smith et al., 2011). The addition of catalase to respiring C. jejuni cultures in the 
presence of 100 µM CORM-3 resulted in an increase in the oxygen concentration in the 
chamber, indicating that respiratory inhibition by CORM-3 generates H2O2, most likely 
via the production of superoxide. 
 
The possibility that the superoxide detected is generated from impurities in the CO-RM 
preparation cannot be discounted, particularly as the amount of superoxide generated by 
CORM-A1, CORM-2, CORM-3 and iCORM-3 was approximately 1% of the CO-RM 
concentration. That iCORM-3 generated more superoxide than CORM-3 suggests that 
superoxide is not caused by the CO release process. It is possible that superoxide is 
formed from the oxidation of ruthenium causing an electron to pass to oxygen, although 
this is unlikely as CORM-3 is known to be stable in water for several hours. 
Furthermore, if superoxide radicals were formed in this way, it is feasible that they 
would spontaneously dismutate to form peroxide, which could react with contaminating 
free iron or copper in the solution to form hydroxyl radicals, which would be detected 
by the BMPO spin trap. In this case, haemoglobin, used as a control in the EPR spectra 
shown by Tavares et al. (2011) would scavenge the peroxide and so decrease the signal, 
as is seen in the published work, rather than CO scavenging by haemoglobin being the 
cause of this decrease, as is proposed.  
 
CORM-2, and to a lesser extent CORM-3, were found to react with the thiol groups of 
NAC (Figure 5.8). This is consistent with the findings of Tavares et al. (2011) that 
CORM-2 is able to diminish the thiol groups in reduced glutathione. They suggest that 
this indicates that CORM-2 generates species that promote oxidation of thiol groups. 
Contrary to expectations, incubation of NAC with CORM-3 was found to increase the 
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rate of superoxide generation by CORM-3 (Figure 5.10F). This could be due to the 
reaction of the thiol group of NAC with CORM-3 (section 5.2.4) generating electrons, 
which then produce superoxide. CORM-3 and iCORM-3, but not CO gas, decrease the 
amount of free thiol groups detected in cysteine, reduced glutathione and sodium 
hydrosulfate (Figure 5.9), which suggests that it is the ruthenium skeleton that reacts 
with thiol groups. It is possible that this involves the binding of a thiol group to 
ruthenium, which displaces a chloride ion on the (i)CORM-3 compound (McLean et al., 
2013). 
 
The present work used EPR spin-trapping to show that ROS is formed by CORM-2, and 
to a much lesser extent by CORM-3, and that this species is likely to be hydroxyl 
radical. However, there are still uncertainties as to why the species generated here do 
not match the literature spectrum of hydroxyl bound to BMPO, and why the spectrum 
presented in Tavares et al. (2011) does not have aH and aN values that match those 
reported in the literature (Zhao et al., 2001).  
 
In order to further investigate the claim of Tavares et al. (2011) that it is the antioxidant 
properties of thiol compounds that abolishes the antibacterial effects of CO-RMs, the 
ability of a range of antioxidants that do not contain thiol groups were assessed for their 
ability to prevent inhibition of respiration by CORM-3 (Figure 5.11). Both ascorbic acid 
(Figure 5.11B; in accordance with the observations of Desmard et al. (2009)) and 
ferredoxin (Figure 5.11C), were unable to abolish the inhibitory effects of CORM-3 on 
respiration, while ubiquinol (Figure 5.11A) was only able to slightly reduce these 
effects. Ubiquinol and ascorbate have identical redox potentials (+ 60 mV), while 
ferredoxin has much lower reduction potential of - 430 mV. For comparison, 
glutathione has a reduction potential intermediate to these of - 172 mV (Nicholls and 
Ferguson, 2002). Therefore, the ability of ubiquinol to slightly diminish the apparent 
inhibition of respiration by CORM-3, is unlikely to be related to the reduction potential 
of this compound, as ascorbate, and the more potent reducing agent ferredoxin, do not 
have the same effects. When ubiquinol is added to respiring membrane particles in the 
oxygen electrode chamber in the absence of CORM-3, respiration appears to be 
stimulated slightly, consistent with the role of this compound in carrying electrons to 
the terminal oxidases, which is likely to explain why the respiration rate is slightly 
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faster in the presence of ubiquinol and CORM-3 than with CORM-3 alone. Taken 
together, these data suggest that it is the thiol group that is crucial in preventing the 
effects of CORM-2 and CORM-3 on respiration, and that not all antioxidants are 
capable of this. 
 
While this work has shown that superoxide is produced by CORM-2 and CORM-3, the 
addition of SOD had no effect on the degree of inhibition caused by CORM-3 on 
respiration (Figure 5.11D). This allows us to conclude that the inhibition of respiration 
by CORM-3 is prevented by thiol-containing compounds via a mechanism that does not 
involve the quenching of reactive oxygen species. It seems clear that while ROS may be 
generated by high concentrations of some CO-RMs, this cannot account for all of the 
deleterious effects of these molecules. In particular, this hypothesis cannot explain why 
respiration is inhibited by CORM-3.  
 
5.3.4 The effects of NAC on the uptake of CORM-2 and CORM-3 by bacterial cells 
Finally, the results presented in this chapter show that NAC has a striking ability to 
reduce the entry of both CORM-2 and CORM-3 into growing E. coli cells. The 
substantial reduction in CORM-2 and CORM-3 entry into bacterial cells in the presence 
of NAC could explain why both these CO-RM compounds are much less toxic in the 
presence of NAC.  
 
In the presence of NAC, ruthenium from CORM-3 accumulates inside the cell to 
approximately the same concentration that is present outside the cell. Little is known 
about how CO-RMs are transported into bacterial cells; for example, it is not known 
whether CO-RMs enter cells by active transport, or by free diffusion. It is possible that 
NAC modifies ruthenium-containing CO-RMs (and perhaps other CO-RMs) in some 
way rendering it unable to use a specific transporter. 
 
However, this reduced uptake cannot explain all of the effects seen with thiol 
compounds on CO-RM activity, as in this work it has been shown that thiol compounds 
also prevent respiratory inhibition in bacterial membrane particles, in which 
presumably, CORM-3 access is not a constraint. 
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5.3.5 Conclusions 
It is now clear that there is likely to be more than one mechanism by which thiol 
compounds prevent the deleterious effects of CO-RMs. The work presented in this 
chapter has contributed to the understanding of how thiol compounds prevent the effects 
of CO-RMs, by eliminating hypotheses suggested in the literature and by the significant 
finding that these compounds drastically reduce the uptake of CO-RMs; however, more 
work is needed in order to fully understand the mechanisms by which these compounds 
exert their effects. One difficulty encountered when trying to understand how thiol 
compounds affect CO-RM activity, is that each research group that has investigated this 
phenomenon has used different CO-RMs, at different concentrations, with different 
experimental designs, which makes it difficult to make generalisations and to determine 
the effects of thiol compounds on different types of CO-RM. In this regard, the recently 
published study by Desmard et al. (2012) was particularly rigorous and helpful as it 
compared the effects of NAC on two ruthenium based CO-RMs with fast CO release 
rates, with those of a manganese based CO-RM and a boranocarbonate CO-RM, both of 
which had slow CO - release rates. NAC was found to completely prevent the effects of 
CORM-2 and CORM-3 on growth, but only partially alleviate growth inhibition caused 
by low concentrations of CORM-371 and had  no effect on growth inhibition caused by 
CORM-A1 (Desmard et al., 2012). It seems therefore, that NAC only interferes with the 
effects of metal-containing CO-RMs, particularly those containing ruthenium. In light 
of this information, it would be helpful to know if non-ruthenium CO-RMs are able to 
produce significant amounts of ROS, particularly hydroxyl radicals. That the uptake of 
ruthenium based CO-RMs is significantly reduced by the presence of NAC provides a 
clear explanation for why this compound reduces the efficacy of these CO-RMs; 
however, it will be important to ascertain whether NAC also reduces the uptake of non- 
ruthenium CO-RMs including CO-RMs for which the activity is not affected by thiol 
compounds such as CORM-A1 (Desmard et al., 2012). It would also be interesting to 
see if other thiol compounds are also able to reduce CO-RM uptake by bacteria. 
 
The results of the current work, when viewed alongside the literature, suggest that the 
low concentrations of CORM-3 that are effective in decreasing oxygen consumption, 
growth and viability in bacterial systems, do not produce significant amounts of ROS, 
and therefore the ability of thiol compounds to abrogate these effects is likely to be 
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distinct from the antioxidant properties of these compounds. However, the literature has 
shown that high concentrations of CORM-2 do produce hydroxyl radicals (Tavares et 
al., 2011), a property that may explain why CORM-2 is a more potent bactericidal agent 
than CORM-3, despite having similar CO-release profiles. 
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Chapter 6 
 
The generation and characterisation of CORM-2 resistant mutants 
 
6.1 Introduction 
 
In order to understand more about the bacterial targets of CO-RMs and their 
mechanisms of toxicity in E. coli, work was done to generate and characterise mutants 
of E. coli that exhibited a CO-RM-resistant phenotype. 
 
The EZ-Tn5 <R6Kγori/KAN-2>Tnp TransposomeTM Kit (Epicentre Technologies) was 
used to generate random transposon mutants of the parent strain Iq Express E. coli (New 
England Biolabs). This method utilizes a hyperactive Tn5 transposon system (Goryshin 
and Reznikoff, 1998), which randomly inserts into the genomic DNA of the host. A 
kanamycin marker allows transposon mutants to be selected. The insertion site of the 
transposon in mutants of interest can then be identified by sequencing outwards from 
the transposon into the chromosomal DNA. No host proteins are required for 
transposition, allowing this system to be used in a wide variety of organisms (Goryshin 
and Reznikoff, 1998); for example, a derivative of EZ-Tn5 <R6Kgori/KAN-2> has been 
used successfully to generate a large pool of mutants of Salmonella enterica serovar 
Typhi, which enabled candidate essential genes in this organism to be identified 
(Langridge et al., 2009). 
 
Tn5 causes transposition by a ‘cut and paste’ mechanism as opposed to replicative 
transposition (Berg, 1977; Goryshin and Reznikoff, 1998). It naturally has a low level 
of transposition, which can be beneficial, allowing long-term, stable associations with 
the host genome; however the introduction of 3 mutations modified this transposon 
causing it to have a much higher frequency of transposition (1000-fold higher), making 
it ideal for use as a genetic tool (Goryshin and Reznikoff, 1998). Another beneficial 
feature of this system is that this transposon inserts into the genome randomly (Kirby, 
2007).  
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Tn5 comprises 3 antibiotic genes, including one conferring kanamycin resistance, the 
transposase (Tnp), and the negative regulator Inh, the synthesis of which is blocked in 
this system. There are also 19-bp inverted repeats at either end of the transposon that are 
recognised by transposase (Goryshin and Reznikoff, 1998). Once the transposome has 
been introduced into the host cell by transformation, interaction of the transposase with 
Mg2+ activates this enzyme (reviewed by Kirby, 2007). The transposase enzyme binds 
to sequences at either end of the transposable element and then catalyses the cleavage of 
the phosphodiester bonds at either end of the transposable element. This multifaceted 
enzyme then inserts the transposon into random sites in the target DNA by strand 
exchange, before being released. 
 
This chapter describes the generation of random transposon mutants using the EZ-Tn5 
<R6Kγori/KAN-2>Tnp TransposomeTM described above, followed by screening of the 
resulting mutants for resistance to CORM-2. Various assays were performed in order to 
verify the CORM-2 resistance of transposon mutants of interest and then nucleotide 
sequencing was used to identify the disrupted gene. 
 
6.2 Results 
6.2.1 The use of random transposon mutagenesis to generate E. coli mutants 
followed by screening for CORM -2 resistance. 
Critical in this work was the design of a screen to select for CO-RM resistance. CORM-
2 was used in this screen as, unlike CORM-3, it is commercially available and therefore 
more financially viable for use in large screens. Iq Express E. coli (a BL21 derivative, 
purchased from New England Biolabs) was used as the recipient strain for the 
transposon, as it is a chemically competent strain with a high efficiency for 
transformation. Initial trails to determine the minimum concentration of CORM-2 that is 
toxic to Iq Express E. coli revealed that exposure of cultures to 40 μM CORM-2 for 30 
min resulted in complete loss of viability (Figure 6.1). Therefore, this concentration was 
used in the mutant screen.  
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Figure 6.1 The survival of Iq Express E. coli in the presence of various 
concentrations of CORM-2. E. coli was grown aerobically to an OD600 of 50 Klett 
units, various concentrations of CORM-2 (0 – 50 μM) were added, and the cultures 
incubated at 37 °C with shaking at 200 rpm. After 30 min, samples (50 μl) were taken 
and serially diluted to allow viability counts to be performed. Data shows the mean and 
standard deviation of 5 technical replicates, and are representative of 2 biological 
replicates. 
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Transposon mutagenesis was performed using the EZ-Tn5™ <R6Kγori/KAN-2>Tnp 
Transposome™ Kit from Epicentre Biotechnologies, according to the manufacturer’s 
instructions. Briefly, the transposome complex (1 µl) was used to transfom Iq Express 
chemically competent E. coli (50 µl) using the high efficiency transformation protocol 
(heat shock) as described in section 2.4.3. Transformants were selected by plating the 
cell suspension on to nutrient agar, supplemented with kanamycin (30 µg ml-1).  
 
Mutagenised cultures of Iq Express were grown to early exponential phase (50 Klett 
units) in 30 ml defined minimal medium by incubation at 37 °C with shaking at 250 
rpm, then exposed to a bactericidal concentration of CORM-2 (40 µM) for 30 min and 
then spread onto nutrient agar plates containing kanamycin and incubated at 37 °C 
overnight. It was expected that only a small number of mutants would be ‘CORM-2 
resistant’ and therefore survive this screen; however nearly 300 were obtained. It is 
likely that many of these survivors are siblings generated during the outgrowth stage 
following mutagenesis. A control, in which the mutagenized cultures were treated with 
the vehicle DMSO, yielded too many colonies to count, confirming that treatment with 
CORM-2 had successfully killed a large portion of the kanamycin resistant colonies.  
 
A second selection process of the putative CORM-2 resistant colonies was performed. 
A trial was done in a 96-well plate in order to establish the concentration of CORM-2 
that would substantially reduce the growth of the parent strain Iq Express. The parental 
strain was incubated at 37 °C, until the cultures reached an OD600 of 0.2. A range of 
CORM-2 concentrations (0 - 60 µM) were added to the wells: 10 µM CORM-2 caused 
3.9% less growth than the control in which no compound was added, 20 µM CORM-2 
caused 14.6% less growth than the control and concentrations above 30 µM caused 
between 64 and 69% growth inhibition. This led to 40 µM CORM-2 being used as a 
stringent selection for CORM-2-resistant mutants. 
 
Each mutant was inoculated into 200 μl defined minimal medium in individual wells of 
a 96-well plate and incubated at 37 °C for 8 h until a typical OD600 of between 0.1 and 
0.3 was reached. CORM-2 (40 µM) was then added to each well and incubated at 37 °C 
with shaking for 16 h and the OD600 measured using a multilabel reader (VictorTM X3, 
Perkin Elmer). The change in OD600 was calculated and an increase of more than 0.2 
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was considered to indicate substantial growth in the presence of CORM-2. This 
identified 4 mutants as CORM-2 resistant, designated IB2 (A600 increase of 0.404), 
IB11 (ΔA600 = 0.413), 3A33 (ΔA600 = 0.200) and 3B8 (ΔA600 = 0.216), according to their 
position in the 96-well plates. The OD600 of each of these mutants before and after the 
addition of CORM-2 and the subsequent change in absorbance are given in Table 6.1. 
The mutant 1B11 is of particular interest as it appeared to have low growth initially, but 
then grew well in the presence of CORM-2. 1B2 is also of interest because it had a large 
increase in growth following the addition of CORM-2. 
 
6.2.2 Characterisation of mutants of interest.  
The 4 mutants of interest were then further characterised by conducting growth studies 
in larger volumes of medium in the presence of 25 μM CORM-2 (Figure 6.2). The 
addition of 25 μM CORM-2 to the parent strain Iq Express, reduced the growth rate of 
this strain and caused a delay in the onset of exponential phase of approximately 2 h, 
whereas the growth profiles of the transposon mutants were not affected.  
 
The relative CORM-2 resistance of each mutant of interest was further investigated by 
performing CORM-2 susceptibility assays. At the point of inoculation, various 
concentrations of CORM-2 (0 – 2 µM) were added to cultures of the parent strain Iq 
Express and the 4 transposon mutants of interest. This assay uses extremely low 
concentrations of CORM-2, because the stressor is added at the point of inoculation, at 
which higher concentrations would completely prevent growth. Cultures were incubated 
at 37 °C with shaking at 250 rpm for 17 h, before the OD600 was measured using a 
spectrophotometer (Jenway). Figure 6.3 shows the growth for each strain subjected to 
various concentrations of CORM-2 as a percentage of growth for that strain in the 
absence of CORM-2. All four mutants exhibited stronger growth in the presence of 
CORM-2 than the parental strain. In particular, the mutants 3B8, 1B2 and 1B11 
exhibited much greater resistance to growth inhibition by CORM-2 than the parental 
strain, while the mutant 3A33 showed a more moderate ‘CORM-2-resistant’ phenotype. 
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Table 6.1 OD600 of the mutants of interest obtained from the second stage of the 
CORM-2 screen. The OD600 of each of the parental strain and the mutants of interest 
grown in defined minimal medium was measured using a multilabel reader (VictorTM X3, 
Perkin Elmer), before and after the addition of 40 µM CORM-2. The OD600 and the 
subsequent change in absorbance are given for each mutant of interest. 
  
Strain OD600 before CORM-2 OD600 after CORM-2 ΔOD600 
Iq 0.162 0.168 0.006 
1B2 0.145 0.549 0.404 
1B11 0.063 0.476 0.413 
3A33 0.198 0.398 0.200 
3B8 0.171 0.387 0.216 
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Figure 6.2 The growth of selected transposon mutants in the presence and absence 
of CORM-2. Growth of the parent strain Iq Express (A) and the transposon mutants; 
1B2 (B), 1B11 (C), 3A33 (D) and 3B8 (E) was measured spectrophotometrically using 
a Klett meter in the presence of 25 μM CORM-2 (open circles) or the equivalent 
volume of the vehicle DMSO (closed circles). CORM-2 or DMSO was added when 
cultures reached an OD600 of approximately 30 Klett units (as indicated by the arrows). 
Cultures were inoculated at time = 0. Data are the means and standard deviations of two 
biological replicates. 
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Figure 6.3 CORM-2 susceptibility assay. At the point of inoculation, various 
concentrations of CORM-2 (0 – 1.5 µM) were added to cultures of the parent strain Iq 
Express (closed circles, burgundy line), and the 4 transposon mutants of interest: 3A33 
(open circles, orange line), 3B8 (closed triangles, yellow line), 1B2 (open triangles, 
green line) and 1B11 (closed squared, blue line). The OD600 was measured 17 h after 
inoculation using a spectrophotometer and the growth in the presence of CORM-2 
compared to that in the absence of CORM-2 for each strain to generate a percentage. 
These data are representative of 3 biological replicates. 
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Each transposon mutant was then grown on nutrient agar plates containing increasing 
concentrations of CORM-2 (30 μM – 40 μM; Table 6.2). Overnight cultures of each 
mutant of interest and the parental strain were grown and 50 μl was added to 2.95 ml of 
molten defined minimal medium (cooled to 50 °C) with 0.7% agar, before the addition 
of various concentrations of CORM-2 (20 - 40 μM). This mixture was poured onto a 
base layer of defined minimal medium with 1.5% agar and incubated overnight. The 
ability of each strain to grow on the plates containing CORM-2 was assessed by eye and 
characterised according to their ability to grow. The results obtained suggest that all 
four transposon mutants are more resistant to CORM-2 than cultures of Iq Express, 
which had poor growth on plates containing 35 μM CORM-2 and was unable to grow 
on plates containing 40 μM CORM-2, whereas each transposon mutant tested was able 
to grow on plates containing up to 40 μM CORM-2. The transposon mutant 3B8 had the 
most growth on CORM-2 plates at all concentrations. 
 
Finally, in order to further assess the relative ability of the transposon mutants of 
interest to grow in the presence of this compound, CORM-2 gradient plates were made 
(Gerhardt, 1994). Gradient plates involve two layers of agar, the first of which was 
constructed from defined minimal medium containing 1.5 % agar, which was set with 
the petri dish at an angle (achieved by balancing the plate on the edge of a plate lid). 
The second layer consisted of defined minimal medium containing 0.7% agar, to which 
(after cooling to approximately 50 °C) 60 μM CORM-2 was added. This agar 
containing CORM-2 is poured on to the first layer, resulting in a level agar plate that 
has a maximal quantity of CORM-2 at one apex of the plate, which decreases gradually 
across the plate (for a diagrammatic representation of the construction of this plate, see 
Figure 6.4A and B). Cultures of each transposon mutant of interest, and the parent 
strain, were grown overnight in LB (10 ml) at 37 °C with shaking at 250 rpm, these 
cultures were then harvested as described above, washed by resuspending in defined 
minimal medium, harvested once more and finally resuspended in 200 μl defined 
minimal medium. 50 μl of this suspension was streaked onto the CORM-2 gradient 
plates using a Gilson pipette to release the cell suspension along the concentration 
gradient, starting at the apex that had the least CORM-2. Care was taken to apply the 
suspension evenly and consistently between strains. More resistant strains are expected 
to grow further along the plate towards the higher concentration of CORM-2. In each 
189 
 
 
 
 
 
 
 
Table 6.2 The growth of transposon mutants of interest on plates containing 
CORM-2. The information in this table indicates the ability of each transposon mutant 
of interest, and the parent strain Iq Express, to grow on nutrient agar plates containing a 
range of CORM-2 concentration (30 – 40 μM). *** strong growth, ** intermediate 
growth, * little growth, - indicates no growth. These results are representative of two 
biological replicates. 
  
 Growth on plates containing CORM-2? 
 30 μM 35 μM 40 μM 
Iq Express ** * - 
1B2 ** ** ** 
1B11 ** ** ** 
3B8 *** *** *** 
3A33 ** ** ** 
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Figure 6.4 CORM-2 gradient plates. (A) and (B) represent the stages involved in 
making a gradient plate. In (A) the petri dish is tilted by resting one edge on the lid of a 
petri dish. 12.5 ml defined minimal medium with 1.5% agar was then poured into the 
plate and allowed to solidify on an angle. The plate is the returned to a flat surface and 
defined minimal medium containing 0.7% agar and 60 µM CORM-2 was poured on to 
make a level plate with a CORM-2 gradient (B). A concentrated suspension (50 µl) of 
each mutant was then applied to a plate in a line parallel with the concentration gradient. 
(C) shows a photograph of a gradient plate obtained from one biological replicate and is 
representative of the results obtained on each.   
High CORM-2 
concentration 
Low CORM-2
concentration 
A 
B 
C 
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biological replicate, all 4 mutants exhibited stronger growth, and grew further along the 
CORM-2 concentration gradient than the parental strain Iq express (Figure 6.4C). This 
provides further evidence of the CORM-2 resistant phenotype of these mutants. 
  
6.2.3 Sequencing the CORM-2 resistant mutants 
In order to determine where the transposon had been inserted into the E. coli genome, 
genomic DNA was extracted from each transposon mutant and digested by the 
restriction enzyme RsaI. This restriction enzyme recognises the sequence 5’GTAC3’ 
and cuts between the T and the A to generate blunt ends. RsaI cuts once inside the 
kanamycin resistance gene, although it cuts several times within the R6K origin of 
replication and many times within the genomic DNA of E. coli. The sequence of the EZ 
Tn5 transposon is given in Figure 6.5 and the RsaI cut sites are marked. The digested 
chromosomal DNA was then ligated using T4 DNA ligase to form small, circular 
fragments of DNA, which were then amplified using the KAN-2 FP1 Forward Primer 
from the EZ-Tn5 <R6Kγori/KAN-2>Tnp TransposomeTM Kit, in conjunction with a 
primer designed to be internal to the Rsa1 site using the polymerase chain reaction 
(PCR). The sequence of both primers is given in Table 2.2, while Figure 6.6 shows a 
diagrammatic representation of the rescue cloning process. The PCR product generated 
from these primers with DNA from each transposon mutant of interest was sent for 
nucleotide sequencing (Beckman Coulter genomics) using the KAN-2 FP1 Forward 
Primer. An NCBI nucleotide blast search was then done to identify the sequence, and 
positive matches were found for three of the four sequences, a summary of the results is 
shown in Table 6.3.  
 
The transposon mutant strain 3B8 was found to have 97% sequence identity with the 
gene frvB, also known as yiiJ. This gene is 1452 bp in length and encodes the enzyme 
IIB and IIC domains of a predicted PEP-dependent sugar-tranporting phosphotranferase 
system. It is an inner membrane protein and a predicted transporter. Sequence similarity 
of frvB to characterized fructose-specific enzymes IIBC suggests this transporter may be 
specific for fructose (Reizer et al., 1994) 
 
The transposon mutant strain 1B11 was found to have 98% sequence identity with the 
gene sgaU, also known as ulaE. This gene is 855 bp in length and encodes the enzyme 
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CTGTCTCTTATACACATCTCAACCATCATCGATGAATTGCTTCGTTAATACAGATGTAGGTGTTCCACAG
GGTAGCCAGCAGCATCCTGCGATGCAGATCCGGATGCCATTTCATTACCTCTTTCTCCGCACCCGACAT
AGATCCGAAGATCAGCAGTTCAACCTGTTGATAGTACGTACTAAGCTCTCATGTTTCACGTACTAAGCT
CTCATGTTTAACGTACTAAGCTCTCATGTTTAACGAACTAAACCCTCATGGCTAACGTACTAAGCTCTCA
TGGCTAACGTACTAAGCTCTCATGTTTCACGTACTAAGCTCTCATGTTTGAACAATAAAATTAATATAA
ATCAGCAACTTAAATAGCCTCTAAGGTTTTAAGTTTTATAAGAAAAAAAAGAATATATAAGGCTTTTAA
AGCTTTTAAGGTTTAACGGTTGTGGACAACAAGCCAGGGATCTGCCATTTCATTACCTCTTTCTCCGCAC
CCGACATAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACGAAACACGG
AAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGC
TCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGAC
AGGAGCACGATCATGCGCACCCGTGGCCAGGACCCAACGCTGCCCGAGATGCGCCGCGTGCGGCTGCT
GGAGATGGCGGACGCGATGGATATGTTCTGCCAAGGGTTGGTTTGCGCATTCACAGGGTGTCTCAAAAT
CTCTGATGTTACATTGCACAAGATAAAAATATATCATCATGAACAATAAAACTGTCTGCTTACATAAAC
AGTAATACAAGGGGTGTTATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCC
AACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATC
TATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAAT
GATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCAT
TTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGAAAAACAGCATTCCAGGTA
TTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCAT
TCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAA
TGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCT
GGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGA
TAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCG
ATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTT
CAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCT
AATCAGAATTGGTTAATTGGTTGTAACACTGGCAGAGCATTACGCTGACTTGACGGGACGGCGGCTTTG
TTGAATAAATCGAACTTTTGCTGAGTTGAAGGATCAGATCACGCATCTTCCCGACAACGCAGACCGTTC
CGTGGCAAAGCAAAAGTTCAAAATCACCAACTGGTCCACCTACAACAAAGCTCTCATCAACCGTGGCG
GGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTCAGGGTTGAGATGTGTATAAGAGACAG 
 
Figure 6.5 The sequence of the EZ Tn5 transposon. The Tn5 Mosaic Ends are 
highlighted in yellow, the RsaI cut sites in grey. The R6k origin of replication is given 
in a blue font, while the Tn903 Kanamycin resistance gene is in orange. In order to 
identify the insertion site of the transposon in mutants of interest, the forwards primer 
from the EZ-Tn5 <R6Kγori/KAN-2>Tnp TransposomeTM Kit was used, the sequence 
complementary to this primer (Kan2FP-1) is highlighted in turquoise, while the primer 
internal to Kanamycin RsaI site (highlighted in green) was designed by Iain Kean for 
the purpose of allowing sequencing of the genetic material adjacent to the transposon. 
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Figure 6.6 Identifying the transposon insertion site. Following insertion of the 
transposon (shown in pink) into the chromosomal DNA (shown in black) of the host, 
genomic DNA was extracted from the mutants of interest and digested with the 
restriction enzyme RsaI. This cuts once within the transposon and at many sites within 
the genomic DNA. The DNA fragments were ligated using T4 DNA ligase, and then the 
DNA adjacent to the transposon was amplified by PCR using a primer complementary 
to the sequence immediately following the RsaI cut site internal to the transposon 
(shown in green), in conjunction with a primer matching the DNA sequence at the 3’ 
end of the transposon (shown in blue).  
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Table 6.3 The genes disrupted in the transposon mutant strains that have been 
identified as CORM-2 resistant.   
Transposon 
Mutant 
Disrupted gene 
(all commonly 
used names) 
Sequence 
identity 
(%) 
Gene 
size (bp)
Gene function 
3B8 frvB 
yiiJ 
 
97 1452 Putative fructose-like PTS 
system enzyme IIB 
1B11 sgaU 
ulaE 
98  855 L-xylulose 5-phosphate 3-
epimerase 
 
3A33 manX 91 972 PTS system mannose - 
specific transporter subunit 
IIC 
1B2 No sucessful 
sequence match 
obtained 
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L-xylulose 5-phosphate 3-epimerase, an isomerase that catalyses the conversion of L-
xylulose 5-phosphate to L-ribulose 5-phosphate, a step in the catabolism of L-ascorbate 
in E. coli (Yew and Gerlt, 2002). Interestingly, the sga operon encodes three 
components of a PTS system that imports L-ascorbate into the cell. 
 
The transposon mutant strain 3A33 was found to have 91% sequence identity to a short 
section (21 bp) of the gene manX. This gene is 972 bp in length and encodes subunit IIC 
of a mannose - specific transporter in the inner membrane, which like FrvB and SgaU, 
is a component of the sugar PTS system.  This transporter is required for bacteriophage 
lambda DNA penetration (Esquinas-Rychen and Erni, 2001).  
 
After several attempts, the PCR product from IB11 failed to give a sequence that 
matched any known gene in the E. coli gene database. Therefore, due to time 
constraints, work with this mutant was terminated. 
 
It seemed significant that all three of the genes identified in this work encode 
components of a PTS transport system, which may indicate that CORM-2 enters cells 
via these, or related transporters. This suggests that a key mechanism of bacterial 
resistance to CO-RMs could be the disruption of transport of these compounds into the 
cell. 
 
6.2.4 The characterisation of independent mutants 
In order to verify that mutations in the 3 genes mentioned above are sufficient to cause 
resistance to CORM-2, and that this phenotype was not caused by downstream effects 
of the transposon insertion, independent mutants were sought. Mutants in manX, frvB 
and sgaU from the Keio collection were obtained from Simon Andrews, The University 
of Reading. These mutations were then transferred by P1 vir phage transduction into an 
MG1655 background, and the transductants selected on kanamycin plates.  
 
Primers were designed using Primer 3 software, version 0.4.0 to allow amplification of 
these three genes. These primers were then used to amplify the relevant section of DNA 
in each of the mutants and in the wild type MG1655 strain, and the PCR products were 
then run on an agarose gel. As expected, each primer pair generated a sole product of 
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the correct size from the wild type DNA, but produced a differently sized product in 
each of the transductants, indicating the absence of the gene (and replacement with a 
kanamycin marker) in each case (Figure 6.7), confirming that the appropriate mutations 
had been transferred to an MG1655 background. 
 
The sensitivity of these independently generated mutants to CORM-2 was then 
compared to the wild type MG1655 strain. Cultures of each strain were grown in 
defined minimal medium (30 ml) with glycerol (0.5%) as a carbon source to 30 Klett 
units as described previously (section 2.1.6). CORM-2 (4 µM) was added and the 
growth was monitored over time and compared to that of the MG1655 wild type strain 
(Figure 6.8). Under these conditions, the growth of the sgaU and frvB mutants (Figure 
6.8B and C respectively) was actually increased by this low concentration of CORM-2. 
The growth of the manX mutant was not enhanced by this concentration of CORM-2; 
however, in this assay, the growth of this mutant was less inhibited by CORM-2 than 
that of the wild type strain (Figure 6.8A). This provides evidence that mutations in these 
genes cause a CORM-2 resistant phenotype, and may, in some cases, result in enhanced 
growth in the presence of this compound. 
 
The growth of these three mutants in the presence of CORM-2 was assessed further by 
performing CORM-2 susceptibility assays in which low concentrations of CORM-2 (0 – 
1 µM) were added to cultures of MG1655 wild type and the 3 mutants of interest. The 
sgaU mutant was significantly more resistant than the wild type strain at 0.25 µM 
CORM-2 (P < 0.05) and at 0.5 µM CORM-2 (P < 0.1) (Figure 6.9A, yellow bars). The 
manX mutant was significantly more sensitive to CORM-2 (0.25 and 0.5 µM) than the 
wild type (P < 0.1) (Figure 6.9A, green bars). However, while the frvB mutant appeared 
to be more resistant to CORM-2 than the wild type strain (Figure 6.9A, orange bars); 
this was not statistically significant. Importantly, the growth of all of the strains was not 
affected by up to 3 µM RuCl2(DMSO)4 (Figure 6.9B). It should be noted however that 
the statistical analysis was performed on percentage data which compared the growth of 
each strain with CORM-2 to that without CORM-2. This was done in order to account 
for differences in the growth of each strain in the absence of CORM-3. It is 
acknowledged that it is not ideal to perform statistical tests on percentage data, and so 
care must be taken when interpreting these results.  
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Figure 6.7 Confirmation of the absence of the mutated gene in the MG1655 
transductants.  Genomic DNA was extracted from a kanamycin resistant colony from 
each transduction event (sgaU, frvB, manX). A PCR reaction was performed on each 
DNA sample using primers designed to amplify the mutated gene in each case. (Lanes 2 
- 4 contain the PCR product of the SgaU primers from wild type DNA (lane 2, positive 
control, 800 bp) and the sgaU DNA (lanes 3 and 4, replicates, 1350 bp), lanes 5 - 7 
contain the PCR product of the FrvB primers from wild type DNA (lane 5, positive 
control, 1450 bp) and the frvB DNA (lanes 6 and 7, replicates, 1400 bp), finally, lanes 8 
- 10 contain the PCR product of the ManX primers from wild type DNA (lane 8, 
positive control, 1100 bp) and the manX DNA (lanes 9 and 10, replicates, 1400 bp),  
Lanes 1 and 11 show the molecular weight marker (Hyperladder 1, Bioline), the sizes of 
which are indicated on the right hand side.  
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Figure 6.8 CORM-2 growth assays with the putative CORM-2 resistant mutants in 
an MG1655 background. CORM-2 (4 µM) was added at early exponential phase to 
cultures of E. coli: (A) manX, (B) sgaU and (C) manX. Nothing was added to the 
controls. The growth of the wild type MG1655 strain with and without CORM-2 is 
shown in each case for comparison. 
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Figure 6.9 CORM-2 susceptibility assay with the putative CORM-2 resistant 
mutants in an MG1655 background. At the point of inoculation, various 
concentrations of (A) CORM-2 (0.25 - 1 µM) or (B) RuCl2(DMSO)4 (0 - 3 µM) were 
added to cultures of the wild type MG1655 (brown) and the 3 mutants of interest: frvB 
(orange), sgaU (yellow) and manX (green). OD600 was measured 
spectrophotometerically and the percentage growth for each strain in the presence of 
each concentration of compound, compared to the growth in the absence of compound 
was calculated. Data for CORM-2 are averages and standard errors of 6 biological 
replicates, and for RuCl2(DMSO)4 are the averages and standard deviations of 2 
biological replicates. Asterisks indicate significantly higher percentage growth of the 
mutant strain compared to wild type in the presence of CORM-2 as measured using 
Student’s t test (*, P < 0.1; **, P < 0.05). It is however acknowledged that it is not ideal 
to perform statistical analysis on percentage data. 
 
  
* 
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6.2.5 The effects of sub-inhibitory concentrations of CO-RM on bacterial growth 
Interestingly, very low concentrations of CORM-2 caused an increase in growth in the 
wild type MG1655 strain, as well as the mutant strains (Figure 6.9). It was ruled out that 
this was caused by the addition of the vehicle DMSO, as addition of a volume of DMSO 
equivalent to the largest volume of CORM-2 added in the previous experiment did not 
result in any change in optical density compared to growth of the strains with no 
additions (data not shown). Consequently, the effects of very low concentrations of both 
CORM-3 (a ruthenium containing CO-RM) and CORM-401 (a manganese-based CO-
RM) was then investigated with two aims: 1) to assess whether the mutant strains 
exhibited resistance to CO-RMs other than CORM-2, and 2) to investigate whether sub-
inhibitory concentrations of these CO-RMs also caused a stimulation of growth as seen 
with CORM-2.  
 
None of the mutant strains exhibited resistance to CORM-3 (Figure 6.10A) or CORM-
401 (Figure 6.10B), which suggests that any resistance these strains have to CORM-2 is 
specific to this compound, and not to wider features of CO-RMs in general or to CO. It 
is notable however that all strains, including wild type, also exhibited increased growth 
in the presence of low concentrations of CORM-3 and CORM-401. Wild type cultures 
grew approximately 80% more than untreated cultures when treated with 0.5 µM 
CORM-3, and approximately 50% more when treated with 1 µM CORM-3, and yet 
treatment with 2 µM CORM-3 almost completely prevented growth of this strain 
(Figure 6.10A, brown bars). Similarly, sub-inhibitory concentrations of CORM-401 (< 
50 µM) had a stimulatory effect on the growth of wild type cultures, with maximal 
stimulation (40% more than untreated cultures) occurring at 15 µM CORM-401. The 
stimulation of growth by sub-inhibitory concentrations of both ruthenium- (CORM-2 
and CORM-3) and manganese- (CORM-401) containing CO-RMs is an unexpected and 
interesting finding that requires further investigation.  
  
6.2.6 Uptake of CORM-2 by sgaU and frvB mutants 
It was hypothesised that the sgaU and frvB mutants may be partially resistant to 
CORM-2 because of reduced uptake of this compound into the bacterial cell caused by a 
defect in the PTS system, encoded by the sga and frv operons, which usually import L-
ascorbate and fructose, respectively. Therefore ruthenium uptake in sgaU and frvB 
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Figure 6.10 CORM-3 and CORM-401 susceptibility assay with the putative 
CORM-2 resistant mutants in an MG1655 background. At the point of inoculation, 
various concentrations of (A) CORM-3 (0 - 3 µM) or (B) CORM-401 (0 - 200 µM) 
were added to cultures of the wild type strain MG1655 and the 3 mutants of interest: 
frvB (orange), sgaU (yellow) and manX (green). OD600 was measured 
spectrophotometerically and the percentage growth for each strain in the presence of 
each concentration of CO-RM, compared to the growth in the absence of the CO-RM 
was calculated.  
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mutant cells treated with CORM-2 was measured over a time-course using ICP-MS 
analysis, as described previously (section 5.2.10), and compared to that in wild type 
MG1655 cells. The results of this investigation indicate that CORM-2 enters both sgaU 
cells (Figure 6.11A) and frvB cells (Figure 6.11B) at a similar initial rate as in wild type 
cells, but that ruthenium reaches a slightly lower equilibrium level within the mutant 
cells. This difference is significant in frvB cells at the 40 min time point (p = 0.055) and 
in sgaU cells at the 40 min time point (p = 0.01) and the 80 min time point (p = 0.06). 
 
6.3 Discussion 
There are still many unanswered questions surrounding the interaction of CO-RMs with 
bacteria and the nature of their bactericidal effects. It was therefore considered useful to 
generate and characterise CO-RM resistant strains of E. coli in the hope that this would 
reveal previously unappreciated targets of CO-RMs and facilitate a better understanding 
of the bacterial response to these compounds. 
 
The approach taken was the generation of a large pool of random transposon mutants, 
followed by selecting for CORM-2 resistant mutants by the application of a 
concentration of CORM-2 that is toxic to the parental strain (40 µM, Figure 6.1). 
Surviving mutants were screened further to confirm their CORM-2 resistant phenotype 
(Figure 6.2, 6.3, 6.4 and Table 6.2) and then the insertion sites of the transposon in the 
resistant mutants were identified by rescue cloning.  
 
It is very interesting that all three of the CORM-2 resistant mutants identified in this 
work had mutations in genes encoding components of sugar-transporting PTS enzymes. 
This could indicate that CORM-2 enters E. coli cells via PTS transporters, as this would 
explain why mutations in genes that encode components of these transporters might be 
resistant to CORM-2. Currently, almost nothing is known about the transport of CO-
RMs into bacterial cells, and therefore the comments made in this discussion are largely 
speculative. It is possible that CO-RMs enter bacterial cells by free diffusion through 
the membrane, perhaps down a concentration gradient, which provides the driving 
force; however, it seems plausible that CO-RMs enter bacterial cells using a transporter 
system, either by a passive or active mechanism. Some PTS transporters are able to 
203 
 
Time (min)
0 20 40 60 80 100
[R
u]
 in
si
de
 th
e 
ce
ll 
 ( μ
M
)
-200
0
200
400
600
800
1000
wild type with CORM-2 
sgaU with CORM-2 
Time (min)
0 20 40 60 80 100
-200
0
200
400
600
800
1000
wild type with CORM-2 
frvB with CORM-2 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 The uptake of CORM-2 by wild type MG1655 E. coli and the sgaU and 
frvB mutants. Cultures of MG1655 wild type and the sgaU mutant of E. coli in an 
MG1655 background (A, open circles) and frvB mutant (B, open circles) both in an 
MG1655 background were grown to mid-log phase (OD600 ~0.5) prior to the removal of 
a 20 ml sample from each, both before and at regular intervals after the addition of 
CORM-2 (20 μM). Cell pellets were assayed for ruthenium content by inductively 
coupled plasma - mass spectrometry. Data are the means and standard deviations of 3 
biological replicates. Asterisks indicate statistically significant differences in the 
ruthenium content of cultures of the mutant strains compared to wild type as measured 
using Student’s t test (*, P ≤ 0.06; **, P = 0.01).  
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transport only one specific sugar; for example, N-acetylglucosamine is the only sugar 
that can be transported by EIINag from E. coli, which is encoded by nagE. Interestingly 
though, this transporter has been shown to transport the antibiotic streptozotocin into the 
cell (Lengeler, 1980). In contrast, the mannose PTS transporter, encoded by the 
manXYZ operon has a diverse substrate specificity, and is able to transport a variety of 
hexose sugars, including mannose, glucose, fructose and the amino sugars, glucosamine 
and N-acetylglucosamine. It is therefore feasible that CO-RMs could use sugar 
transporters to enter bacterial cells. CORM-2 has a molecular weight of 512, whereas 
that of CORM-3 is 310, both of which are larger than the molecular weights of 
ascorbate, mannose and fructose, which are 176 for the former and 180 for each of the 
latter. There are however some broad similarities in the structures of ascorbate and 
CORM-3, such as the pentose ring containing an oxygen atom and a double bond to 
oxygen from the adjacent carbon atom in the ring. Table 6.4 shows the chemical 
structures of CORM-2, CORM-3 and CORM-401, and the sugars ascorbate (transported 
by the product of the sga operon), fructose (transported by the product of the frv 
operon), and mannose (transported by the product of the man operon). 
 
The ruthenium uptake measurements are consistent with the the sgaU and frvB mutants 
importing lower levels of CORM-2 into the cell. However, the observation that a large 
portion of the ruthenium applied as CORM-2 is still able to enter these mutants suggests 
that there are other mechanisms of entry of CORM-2 into the cell, perhaps by free 
diffusion, or by other transport proteins. This is consistent with these mutants only 
being partially resistant to growth inhibition by CORM-2. Moreover, preliminary data 
were collected, which suggested that the entry of CORM-3 into both of these mutant 
strains did not differ from that of wild type cells (data not shown), which combined with 
a lack of resistance of these mutants to CORM-3, suggests that this CO-RM enters the 
cell via different transporters. 
 
Subsequent measurements of the growth of independently generated mutants of sgaU, 
frvB and manX in an MG1655 background, in the presence of CORM-2, revealed that 
only the sgaU mutant was statistically significantly resistant to this compound (Figure 
6.9, yellow bars). The gene sgaU encodes the enzyme L-xylulose 5-phosphate 3- 
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epimerase, which catalyses the isomerisation of L-xylulose 5-phosphate to L-ribulose 5-
phosphate; a subsequent epimerase conversion, catalysed by another member of the 
operon, converts this to D-xylulose-5-phosphate, an intermediate of the pentose 
phosphate pathway (Yew and Gerlt, 2002).  Members of the operon upstream of sgaU 
encode proteins responsible for the uptake and phosphorylation of L-ascorbate, via a 
phosphotransferase uptake system (Zhang et al., 2003). Mutants with deletions in the 
sga operon are unable to ferment L-ascorbate (Yew and Gerlt, 2002). Structural 
similarities of the active site of SgaU to the active sites of other epimerases suggest a 
metal-dependent epimerization mechanism for this enzyme (Shi et al., 2008). 
 
The original transposon mutants exhibited a stronger CORM-2 resistance phenotype 
than the independently generated mutants. This is likely to be due to the different 
genetic backgrounds of the strains. The transposon mutants were BL21 derivatives with 
a series of genetic modifications, which rendered the strain highly competent and ideal 
for the overexpression of proteins. The genotype of this strain is given in Table 2.1. The 
Iq express parent strain appears to be more sensitive to CORM-2 than MG1655 (data not 
shown). This is not ideal, and with hindsight, it seems that further attempts should have 
been made to generate MG1655 that were sufficiently competent to allow the 
transposon mutagenesis to be performed directly in this strain.  
 
It is possible that the CORM-2 resistant phenotype of the original transposon mutants 
were caused partly, or completely, by downstream effects of the transposon insertion, 
this may be particularly true in the case of the transposon mutant designated 3A33 (later 
identified as manX) as the independently generated manX mutant did not appear to be 
resistant to CORM-2, and in fact, was significantly more sensitive to CORM-2 than the 
wild type strain. The manX gene is up-regulated 13.2-fold by organic solvents (Okochi 
et al., 2007), which may explain the sensitivity of this strain to CORM-2 as this 
compound is delivered in the organic solvent DMSO. Alternatively, it is possible that 
the transposon insertion site in this mutant was incorrectly identified, as it only matched 
the manX gene by 91% over a 21 base pair sequence, although there were no better 
matches for the transposon insertion site in this mutant. Furthermore, the transposon 
mutant 3A33 exhibited the weakest CORM-2 resistant phenotype in the initial 
resistance screen with a change in OD600 of 0.2 (assigned as the minimum change to 
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indicate significant growth) following the addition of CORM-2, and in the initial 
characterisation assays (Figure 6.3, orange line). 
 
Although the characterisation of independently generated strains with mutations in the 
genes identified by transposon mutagenesis as conferring resistance to CORM-2 was an 
important control, if time had allowed, these strains would have ideally been 
complemented with the appropriate functional gene in order to confirm that this restored 
the wild type phenotype. This would provide unequivocal evidence that mutations in 
these genes were the cause of the CORM-2 resistance.  
 
Analysis of the transcriptome of E. coli following exposure to sub-lethal concentrations 
of CO-RMs is an alternative approach to identify previously unappreciated effects of 
CO-RMs and to further our understanding of the global effects of these compounds on 
bacterial cells. Such studies have been carried out by this laboratory using CORM-3 
(Davidge et al., 2009b; McLean et al., 2013) as mentioned previously (section 1.3.4) 
and the manganese based CO-RM, CORM-401 (Lauren Wareham, unpublished). 
Searches of these transcriptomic databases for the genes identified in the current work 
revealed that sgaU is down-regulated 1.62-fold in the presence of 40 µM CORM-3 30 
min after addition of the compound, and that this down-regulation is maintained at 80 
min after addition (Samantha McLean, unpublished). This trend is seen with many 
genes in the sga operon, with the most significant change being the 2-fold down-
regulation of sgaB. This supports the hypothesis that some CO-RMs may enter E. coli 
cells via this transporter. Interestingly, despite the lack of CORM-2 resistance in the 
independent manX mutant in the MG1655 background, the manXYZ operon was down-
regulated by 2.78 - 3.22-fold 40 min after the addition of CORM-3. This mutant was not 
found to exhibit resistance to CORM-3 (Figure 6.10A, green bars). The expression of 
frvB was slightly up-regulated across the time-course by CORM-3. 
 
In contrast, CO gas (bubbled at a rate of 50 ml min-1) caused a very slight up-regulation 
of the sga and man operons across the time-course. There was, however, an overall 
down-regulation of the frv operon, with frvB being down-regulated by approximately 2-
fold at all time-points after 5 min following exposure to CO. The different effects of CO 
gas and CO-RMs on the transcriptome emphasise the very different effects of these 
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compounds on the bacterial cell. Their different effects on the genes of interest here 
suggest that it is not CO, but the CO-RM compound itself that causes the down-
regulation of the sga and manXYZ operons, consistent with the free diffusion of CO 
through lipid bilayers, and so the absence of the need for a transporter for CO gas. 
 
Treatment with the manganese based CO-RM, CORM-401 (66.7 µM), caused a 2.5-fold 
up-regulation of manX after 40 min and a 3-fold up-regulation at 80 min. In contrast, 
frvB was down-regulated by 3-fold at 5 min and 2.7-fold at 10 min following the 
addition of this CO-RM; however, expression of frvB returned to basal levels by the 80 
min time-point. The sgaU gene was slightly up-regulated, by approximately 1.8-fold at 
2.5, 40 and 80 min, following CORM-401 addition (Lauren Wareham, unpublished). 
Again, the mutants of interest did not exhibit resistance to this CO-RM (Figure 6.10B), 
which was not unexpected, as these CO-RMs, particularly CORM-401, differ greatly in 
their size, structure and chemical properties; therefore it is likely that they enter the cell 
via different pathways.  
 
While conclusions cannot be drawn from this data as it describes the transcriptomic 
responses of E. coli to CORM-3 and CORM-401, but not CORM-2, it is interesting to 
note that both the sgaU operon and the manX operon are slightly down-regulated in 
response to CORM-3. This could reflect a bacterial defence against the import of 
ruthenium based CO-RMs.  
 
An alternative approach to this work would have been the screening of an established 
library of transposon mutants of E. coli (or indeed a pathogenic bacterial species) with 
CO-RMs. This would have the advantage of allowing mutants in every non-essential 
gene in an organism to be screened for CO-RM resistance, or indeed sensitivity, 
allowing a much more thorough and systematic investigation of the response of mutants 
to CO-RMs. 
 
An interesting and unexpected finding of this work was that very low concentrations of 
CORM-2 (Figure 6.9), CORM-3 (Figure 6.10A) and CORM-401 (Figure 6.10B) added 
at the point of inoculation cause increased growth of wild type MG1655 E. coli and the 
mutant strains. The growth of these strains with low levels of the CO-RMs was not 
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followed over time and so conclusions about the effect of these compounds on the rate 
of growth cannot be made, but it is clear that the final culture density is significantly 
greater in the presence of sub-inhibitory concentrations of CO-RM (wild type cultures 
grew approximately 80% more than untreated cultures when treated with 0.5 µM 
CORM-3 and 40% more when treated with 15 µM CORM-401). This could suggest that 
a factor, such as exhaustion of the carbon source glycerol, is preventing growth in the 
absence of CORM, but is not limiting in the presence of CO-RM. Initially, it was 
considered that DMSO could be acting as a substrate for E. coli treated with CORM-2 
(for which DMSO is the vehicle), however this was considered unlikely due to the very 
small amount of DMSO added, and indeed a control in which an equivalent volume of 
DMSO was added to the E. coli cultures was not found to stimulate or inhibit growth 
(data not shown). If time had allowed, an important control would be to investigate the 
effects of very low amounts of CO gas on bacterial growth. An interesting hypothesis 
for why some bacteria may grow better in the presence of CO or CO-RMs is that the up-
regulation of HO by CO activates a variety of cytoprotective pathways within the cell 
(Motterlini and Otterbein, 2010). However, this is not the cause of the increase in 
growth in this case as E. coli K12 does not contain a HO enzyme. 
 
There is currently no literature on the effects of very low levels of CO or CO-RMs on 
bacterial growth; however, there is much on the effects of these compounds on 
mammalian cells as outlined in the introduction to this thesis (sections 1.1.3.5 and 
1.2.8). For example, CO has been shown to prevent excessive production of ROS in 
mitochondria by uncoupling electron transport from ATP production (Lo Iacono et al., 
2011), while brief exposure of astrocytes  to CO has been shown to improve respiration 
(Almeida et al., 2012). Furthermore, the concentration of CO has been shown to be 
critical in determining the response. Low concentrations of CORM-3 (0.5 and 1 μM) 
caused an increase in the respiratory control ratio and mitochondrial transmembrane 
potential in isolated heart mitochondria, while higher concentrations (5 and 10 μM) 
caused a decrease in these values (Lancel et al., 2009).  
 
Treatment of intact E. coli with CORM-3 has been shown to result in a transient 
stimulation of respiration prior to respiratory inhibition (Wilson et al., 2013). It was 
concluded that this stimulation was the result of transport of K+ and Na+ ions across the 
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bacterial membrane. It is possible that an increased rate of respiration in the presence of 
low concentrations of CO-RMs causes the improved growth observed in the current 
work.  
 
An alternative possibility is that exposure to low levels of CO-RMs (and perhaps other 
non-specific stressors) activates cellular machinery that is able to counteract stress 
rendering the cell better equipped to deal with stress, and indeed better able to grow, in 
the absence of stress. This hypothesis emphasises the multifaceted effects of CO-RMs. 
It is likely that some cellular processes are benefited by interaction with CO and the 
CO-RM molecules, while others are inhibited; however at high concentrations of CO-
RM, the beneficial effects are masked by the inhibitory effects. 
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Chapter 7 
 
General Discussion 
 
7.1 Summary 
The work presented in this thesis has developed knowledge of the antibacterial 
properties of a range of CO-RM compounds, but in particular the ruthenium-containing 
compounds CORM-2 and CORM-3, in comparison with CO gas. Several similarities 
between these CO-RMs and CO gas were demonstrated; for example, cytochrome bd-I 
was found to be the most resistant oxidase of E. coli to CORM-3, as is true for CO gas. 
It is hypothesised that in both cases, this resistance is caused by the fast dissociation rate 
of CO from this oxidase (Borisov, 2008). Furthermore, inhibition of E. coli respiration 
by CORM-3, as with CO gas, is shown here to be photosensitive, suggesting that CO 
from CORM-3 binds to ferrous haems in a classical, light-sensitive manner. However, 
CORM-3 does not merely act as a CO donor. Unlike CO gas, CORM-3 was not 
preferentially inhibitory to bacterial respiration when added at low oxygen tensions, a 
difference hypothesised to be caused by an accumulation of CO in the micro-domains of 
the target sites inside bacterial cells. This intracellular accumulation of CORM-2 and 
CORM-3 is demonstrated here using ICP-MS (Chapters 5 and 6) and is thought to 
explain in part the increased potency of these compounds as antimicrobial agents in 
comparison with CO gas. 
 
One of the most significant findings of this work was the demonstration that the thiol 
compound NAC dramatically reduces the uptake of both CORM-2 and CORM-3 into E. 
coli cells. This is important due to the many previously unexplained reports in the 
literature that thiol compounds are able to abrogate many of the effects of CO-RMs, 
particularly those containing ruthenium (Desmard et al., 2012), in both prokaryotic 
(Desmard et al., 2009; Murray et al., 2012) and eukaryotic systems (Sawle et al., 2005; 
Taille et al., 2005). Other researchers in the field have proposed that thiol compounds 
protect against the deleterious effects of CO-RMs by virtue of their antioxidant 
properties (Tavares et al., 2011); however, data are presented herein that suggest that 
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CORM-3, at the concentrations routinely used in biological experiments, does not 
produce significant amounts of ROS, in agreement with the work of others (Desmard et 
al., 2009; Desmard et al., 2012), and that other antioxidants, which do not contain thiol 
groups, are unable to confer the same protection (Figure 5.11). It should now be 
explored whether thiol-containing compounds also reduce the uptake of CO-RMs in 
eukaryotic systems as this could have implications for the therapeutic applications of 
CO-RMs. 
 
7.1.1 The effects of CO-RMs on bacterial respiration 
The work described here provides the first evidence that CO from CORM-3 binds to all 
three terminal oxidases of E. coli. The data confirm that application of CORM-3 to 
suspensions of E. coli membrane particles leads to immediate inhibition of respiration. 
It was shown, for the first time, that membranes containing cytochrome bd-I as the only 
terminal oxidase are more resistant to this inhibition than membranes containing the 
other oxidase types, and that this oxidase can confer resistance to growth inhibition by 
CORM-3, as discussed in Chapter 3. This thesis also contains the first report of 
inhibition of a non-haem containing oxidase by CO-RMs, as discussed below. 
 
This thesis aimed to further the understanding of the extent to which inhibition of 
respiration is the cause of the bactericidal nature of the CO-RMs. It is clear that CO 
from CORM-2 and CORM-3 (Figures 3.1 and 3.6) binds to and inhibits terminal 
oxidases and that at high concentrations, this inhibition could be sufficient to kill the 
bacteria. It is shown here (Figure 3.10) that the viability of E. coli treated with 30 µM 
CORM-3 was reduced by 95% within 1 h, but that killing was reduced to 70% when a 
bright light was shone on to the culture vessel, causing the photolysis of haem-CO 
bonds. This provides the first conclusive evidence that the binding of CO from CORM-
3 to haem proteins contributes to killing by these compounds. However, these data do 
not allow a distinction between the relief of CO inhibition of respiration and the lysis of 
haem-CO bonds in other haemoproteins within the bacterial cell. Therefore it is not 
possible to determine based on these results whether the reduction in killing in the light 
was caused by alleviation of the inhibition of repiration, or the lysis of haem-CO bonds 
in other haemoproteins. Furthermore, the substantial killing effect (70%) in the presence 
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of CORM-3 and light could imply that there are other causes of killing by CORM-3, as 
discussed below.  
 
A difficulty associated with the use of E. coli as a model organism in these studies is 
that it has flexible respiratory pathways, and so is able to rapidly adapt to a range of 
environmental conditions. Indeed, transcriptomic analyses by this laboratory have 
shown altered expression of the individual terminal oxidases of this organism in 
response to CORM-3 (Davidge et al., 2009b; McLean et al., 2013) and CORM-401 
(Lauren Wareham, unpublished). This gives rise to the possibility that following 
treatment with CO-RM, particularly at lower concentrations that do not kill all bacteria 
within a short time, E. coli may either synthesise more terminal oxidases, or switch to 
an alternative form of energy generation, such as fermentation, and therefore continue to 
grow after a lag phase. It would therefore be interesting to study the effects of CO-RMs 
on E. coli grown on a non-fermentable substrate such as succinate to investigate 
whether this prevented such recovery. Preliminary data suggests that this is the case 
(Samantha McLean, unpublished). This transient inhibition was not observed in the 
current work with CORM-2 and CORM-3, which appear to be two of the most potent 
antibacterial CO-RMs, possibly due to their ruthenium centre, as will be discussed 
further below. However, CORM-401 (Lauren Wareham, unpublished) and the 
photoCO-RM Mn(CO)3(tpa-κ3N)]Br (Christoph Nagel and Samantha McLean, 
unpublished) are much less detrimental to the growth of E. coli than ruthenium-based 
CO-RMs, which suggests that inhibition of respiration limits growth only transiently 
until the bacteria can switch to an alternative method of energy production. If inhibition 
of respiration by CO-RMs were the main cause of killing by these compounds, then it 
would be expected that all CO-RMs would have similar levels of toxicity, or rather that 
CO-RMs that release more CO per molecule, or had faster rates of CO-release, would 
be more toxic. However, this does not seem to be the case; CORM-401 is much less 
toxic to E. coli than CO-RMs 2 and 3, despite releasing approximately three times more 
CO per mole than these compounds. The notion that inhibition of aerobic respiration is 
not wholly responsible for killing by CO-RMs is also consistent with reports of the 
growth inhibition of anaerobically grown E. coli by both CORM-2 (Nobre et al., 2007) 
and CORM-3 (Davidge et al., 2009b). 
 
214 
 
It seems therefore that ruthenium containing CO-RMs cause killing by other 
mechanisms, in addition to the inhibition of respiration. In order for these mechanisms 
to be elucidated, a thorough understanding of the chemistry of the intact CO-RM and of 
the breakdown products following CO release is required. Initially, the potential effects 
of these CO-RM backbones were not fully appreciated, because control experiments 
using ‘inactive’ compounds devoid of CO did not elicit the same effects as the active 
CO-RMs in a range of growth, viability and respiratory experiments. The need for 
robust control compounds is discussed further below.  
 
The recent paper by Desmard et al. (2012) provides the most through comparative 
report to date of the bactericidal effects of a range of CO-RMs. They show that CO-
RMs with different chemical properties differentially influence bacterial growth and O2 
consumption and that the kinetics of CO release from CO-RMs does not determine their 
antibacterial effects. They conclude that the inhibition of oxygen consumption by CO 
released from CO-RMs is not the only factor influencing their bactericidal effect, and 
that the nature of the transition metal is important in determining the antibacterial 
activity exerted by CO-RMs.  
 
7.1.2 The redox properties of CO-RMs 
Following the realisation that the inhibition of respiration is not the sole cause of the 
bactericidal effects of CO-RMs, the hypothesis that the production of reactive oxygen 
species by these compounds leads to their toxic effects, as proposed by Tavares et al. 
(2011), was explored.  
 
This work demonstrates that while CORM-2 does produce small amounts of ROS, 
probably hydroxyl radicals as reported by Tavares et al. (2011) (Figure 5.14), low 
concentrations of CORM-3 that are effective in decreasing oxygen consumption, growth 
and viability in bacterial systems, do not produce significant amounts of ROS in vitro 
(Figure 5.10 and 5.15) or in vivo, as demonstrated by an assay for hydrogen peroxide 
production (data not shown). The production of ROS by CORM-2 may explain why this 
compound is a more potent bactericidal agent than CORM-3 despite having similar CO-
release profiles. In this work, the ability of thiol compounds to abrogate the effects of 
CO-RMs was shown to be unrelated to the antioxidant properties of these compounds, 
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but rather is likely to be caused by a dramatic reduction in CO-RM uptake into the 
bacterial cell in the presence of certain thiol compounds such as NAC (Figure 5.16). 
 
This work raises questions about the redox properties of CO-RMs. This is an area that is 
currently not well understood. Some transition metal carbonyls e.g. 
Na[Mo(CO)3(histidinate)] and Na3[Mo(CO)3(citrate)] can cause hydroxyl radical 
formation (Seixas, 2010). In addition, the CO-RM ALF062 is also hypothesised to 
produce hydroxyl radicals by reaction of the electron-dense molybdenum with H2O and 
O2 (Tavares et al., 2011) and CORM-2 is hypothesised to produce these radicals via the 
water gas shift reaction (see below) involving the reduction of oxygen by ruthenium 
species. 
CO + H2O             CO2 + H2 
 
CORM-3 is thought to take part in the first stage of the water gas shift reaction. Under 
acidic conditions (CORM-3 has a pH of around 3 in solution), CORM-3 becomes 
[Ru(CO)2(CO2H)Cl(glycinate)]-, which could then lose a proton to form 
[Ru(CO)2(CO2)Cl(glycinate)]2-between pH 6 and 7. The two electrons could then be 
used to reduce a substrate leading to the release of CO2 (Brian Mann, personal 
communication). The ability of CORM-2 and CORM-3 to reduce a variety of 
tetrazolium dyes has been demonstrated recently in this laboratory (Salar Ali, 
unpublished). However in contrast, the Hb spectra shown in the current work (Figure 
5.5) appear to show oxidation of this haemoprotein upon addition of CORM-3. This 
emphasises the complex redox properties of these compounds, which are likely to vary 
under different environmental conditions. It will be important for the future use of CO-
RMs as research tools and potential pharmacological agents that the redox properties of 
these compounds are understood. Cyclic voltammetry could provide a possible means 
by which to investigate these properties. 
 
7.1.3 Other potential mechanisms of killing by CO-RMs 
The results described above suggest that neither inhibition of respiration by CO released 
from CORM-3, nor reactive oxygen species, are fully responsible for the bactericidal 
properties of this compound. As indicated previously (in this discussion and by 
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Desmard et al. (2012)), it seems that the chemistry of the ruthenium center must be 
considered as a possible contributing factor of killing by CORM-2 and CORM-3. 
 
Non-carbonylated ruthenium(II) compounds have been reported to possess potent 
antibacterial properties against the pathogens P. aeruginosa, E. coli, Proteus vulgaris 
and Proteus mirabilis (Anthonysamy et al., 2008). Ruthenium compounds at 
micromolar concentrations have also been shown to inhibit ATPase activity in E. coli 
(Scott et al., 1980). In contrast, Desmard et al. (2009) demonstrated that bacterial 
growth was not affected by ruthenium chloride (1 - 10 µM), however, it has not been 
demonstrated that this compound is able to enter bacterial cells. 
 
The transcriptomic response of E. coli to CORM-3 indicates that there is a global 
cellular response to CORM-3, and probabilistic modelling of these data implicates 
several transcription factors in this response, although the mechanism by which CORM-
3 affects these transcription factors, with the exception of ArcA / FNR (as described in 
section 1.3.4) is not understood (Davidge et al., 2009b). 
 
The transcriptomic data suggest that the metabolism and transport of several metals 
including iron is greatly disrupted by CORM-3 (Davidge et al., 2009b, McLean et al., 
2013) and this is supported by measurements of the intracellular concentration of these 
metals. Genes involved in sulfur metabolism, such as tauABC, ssuAD, cysWA and sbp, 
and in methionine metabolism, including metNI and metBLF are up-regulated by 
CORM-2 (Nobre, 2009) and CORM-3 (McLean et al., 2013) and so this reveals another 
route by which CO-RMs disrupt normal cellular homeostasis. 
 
An investigation into the effects of CORM-3 on a hemA mutant of E. coli  that is unable 
to synthesise haem (Wilson, 2012) revealed that this mutant was more sensitive than 
wild type to the bactericidal effects of CORM-3, which emphasises the importance of 
non-haem targets in killing by this compound. It may also suggest that haem groups in 
wild type E. coli may act as CO sinks, protecting other cellular components from 
damage by CO. The work revealed that CORM-3 differentially alters the transcription 
of genes involved in iron homeostasis and in Fe-S cluster assembly and repair in the 
hemA mutant compared to wild type, which implicates these as targets of CORM-3.  
217 
 
The finding presented in the current work that the non-haem oxidase AOX from V. 
fischeri is hypersensitive to inhibition by CO-RMs also provides further evidence that 
either CO or the CO-RM centre, are able to interact with and inhibit non-haem targets. 
The insensitivity of this oxidase to CO gas suggests that it is some other feature of these 
compounds that are interacting with and inhibiting the activity of this oxidase. A report 
by Santos-Silva et al. (2011) used X-ray crystallography to demonstrate that CORM-3 
is able to bind to hen egg white lysozyme by interacting with histidine and aspartate. 
There is also a report of CORM-2, but not CO gas or iCORM-2, activating ATP-gated, 
human P2X4 receptors by acting as an antagonist (Wilkinson and Kemp, 2011). These 
results emphasise the importance of considering non-haem targets for CO-RMs and the 
potential effects of interactions between the backbone of CO-RMs with proteins.  
 
7.1.4 The entry of CO-RMs into bacterial cells 
Several papers have reported the uptake of the metal center of CO-RMs into cells 
(Desmard et al., 2009; Jesse et al., 2013; McLean et al., 2013; Meister et al., 2010; 
Nobre et al., 2007), and there is spectroscopic evidence that CO from these compounds 
also enters bacterial cells (Lauren Wareham, unpublished), but currently, little is known 
about the mechanisms by which CO-RMs enter bacterial (or indeed mammalian) cells. 
 
It is possible that CO-RMs enter bacterial cells by passive diffusion, but it seems more 
likely given their size, that transporters are involved in their uptake. The present work 
has identified sugar transporting phosphotransferase systems as a possible means of 
CO-RM entry into the bacterial cell because of a partial CORM-2-resistant phenotype 
of E. coli with deletions in the frvB gene (encoding a component of the PTS fructose 
transporter) and sgaU (a component of a xylulose PTS transporter, see Chapter 6). This 
hypothesis is strengthened by data showing reduced entry of CORM-2 into each of 
these mutant strains (Figure 6.11). It now needs to be considered whether it is 
structurally and chemically possible for these transporters to enable CORM-2 entry into 
the bacterial cell, and other means of CO-RM entry should also be sought. 
 
The work presented in this thesis also adds to the current understanding of the bacterial 
uptake of CORM-2 and CORM-3 by demonstrating that the thiol compound NAC 
dramatically reduces the uptake of these compounds. It is hypothesised that this is due 
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to the thiol compound altering the structure of the CO-RM, thereby rendering it 
unsuitable for transport by the usual mechanisms.  
 
In the future, it will be important to investigate the interactions of CO-RMs with 
transporters that accumulate CO-RMs against a concentration gradient. It would also be 
interesting to investigate whether CO-RMs enter bacterial cells by active or passive 
transport, This could be done by measuring the rate of transport (assayed as intracellular 
ruthenium by ICP-MS) in the presence of different concentrations of CO-RM. 
Furthermore, ATPase mutants and uncouplers could be used in order to investigate the 
involvement of the proton motive force in CO-RM transport. The involvement of the 
multidrug efflux pump, implicated by transcriptomics (Davidge et al., 2009b; McLean 
et al., 2013), could be studied by investigating the rate of entry and exit of CO-RMs and 
the sensitivity of an mdt mutant to these compounds. The Mdt protein could be purified 
and CO-RM binding to this protein assayed by fluorimetry, CD, NMR, scintillation-
proximity or other methods. It is known that some CO-RMs are more toxic to bacterial 
cells than to eukaryotic cells (Desmard et al., 2009) and it would be interesting to 
investigate whether this is because bacteria can import CO-RMs more effectively than 
eukaryotic cells. 
 
7.2 Future directions and outstanding questions 
CO-RMs have shown great promise since their advent in the early 2000s as potential 
drugs in a wide range of human diseases and as antimicrobial agents, and this has led to 
the development of a wide range of new CO-RMs. With regards to understanding the 
antimicrobial properties of CO-RMs, it is important that each of these compounds is 
characterised and systematically assessed for its antimicrobial properties under standard 
conditions. Such data should allow clear patterns to emerge, which should further the 
current understanding of why CO-RMs are bactericidal. For example, it will be 
important to know which CO-RMs produce ROS and whether this contributes to the 
biological effects of these compounds. 
 
Throughout this work, it has become increasingly apparent that the compounds used 
currently as controls are far from ideal and, in many cases, do not accurately mimic the 
chemical properties of the intracellular breakdown products of CO-RMs. This is a major 
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limitation in the study of CO-RMs and in many cases prevents clear conclusions being 
drawn as to whether the effects seen are caused by CO from the CO-RM, or are caused 
by undesired, and in many cases, poorly understood, side reactions involving the CO-
RM metal centre devoid of CO. These limitations are not confined to the present work, 
and in many published works no control compounds are used, or the appropriate solvent 
is added in place of a control (Desmard et al., 2007; Desmard et al., 2009; Nobre et al., 
2007). 
 
Within the current work, three different control compounds have been used. 
RuCl2(DMSO)4 is used as a control for CORM-2 as both compounds contain chloride 
ligated to a central ruthenium and the compounds are broadly structurally similar, but 
with the carbonyl groups of the CO-RM replaced with DMSO in the control; however, 
the chemistry of the two compounds in solution is not identical. This compound has 
been used in published work as a control for CORM-3 (Davidge et al., 2009b).  
 
Another control compound used in this work and in published work (Clark et al., 2003; 
Santos-Silva et al., 2011) is iCORM-3. iCO-RM is a term used to indicate an inactive 
form of the compound, produced by prolonged incubation of the CO-RM in solvent or 
buffer to allow all labile CO to be released. However, our recent increased 
understanding of the mechanisms and triggers of CO release from ruthenium based CO-
RMs (ie. the need for a compound, such as dithionite, to be present (McLean et al., 
2013)), suggests that many iCO-RMs, particularly iCORM-3 may not have lost CO, but 
rather have formed a stable tricarbonyl structure (McLean et al., 2013) in which 
components of the buffer prevent CO loss from the compound, even when it is later 
exposed to dithionite in the myoglobin assay. A recent paper has provided the most 
detailed analysis to date of the global effects of iCORM-3 on the transcriptome of E. 
coli, and showed that, while this control compound caused a much smaller impact on 
gene expression than CORM-3, it still had some effects distinct from those of the active 
compound (McLean et al., 2013). For example, the transcription factor ArcA, which 
represses respiratory metabolism, was much less affected by iCORM-3 than CORM-3, 
whereas IscR, which is involved in the regulation of iron-sulfur cluster assembly, was 
affected similarly by CORM-3 and iCORM-3, suggesting that damage to iron-sulfur 
clusters could be a consequence of exposure to the ruthenium centre of CORM-3. This 
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work also revealed that ruthenium from iCORM-3 accumulates in cells approximately 
10-fold less than from CORM-3, which may explain why this compound has a smaller 
impact on bacterial cells (and perhaps mammalian cells, although this has not been 
demonstrated). An alternative explanation for the effects observed in cultures treated 
with iCORM-3 is that the causative agent is a small amount of CO that is released from 
this compound (iCORM-3 preparations typically release up to 5% of the CO compared 
to CORM-3). Despite the progress made in understanding the effects of this control 
compound, it is clear that our comprehension of its chemistry is far from complete, and 
so its use as a control poses more questions than it answers. 
 
The third control compound used in this work is termed miCORM-3 (myoglobin-
inactivated CORM-3 (Wilson et al., 2013). In many ways this is the best control 
compound as it has been exposed to biological molecules (myoglobin); however, 
although precautions were taken to use the minimum quantity of dithionite require to 
reduce the myoglobin used in the preparation of this control compound, it is possible 
that some remains in the final preparation, which is obviously not ideal. A possible 
solution to this would be to bubble the miCORM-3 solution with air prior to use in 
order to oxidise any residual dithionite, although this would still leave some residual 
species from the breakdown of dithionite in the solution. 
 
 Attempts to use myoglobin to inactivate other CO-RM compounds, such as CORM-
401, have been unsuccessful and, the best control available for this compound has been 
the suspected breakdown products of this CO-RM (MnSO4 and dithiocarbamate), 
however work is currently underway to use haemoglobin to biologically remove the CO 
from this CO-RM (Lauren Wareham, unpublished). 
 
Those working on the rational design of new CO-RMs are beginning to show awareness 
of the importance of the availability of well-characterised control compounds; for 
example new photoCO-RMs are in development that carry additional ligands for each 
labile CO. These are then able to replace CO group(s) following their release (Nagel 
and Schatzschneider, unpublished). This results in stable and well characterised 
breakdown products following intracellular CO release and such compounds can be 
synthesised separately and used as accurate control compounds. 
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As mentioned several times throughout this thesis, the discovery in 2012 that dithionite 
promotes CO release from CORM-2 and CORM-3 necessitates that several pieces of 
CO-RM dogma be reconsidered (McLean et al., 2013). A systematic assessment of the 
kinetics of CO entry into cells in the absence of dithionite has begun using the truncated 
globin Ctb from C. jejuni as a reporter when overexpressed in E. coli (Mariana Tinajero 
Trejo and Lauren Wareham, unpublished). This will provide important information as to 
the rate and amount of CO that is able to enter cells under native biological conditions 
from a range of CO-RMs. 
 
Furthering our understanding of CO-release kinetics and of the interactions of CO-RMs 
with bacterial cells could provide important information about the effects of these 
compounds on mammalian cells where they are hoped to have great potential as 
therapeutic agents. For example, the finding that the thiol compound NAC prevents the 
entry of ruthenium-containing CO-RMs into bacterial cells may have implications for 
mammalian CO-RM research, where the abrogation of the effects of CO-RMs by thiol 
compounds is also seen (Sawle et al., 2005; Taille et al., 2005). 
 
It will be important for the future use of CO-RMs as a treatment for bacterial infections 
to consider the effects of CO-RMs on bacteria within a host. Preliminary studies have 
already been done to investigate the effects of CORM-3 on the uptake and killing of 
Neisseria meningitidis in macrophages (Wilson, 2012). These studies found that 
CORM-3 had no significant effect on the ability of macrophages to phagacytose N. 
meningitidis, or to kill bacteria that had already been internalised. In contrast, the ability 
of macrophages to phagacytose P. aeruginosa is improved by CORM-3 (Desmard et al., 
2009), and the CO-RM ALF-186 is able to promote clearance of S. typhimurium in mice 
by promoting the bactericidal activities of macrophages (Onyiah et al., 2013). These 
results are interesting, because, as an anti-inflammatory agent, it could be expected that 
CO-RMs would supress the immune response to infection (Chin and Otterbein, 2009). 
 
7.3 Conclusions 
This thesis reports an investigation into the mechanisms by which CO-RMs affect the 
respiration and growth of bacteria. While several key findings have advanced our 
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understanding of these processes, there is still much work to be done in order for the 
mechanisms of the antibacterial activity of CO-RMs to be fully understood. 
 
When the antibacterial properties of CO-RMs first became apparent, they were 
considered to have great promise in the treatment of antibiotic-resistant infections, 
which pose a looming global crisis. However, it is becoming apparent that CO-RMs 
differ in their bactericidal properties; CORM-2 and CORM-3 have potent antimicrobial 
effects, while other CO-RMs may only transiently inhibit growth.  
 
One potential use of CO-RMs in the fight against antimicrobial infections is as an 
adjunctive or adjuvant treatment (Pena et al., 2012). Research in underway to 
investigate whether CO-RMs could be used in combination with established antibiotics 
in order to reduce the dose of antibiotic needed, or perhaps even potentiate the effects of 
antibiotics (Salar Ali and Robert Poole, unpublished). 
 
It seems unlikely that CORM-2 and CORM-3 would ever be suitable therapeutic agents 
to treat bacterial infections, due to the limitations of using a non-biological metal in 
such treatments. It will therefore be important to develop new CO-RMs which are 
potent antibacterial agents, and yet are not toxic to mammalian cells. This may be 
achieved through the use of biologically innocuous metals in place of ruthenium, or by 
modifications that allow the more precise targeting of these CO-RMs to prokaryotic 
cells. A thorough understanding of the mechanisms of action of each new CO-RM will 
be required in order to allow the rational design of therapeutically viable CO-RMs. 
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